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Abstract 
DNA methylation patterns are malleable and are modifiable by environmental 
factors, including diet. Folate (a water-soluble B vitamin) is a major methyl 
donor for methylation of DNA and other cellular macromolecules. Since 
patterns of DNA methylation are established early in embryonic and fetal life, 
I hypothesised that reduced maternal dietary folate intake would alter DNA 
methylation patterns and corresponding gene expression in the progeny. A 
second hypothesis was that maternal dietary folate intake would modify 
effects of later dietary exposures on DNA methylation, in particular effects of 
a high fat diet. Third, I hypothesised that loci where DNA methylation was 
affected by dietary folate in utero and / or by dietary fat would also show age-
related differences in DNA methylation and gene expression. 
 
This project aimed to investigate the effects of feeding a folate-depleted 
(0.4mg/kg) versus a folate adequate (2.0mg/kg) diet during pregnancy and 
lactation, and high fat (HF, 20%) versus low fat diet (LF, 5%) from weaning 
until 6 months of age on gene promoter methylation in offspring of C57BL/6J 
mice. DNA methylation at ten loci: Igf2-DMR1, Esr1, p16, Slc39a4-CGI1 & -
CGI2, Obfc2a-amp1, -amp2 & -amp3, and Ppm1k-amp1 & -amp2 was 
measured by Pyrosequencing in fetal gut tissue. In adult offspring, 
methylation and expression of this gene panel was quantified in the colon 
and proximal small intestine (prox SI). Finally, the impact of folate status and 
age on ESR1, OBFC2A and SLC39A4 methylation and expression was 
investigated using macroscopically normal human colon mucosal biopsies. 
 
In fetal mouse gut, there was no effect of maternal folate supply on 
methylation at any of the CpGs investigated in Esr1, p16, Igf2-DMR1, 
Slc39a4-CGI2 and Obfc2a. However, DNA methylation at Slc39a4-CGI1 and 
Ppm1k-amp1 were significantly lower in gut DNA from folate depleted mice 
(ANOVA, p<0.05). In adult offspring, methylation at Slc39a4-CGI1 was 
significantly lower in the prox SI from mice fed the HF diet (ANOVA, p<0.05, 
n=24 for LF, n=24 for HF diet). In contrast, methylation at p16, Obfc2a-amp1, 
Obfc2a-amp2, Ppm1k-amp1 and Ppm1k-amp2 was higher in the prox SI of 
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adult offspring fed the HF diet (p<0.05). HF feeding led to significantly lower 
expression of p16, Obfc2a and Ppm1k in the prox SI (p<0.05). For adult 
mouse colon, methylation at Esr1 and Obfc2a-amp2 was increased in those 
fed the HF diet whereas for Slc39a4-CGI1 and Slc39a4-CGI2, methylation 
was lowered in the HF group (p<0.005). And there was no detectable change 
in gene expression of this gene panel in colon as a result of HF feeding. In 
human colorectal mucosal biopsies, methylation of all 8 CpGs assayed in 
ESR1 was positively correlated with age (p<0.05, n=34) but there was no 
apparent age-related change in ESR1 expression (p>0.05).  
 
In summary, maternal folate depletion reduced methylation at Slc39a4 and 
Ppm1k in the murine fetal gut but this effect disappeared when mice were 
given the same folate supply from weaning. HF feeding altered methylation of 
Esr1, Slc39a4 and Obfc2a in adult mouse colon and Slc39a4, p16, Obfc2a, 
and Ppm1k in the prox SI. The effect of maternal folate depletion and HF 
feeding of offspring on DNA methylation appeared to be CpG, locus and 
tissue specific in mice. Expression of p16, Obfc2a and Ppm1k was lowered in 
the prox SI of HF fed mice. In the human colorectum, ESR1 methylation 
increased with age but there was no detectable effect on expression. 
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CHAPTER 1 
 
General Introduction 
 
1.1 Epigenetics  
1.1.1   DNA methylation 
Epigenetics was first defined by Conrad Waddington (1942) as the “interaction 
between genes and their products which bring phenotype into being”. A more 
recent description of epigenetics refers to a stably heritable phenotype 
resulting from changes in chromosomes that are not mediated by genotype 
(Psofaki et al, 2010). Epigenetic markings are inherited during mitosis and 
contribute to cellular development, differentiation, stress responses and 
pathology (Hanson et al, 2011; Cooney, 2009). In addition, some epigenetic 
marks can be inherited during meiosis (Sutherland et al, 2000) though that is 
not an essential prerequisite of an epigenetic mark. DNA methylation and post-
translational modifications of histones are two of the most studied and well 
known epigenetic phenomena (Gravina & Vijg, 2010; Rodriguez-Rodero et al, 
2010; Kahn & Fraga, 2009). Stable maintenance of DNA methylation and 
histone modifications patterns are essential for cell, tissue and organism 
functions (Esteller, 2008).  
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DNA methylation is one of the major epigenetic controls involved in the 
regulation of gene expression and maintenance of genomic stability; it is 
crucial during embryonic development and is involved in age-related diseases 
such as cancer (Bocock & Aagaard-Tillery, 2009; Jones & Baylin, 2002). In the 
embryonic pre-implantation period during mammalian development, the 
embryonic genome is progressively de-methylated. Re-methylation of DNA 
after implantation then leads to cell and tissue-specific methylation patterns 
being established (Kim et al, 2009; Reik et al, 2001). In contrast to 
unmodifiable genetic inheritance (the DNA sequence) which forms an 
organism’s heredity template, epigenetic patterns established during 
development are plastic and can be altered by environmental factors 
throughout life and during ageing (Bocock & Aagaard-Tillery, 2009; Bird, 
2007). This plasticity can be illustrated by the near identical epigenetic profiles 
of monozygotic twins at birth, which diverge progressively with time so that 
such individuals within pairs of twins acquire significantly different genomic 
DNA methylation and histone acetylation patterns and varied phenotypes in 
later life (Poulsen et al, 2007; Fraga et al, 2005).  
In mammals, DNA methylation occurs when a methyl-group (-CH3) is donated 
by S-adenosyl methionine (SAM) to the carbon five position of a cytosine 
pyrimidine ring, catalysed by DNA methyl-transferases (Dnmts) to form 5-
methylcytosine (Fig 1.1). The Dnmt substrate is the cytosine phosphate-
guanine dinucleotide (CpG site), and approximately 80% of CpG sites are 
methylated across the genome in healthy mammalian tissues (Choi et al, 2009; 
Mathers & Ford, 2009). CpG dinucleotides cluster at the 5’ regulatory region 
of approximately 70% of human genes, forming what are known as CpG 
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islands (CGIs). CGIs are typically un-methylated when they are found at the 
promoter regions of housekeeping genes (Sedivy et al, 2008; Bird, 1986).   
In general, when CGIs in promoters are methylated, transcription of the 
corresponding gene is halted and subsequently gene expression is down-
regulated, with the potential for effects on essential cell functions (Calvanese 
et al, 2009; Qiu, 2006). On the other hand, methylation of gene bodies can 
activate transcription (Zeybel et al, 2013). Gene-specific DNA hyper-
methylation has been reported in mammalian ageing (Sedivy et al, 2008). 
Moreover, CGIs in some genes for example tissue and germline specific 
genes, imprinted genes and genes that undergo X-chromosome inactivation 
in females are usually highly methylated (Hall et al, 2014; Reik, 2007).  
 
 
Figure 1.1  During DNA methylation a methyl group (-CH3) is added to 
a cytosine residue catalysed by methyltransferases to form 5-
methylcytosine   
(source from: http://helicase.pbworks.com/w/page/17605615/DNA%20Methylation) 
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1.1.1.1  DNA methyltransferases  
DNA methyltransferase (Dnmt) was first recognised in 1983 by Bestor et al 
using mouse erythro-leukaemia cells. These authors discovered that Dnmts 
had a strong preference for methylation of hemimethylated sites and 
suggested that binding to DNA, followed by one-dimensional diffusion of 
enzyme along the DNA molecule, is important in the mechanism by which DNA 
methyltransferase locates its recognition sites. It is now recognised that 
methyltransferases have a methylation maintenance role following DNA 
replication in ensuring that the newly-synthesised DNA strand has a 
complementary methylation pattern to that of the parental strand and thus 
contributes to the preservation of genome stability (Jones & Liang, 2009). In 
mouse, there are four types of Dnmts – Dnmt1, Dnmt2, Dnmt3A/B, and 
Dnmt3L (shown in Fig 1.2, reviewed in Goll & Bestor, 2005).  
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Figure 1.2   The four types of methyltransferases in mouse based on 
sequence homologues within catalytic domains (adapted from Goll & 
Bestor, 2005) AA = amino acids, BAH = bromo-adjacent homology domains, 
cys-rich = cysteine-rich region 
 
 
 
 
The Dnmt1 protein consists of 1620 amino acids (AA) residues with a C-
terminal domain of around 500 AA. It consists of two bromo-adjacent homology 
(BAH) domains that are common in proteins involved in chromatin regulation 
and can function as a protein-protein interaction module. The cysteine-rich 
region of Dnmt1 binds zinc ions but the function of this region is not clear (Fig 
1.2, Goll & Bestor, 2005). The catalytic methyltransferase domain in Dnmt1 
has a preference to bind hemimethylated CpGs (Fatemi et al, 2001). Dnmt1 is 
considered to operate as the primary maintenance Dnmt after DNA replication 
and is responsible for the transfer of parental methylation patterns to daughter 
cells. Dnmts also act alongside DNA damage repair pathways for the 
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protection of cells from mutagenic events (as reviewed in Jin & Robertson, 
2013).  
Dnmt2 is the most conserved and commonly dispersed methyltransferase and 
is distinctive due to the absence of N-terminal extensions. Whilst its sequence 
and structure deemed Dnmt2 to be a likely methyltransferase, no biochemical 
functions for Dnmt2 have been reported. Furthermore, mice with Dnmt2 
deletions appeared to have normal genomic and methylation phenotypes (Goll 
& Bestor, 2005).  
Dnmt3A and Dnmt3B act as de novo enzymes for the methylation of 
completely unmethylated CpG sites. It is believed these two Dnmts have a role 
in the establishment of DNA methylation patterns, epigenetic remodelling and 
reprogramming during differentiation in mammalian development (Crider et al, 
2012). Both Dnmt3A and 3B proteins contain a C-terminal catalytic domain, a 
N-terminal regulatory region and a PWWP domain (Chen et al, 2004). The 
PWWP domain comprises a highly conserved proline-tryptophan-tryptophan-
proline motif which is present in several chromatin associated proteins, 
especially in pericentric heterochromatin (Fig 1.2, Goll & Bestor, 2005; Chen 
et al, 2004) but its function remains uncertain.  
DNA methyltransferase 3-like (Dnmt3L) is expressed exclusively in germ cells. 
Dnmt3L consists of a cysteine-rich domain, and its N- and C-terminal domains 
are similar to those of Dnmt3A and 3B but without the PWWP domain (Fig 1.2). 
Dnmt3L is required for the establishment of germ cell patterns in both sexes, 
though no methyltransferase activity has been reported for the Dnmt3L protein 
(Goll & Bestor, 2005). Although Dnmt3L itself is catalytically inactive, it is 
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essential for the function of Dnmt3A and Dnmt3B and activates these proteins 
by binding to their catalytic domain (GeneCards, 2014). 
 
1.1.2   Post-translational histone modifications 
Within each cell nucleus, there are two copies of each of the four histone 
proteins (H3 & H4 and H2A & H2B respectively) forming an octameric histone 
core called a nucleosome. Each nucleosome of globular proteins is wrapped 
around by 146 bp of double-stranded DNA and linked together by a small 
section of DNA and a copy of histone linker H1. Nucleosomes are essential in 
DNA organisation and the storage of organism’s genetic information in a 
usable form (Peterson & Laniel, 2004). Highly conserved N-terminal histone 
tails overhang from the globular core and these amino acid residues are post-
translationally (PT) modified by several enzymes. Acetylation and methylation 
are two of the most well studied PT histone modifications, followed by 
phosphorylation and ubiquitination. For example, arginine residues can be 
methylated, serine residues can be phosphorylated while lysine can be 
methylated, acetylated or ubiquitinated (Kouzarides, 2007).  
Histone acetyltransferases (HATs) and histone deacetylases (HDACs) are 
enzymes that can add and remove respectively acetyl groups from histone 
tails. When lysine residues are acetylated by HAT, this neutralises the positive 
charge on the lysine residues which causes relaxation of DNA wrapped around 
histones and makes it relatively more accessible to the transcriptional 
machinery. For this reason, acetylation is often associated with active gene 
transcription (Fig 1.3). On the other hand, when deacetylation of lysine 
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residues is catalysed by HDACs, DNA is more tightly wrapped around the 
histones, rendering the DNA inaccessible for transcription (reviewed in 
Beaujean, 2014; Peterson & Laniel, 2004). At any given amino acid residue, 
histone proteins, can be single (mono-) or multiple (di- or tri-) methylated 
depending on the specific amino acid residue. For example, lysine residues 
can be methylated with up to 3 methyl groups. The modification of H3K4me 
(H3 lysine 4 {this number denotes the position of lysine in the N-terminal tail} 
mono-methylation) is associated with gene expression while H3K9me3 (H3 
lysine 9 tri-methylation) is associated with repressed gene expression 
(Kouzarides, 2007).  
Similar to acetylation, histone phosphorylation is often associated with active 
gene transcription. Furthermore, when DNA is damaged by e.g. double strand 
breaks, phosphorylation of the histone variant H2AX occurs and this may be a 
useful marker for assessing DNA damage (Sharma et al, 2012). In some 
cases, phosphorylation of the same histone can have opposite biological 
functions under different circumstances. During the interphase in yeast and 
humans, histone H3 phosphorylation at Ser10 (H3S10P) acts as a modified 
active transcription site, while during chromosome condensation in mouse 
fibroblasts, the action of H3S10P is reversed (Kouzarides, 2007). In contrast 
to histone phosphorylation, ubiquitination of H2A histone is associated with 
repressed transcription of chromatin regions during meiosis in mouse 
(Baarends et al, 2005).  
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Figure 1.3  Acetylation of histones causes relaxation of DNA and allows 
active gene transcription (adapted from: http://helicase.pbworks.com) 
    
 
 
 
1.1.3   Non-coding RNAs 
Non-coding ribonucleic acids (ncRNAs) are a relatively recent addition to the 
known repertoire of epigenetics marks and molecules. They are a collection of 
RNA molecules which do not encode protein products and which have been 
classified into two major groups – small and long non-coding RNAs (Toiyama 
et al, 2014). Small ncRNAs cause post-transcriptional gene silencing in a wide 
range of species including yeast, worms, flies and mice. There are three types 
of small ncRNAs that target mRNA transcripts in the cytoplasm and thus can 
interfere with gene expression (Bourc’his & Voinnet 2010). They are:  
 small interfering RNAs (siRNAs),  
 PIWI-interacting RNAs (piRNAs) and  
 microRNAs (miRNAs)  
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RNA interference (RNAi) is a sequence-specific process that causes post-
transcriptional gene repression in plants and animals and both siRNAs and 
piRNAs have been implicated in this process (Castel & Martienssen, 2013). 
SiRNAs are endogenous double-stranded small ncRNAs that are between 20 
to 25 nucleotides in length, and are one of the facilitators of the RNAi process 
(Elbashir et al, 2001). They are cleaved from long double-stranded and small 
hairpin RNAs catalysed by a ribonuclease-III like enzyme called Dicer. 
Interestingly, Li et al (2006) identified various siRNA that can target non-
regulatory regions in specific gene promoters and initiate expression of these 
genes in human cell lines and this suggests small RNA molecules have diverse 
effects on gene regulation.   
Like siRNAs, piRNAs are short ncRNAs that are mostly 24 to 32 nucleotides 
long and have a role in transcriptional gene repression. They are the most 
abundant small ncRNAs and are encoded in the germ line of numerous 
mammalian species in clusters of piRNA-induced silencing complex (piRISC) 
(Siomi et al, 2011). The main role for piRISC is in protecting the integrity of the 
genome from invasion by transposable elements — often referred to as 
'genomic parasites' — by silencing them (Siomi et al, 2011). piRNAs appear to 
have multiple roles in gene regulation through involvement in re-arrangement 
of DNA, mRNA turnover and translation in both germline and somatic cells 
(reviewed in Ku & Lin, 2014).  
The human genome encodes at least 1000 microRNA which are small ncRNAs 
approximately 22 nucleotides long (Costa, 2008; Lee et al, 2004). They are the 
most well studied and understood group of ncRNAs and, through repression 
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of expression of approximately 30% of all genes, play an important role in most 
cell functions (reviewed in Esquela-Kerscher & Slack, 2006). Dysregulated 
gene expression through altered microRNA expression appears to contribute 
to the biology of ageing (reviewed in Jung & Suh, 2012). Several miRNAs 
including miRNA-7, miRNA-14 and miRNA-21 has been implicated in 
pathways involved in longevity including the insulin/IGF1, DAF-12 and TOR 
signalling pathways in worms (reviewed in Grillari and Grillari-Voglauer et al, 
2010). The fact that one single miRNA can regulates expression of several 
genes by targeting and binding to the corresponding mRNA transcripts renders 
them appealing as potential therapeutic targets. For this reason, miRNAs have 
been suggested as prospective diagnostic biomarkers for gastric and 
colorectal cancers (Toiyama et al, 2014).  
To date, several thousands of long ncRNAs have been identified. They are 
abundant in the nucleus where they are involved in multiple biological functions 
including nuclear organisation and gene regulation (reviewed in Quinodoz & 
Guttman 2014). For example, long ncRNAs have a critical role during 
embryonic development (Ulitsky et al, 2011), are cardioprotective (Han et al, 
2014), and are vital downstream targets and regulators in human T cell acute 
lymphoblastic leukaemia (Trimarchi et al, 2014). Long ncRNAs exist in clusters 
within intergenic regions of the genome and may be transcribed similarly to 
mRNAs (Guttman et al, 2009). For this reason, the majority of studies on long 
ncRNA concentrate on their function in gene regulation. Various long ncRNAs 
has been shown to recruit regulatory proteins within chromatin to specific DNA 
binding sites for gene expression. Although numerous long ncRNAs have been 
implicated in the organisation of nuclear structures, how they regulate 
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nucleosome remodelling is still not clear (Quinodoz & Guttman 2014, Han et 
al, 2014).    
 
 
1.2 Epidemiology, biology and theories of ageing 
1.2.1  Epidemiology of ageing  
In most countries worldwide, life expectancy is increasing year on year and 
contributes substantially to increased population numbers. For example, in the 
United States (U.S.) the total number of people aged 85 years and over has 
increased from around 100,000 in 1900 to 5.3 million in 2006, and is expected 
to rise to approximately 21 million by 2050 (Federal Interagency Forum, 2008). 
Current data from the World Health Organisation (2014) show that in the 
United Kingdom (U.K.), life expectancy at birth in 2012 was 81 years (for both 
sexes) compared to 78 and 76 years in 2000 and 1990 respectively. The most 
likely reasons for this increase in life expectancy are: 
 improved knowledge in medicine and disease prevention 
 better quality of health and social care 
 improved income and living conditions  
As each individual ages, the risk of acquiring one or more chronic age-related 
diseases increases and there is consequently increased financial burden on 
the health care system (Federal Interagency Forum, 2008). Ageing is the major 
factor in the progressive decline in physiological functions and therefore has a 
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major role in the development of several degenerative diseases such as 
Alzheimer’s disease, coronary heart diseases and most cancers. Ageing may 
have a negative impact on quality of life and contributes to increased mortality 
(Mathers, 2015). However, there is considerable inter-individual variation in 
risk of age-related disease and in life expectancy (Falandry et al, 2014).  
Both genetic and environmental factors contribute to the ageing process and 
to the risk of developing age-related disorders, with approximately 25% of the 
variation in life expectancy can be accounted for by hereditary factors 
(Kirkwood, 2008). For example, the APOE 4 allele is a major genetic risk factor 
for both Alzheimer’s and cardiovascular disease (Rondina et al, 2014; Delaney 
et al, 2013). Lifestyle factors notably smoking behaviour, diet and physical 
activity modulate the ageing process and contribute to the risk of poorer health 
in later life. For example, obesity (due to poor diet and / or inadequate physical 
activity) is a strong determinant of mortality risk (Prospective Studies 
Collaboration, 2009). Dietary patterns influence ageing and the risk of age-
related diseases and there is substantial evidence that regular consumption of 
foods from the Mediterranean dietary pattern lowers the risk of both cognitive 
impairment and Alzheimer’s disease (Feart et al, 2015) and cardiovascular 
disease (Richter et al, 2014; Estruch et al, 2013). In the case of colorectal 
cancer, nutritional factors such as low dietary fibre intake (Aune et al, 2011), 
high intake of red and processed meat (Chan et al, 2011) and sedentary 
lifestyle have been suggested as major contributors to higher occurrence 
(Mehta & Shike, 2014). 
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1.2.2  Biology and theories of ageing 
Progressive accumulation of damage to macromolecules in the cell can lead 
to functional decline over time and contributes to the ageing phenotype 
(Mathers, 2015). López-Otín et al (2013) proposed the nine candidate 
hallmarks of ageing grouped under three categories. They are:  
- primary hallmarks, these are the primary causes of cellular damage 
including genomic instability, telomere attrition, epigenetic alterations 
and loss of proteostasis, 
- antagonistic hallmarks are response mechanisms which counteract 
cellular damage that consists of deregulated nutrient-sensing, 
mitochondrial dysfunction and cellular senescence, 
- integrative hallmarks such as stem cell exhaustion and altered 
intercellular communication arise as a consequence of the primary and 
antagonistic hallmarks and eventually contributed to the ageing 
phenotype (as shown in Fig 1.4). 
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Figure 1.4  Nine hallmarks of ageing as proposed by López-Otín et al 
(2013) 
 
 
 
 
All four primary hallmarks of ageing are harmful initiators and have undesirable 
effects in the organism, whereas the antagonistic hallmarks can have either 
beneficial or detrimental effects depending on the level and duration of 
response generated (López-Otín et al, 2013). For example, cellular 
senescence describes the accumulation of damage at molecules which leads 
to deterioration of cellular function and, eventually, to irreversible cell cycle 
arrest and ultimately ageing (Hayflick, 1965). However, at low intensity, 
senescence is a protective mechanism against carcinogenesis (López-Otín et 
al, 2013). Similarly, reactive oxygen species (ROS) may have anti-oncogenic 
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properties by inducing senescence and apoptosis in cells. On the other hand, 
high levels of ROS sustained over longer time periods can cause cell damage 
and may contribute to carcinogenesis (Valko et al, 2006). Integrative hallmarks 
occur when the cell’s capacity to repair damage is exceeded and restoration 
of homeostasis is not achieved, especially in stem cells which are vital for the 
preservation of normal somatic cells (Mathers, 2015; López-Otín et al, 2013).    
Many ageing theories have been proposed to explain the biological processes 
involved in ageing at the cellular and molecular level. The mitochondrial free 
radical theory of ageing, which was first proposed by Harman (1956), suggests 
that organismal ageing is a consequence of ROS generation and, thus 
oxidative damage, in the mitochondria. It was suggested that to delay ageing, 
ROS must be scavenged at the cellular level. However, recent evidence 
suggests that ROS are not direct causes of the molecular damage observed 
in ageing and, instead, ROS function as signalling molecules to induce a pro-
survival adaptive response (Liu et al, 2014).  
Recently, Trindade et al (2013) suggested the categorisation of evolutionary 
theories of ageing into four groups: Secondary (beneficial), Maladaptive 
(neutral), Assisted death (detrimental), and Senemorphic (fluctuates between 
beneficial to detrimental). Examples of ageing theories and mechanisms for 
each theoretical classification are listed in Table 1.1 
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Table 1.1  A classification of evolutionary ageing theories proposed by 
Trindade et al (2013), with potential mechanisms involved and examples 
shown within each category 
Theory group 
Longevity inhibiting 
process 
Examples of ageing 
theories 
Secondary 
- Reproduction trade off 
- Pleiotropy  
 
- Disposable soma  
- Antagonistic 
pleiotropy 
Maladaptive 
- Mutational load & 
genetic drift 
- Genetic linkage 
 
- Mutation 
accumulation 
- Somatic damage 
Assisted death 
- Reduced ability of 
protection & repair 
- Programmed instability & 
death 
- Demographic control 
- Increase variability 
Senemorphic  Consists of various 
processes & mechanisms 
- Germ-soma conflict 
- Senomorphic ageing 
 
 
One example of the secondary theory is the antagonistic pleiotropy proposed 
by Williams (1957). This theory assumes longevity is limited as a trade-off for 
speedier reproduction. As illustrated in Fig 1.5 A, a fitter individual (F) produces 
two offspring within a certain duration of time (t) and in double the amount of 
time (2t), individual F has produced four offspring. Although this speedy 
reproduction is beneficial for species and / or organism survival, it did not 
allows organism enough time to recover and regenerate (shown in curly arrow 
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with red cross) and therefore has an effect on homeostasis in later life (jagged 
edges and non-green colour on individual F). On the other hand, a relatively 
slower reproducing individual (S) is capable of regeneration (shown in curly 
arrow without red cross), and has less damage to the body (without jagged 
edges and green colour). However, individual S only produced two offspring 
within the duration of 2t compared to four in individual F (Trindade et al, 2013).  
 
Figure 1.5  Examples of secondary ageing theories: A) Antagonistic 
Pleiotropy and B) Disposable Soma (figure obtained from Trindade et al, 
2013) 
 
 
 
Another example of the secondary theory is the disposable soma theory 
proposed by Kirkwood and Holliday (1979). This theory proposes that both the 
maintenance of somatic cells and organismal reproduction involve substantial 
expenditure of energy and other resources. To enhance reproductive success, 
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energy and resources are prioritised at the expense of somatic maintenance 
and regeneration of cells, thus longevity is secondary to reproduction of the 
next generation. As shown in Fig 1.5 B, the fitter individual F utilises relatively 
more of the available energy (and other resources) for the production of more 
offspring (in this case, two offspring). As a result, less energy is reserved for 
the regeneration and maintenance hence body homeostasis is not optimised 
for individual F. Therefore, over time, individual F will accumulates more 
cellular damage compared with individual S. However, because individual S 
produces only one offspring and has more energy available for the 
maintenance of somatic cells, there is less damage to the body in later life 
(Trindade et al, 2013).    
Under the maladaptive ageing theory group, senescence is the major influence 
on longevity in the wild. Rattan (2006) concluded that ageing is a multi-factorial 
process and this idea is similar to the senemorphic ageing theory category 
proposed by Trindade et al (2013). There is a growing consensus that 
organismal ageing results from the accumulation of damage to all the cell 
macromolecules including DNA mutations, mis-folding of proteins and lipid 
oxidation (Kirkwood, 2008).  
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1.3  Ageing and Epigenetics 
Ageing is a complex progressive physiological decline process that involves 
multiple contributors. In addition to each individual’s genetic background, 
which explains approximately 25% of the inter-person variance in lifespan, 
epigenetic mechanisms also play a role in the ageing process and may have 
an effect on an organism’s lifespan (Progribny & Vanyushin, 2010; Kahn & 
Fraga, 2009; Mathers, 2006). Epigenetic marks such as aberrant DNA 
methylation patterns (Maegawa et al, 2010), altered post-translational 
modification of histones (López-Otín et al, 2013) and micro-RNA expression 
(Jung & Suh, 2012) have been implicated in ageing. Sedivy et al (2008) stated 
that although it is not clear whether age-related aberrant gene expression is 
caused entirely by epigenetic changes or by the accumulation of DNA damage 
over time, and that the functional significance of age-related epigenetic 
modifications remains unclear, it is reasonable to consider relaxation of 
epigenetic control as one of the main contributors to these changes during 
ageing and to the related physiological decline and pathological phenotypes. 
The possible role of genomic and gene-specific DNA methylation during 
ageing and age-related diseases is discussed below.  
 
1.3.1   Genomic DNA hypo-methylation during ageing and in age-
related diseases  
Vanyushin et al (1973) investigated 5-methylcytosine content in several 
tissues from different animal species and observed that 5-methylcytosine 
content in cells decreased with age. Other studies have also reported genomic 
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DNA hypo-methylation in ageing cells and tissues (Pogribny & Vanyushin, 
2010). Since ageing is one of the main features of cancer, it is relevant to note 
that genome-wide global DNA hypo-methylation has also been reported in 
cancer (Eden et al, 2003; Gaudet et al, 2003).  
Global DNA methylation refers to the density of methylated cytosines relative 
to total cytosines in the genome and direct assessment of global DNA 
methylation can be made using chromatographic approaches e.g. high 
performance liquid chromatography (HPLC) and mass spectrometry. 
However, in most of the literature, surrogate measures of global DNA 
methylation have been used including methylation of common repetitive 
elements in DNA (Lisanti et al, 2013). Recent work from this laboratory 
concluded that the gold standard measurement of global DNA methylation by 
HPLC could not be substituted with confidence by any of the surrogate assays 
for detecting global DNA methylation but that the LINE-1 assay seemed likely 
to be an acceptable surrogate in many cases (Lisanti et al, 2013).  
Hypo-methylation of repetitive sequence elements (Alu element {Alu}, long 
interspersed nucleotide element-1 {LINE-1} and satellite-α {SAT-α}, which 
represent 17, 11 and 4% of the genome respectively) has been reported during 
ageing and in various cancers in humans (Li et al, 2014; Kamiyama et al, 2012; 
Hansen et al, 2011; Jones & Baylin, 2007). For example, in sporadic colorectal 
cancers, global methylation is 30% lower than normal colorectal tissues, and 
LINE-1 hypo-methylation was found in eight out of nine gastric tumours 
(reviewed in Wilson et al, 2007). 
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1.3.2  Locus-specific DNA methylation and gene expression 
during ageing and in age-related diseases 
The intricate association between DNA methylation and ageing is likely to be 
multi-factorial. Whereas global DNA hypo-methylation has been reported with 
increasing age, hyper-methylation of gene specific promoter DNA methylation 
during ageing and cancer has also been documented (López-Otín et al, 2013).  
Hyper-methylation of tumour suppressor genes was observed in old compared 
to young mouse intestine (Maegawa et al, 2010). There has been suggestion 
that changes in DNA methylation patterns with age could play a part in the 
mutation process (Waki et al, 2003). Promoter hyper-methylation of DNA 
repair genes can lead to increased DNA damage and genomic instability. For 
example, hyper-methylation of CGI within the MutL homologue 1 (MLH1) 
promoter caused inactivation of this gene and consequently microsatellite 
instability. Silencing of the O6-methylguanine DNA methyltransferase (MGMT) 
gene as a result of promoter hyper-methylation enhanced G → A mutations 
(reviewed in Jones & Baylin, 2002). Methylation of five genes (EPHA10, 
HAND2, HOXD4, TUSC3 and TWIST2) in peripheral blood leukocytes were 
significantly increased in four different life stages (newborns → young adults 
→ adults → old age, median ages 0, 27, 50 & 85 years respectively). 
Furthermore, higher CGI methylation of this gene panel was also observed in 
haematological malignancies such as leukaemia and lymphoma (Gautrey et 
al, 2014). 
Epigenetic alterations during tumourigenesis have been studied in a variety of 
cancers. Using DNA from more than 600 primary tumour samples in 15 tumour 
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groups, gene-specific promoter methylation was investigated in twelve 
candidate genes that are involved in DNA repair (hMLH1, GSTP1 & MGMT), 
tumour suppression (p14, p15, p16, p73, APC & BRCA1) and have oncogenic 
functions (CDH1, DAPK & TIMP3). Hyper-methylation of p16, p14, MGMT, 
APC and hMLH1 was found in gastrointestinal tumours, while increased 
methylation of p16, DAPK and MGMT was present in head, neck and lung 
carcinomas (Esteller et al, 2001). Hyper-methylation of tumour-related genes 
including APC, p14, p16, RASSF1, RARB and RUNX3 were found in 
oesophageal squamous cell carcinoma (ESCC), with APC methylation 
significantly associated with size and stage of ESCC. Moreover, APC and 
RASSF1 hyper-methylation was associated with poorer overall survival in 
ESCC patients. Given the fact that global hypo-methylation and hyper-
methylation of this panel of tumour-related genes was found in ESCC, and in 
general ESCC patients have a poor survival rate, it has been suggested as a 
combined prognostic tool in the management of ESCC cases (Hoshimoto et 
al, 2014).  
Age-associated promoter hyper-methylation at CpG islands of cell cycle 
regulation genes, tumour suppressor and DNA repair genes has been 
frequently reported in early colon neoplasm but their contribution to disease 
progression remains unclear (Gravina & Vijg, 2010; Psofaki et al, 2010; Sedivy 
et al, 2008). Hyper-methylation of MYOD1 and ESR1 was found in distal 
compared with proximal colon mucosa from healthy subjects, and the ESR1 
promoter hyper-methylation status found in the distal colon was positively 
correlated with age and was associated with decreased ESR1 mRNA 
expression. Interestingly, ESR1 hypo-methylation has been found in normal 
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distal colon mucosa that contained advanced polyps (larger than 2 cm and with 
high grade dysplasia) compared with the same tissue without polyps. These 
observations suggest that low ESR1 methylation could be associated with the 
initiation and progression of colorectal carcinogenesis in the distal colon (Horii 
et al, 2008). This finding is in contrast with the current belief that, in general, 
locus-specific hyper-methylation is associated with ageing and age-related 
diseases. ESR1 hyper-methylation has been reported in numerous cancers 
including hepatocellular (Dai et al, 2014; Hishida et al, 2013) and breast cancer 
(Prabhu et al, 2012; Zhao et al, 2009). Since no correlation was observed 
between ESR1 methylation and colorectal neoplasm in the proximal colon 
(Horii et al, 2008), the association between gene-specific methylation and 
progression of cancer may be tissue and location specific.  
Generally, DNA hyper-methylation at gene promoter regions correlates with 
repressed transcription and thus gene silencing (Akintola & Parrish, 2010). In 
contrast with global cytosine hypo-methylation during ageing, DNA hyper-
methylation at promoters of specific loci – such as Esr1, Igf2 and p16 - has 
been reported in various non-tumourigenic tissues during ageing (So et al, 
2006; Kim et al, 2005; Kondo & Issa, 2004; Issa et al, 1996; Issa et al, 1994). 
The effect of age on DNA methylation of these three specific genes will be 
discussed in detail in Chapter 3.1.1 to 3.1.3 
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1.4  Folate and its role in nutrition and health 
1.4.1  Folate in foods and folic acid 
Folate is a water-soluble B vitamin, also known as vitamin B9, which is found 
naturally in a variety of foods including dark green vegetables, liver, yeast 
extract, some fruits, nuts, legumes and dairy products (everyday foods high in 
folate are listed in Table 1.2).  
 
Table 1.2  A selection of foods that are naturally rich in folate (adapted 
from the National Institutes of Health, 2012) 
Name of food and quantity per serving µg folate per serving 
Cooked Liver, 85g 215 
Boiled spinach, 90g 131 
Cooked black-eyed peas, 86g 105 
Boiled Asparagus, 4 spears 89 
Boiled brussels sprouts (frozen), 78g 78 
Shredded romaine lettuce, 47g 64 
Sliced avocado, 73g 59 
Raw spinach, 116g 58 
Cooked Broccoli (frozen), 78g  52 
Boiled peas (frozen), 70g 47 
Orange juice, 45g 35 
1 medium banana 24 
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Folic acid is a synthetic form of folate, which is used widely in dietary 
supplements and in folate-fortified foods such as flour and breakfast cereals. 
The bioavailability of folic acid is at least 85% while for dietary folate it is around 
50% (National Institutes of Health, 2012). The Food and Nutrition Board in the 
United States has defined the following: 
 1µg dietary folate equivalents (DFE) = 1µg of dietary folate 
 1µg DFE = 0.6µg FA from fortified food/supplements taken with food 
 1µg DFE = 0.5µg FA from supplements taken on empty stomach.  
 
1.4.2  Overview of folate metabolism and its involvement in DNA 
methylation 
Folate is essential for numerous cellular mechanisms including DNA synthesis, 
DNA repair, cell division and cell production (Barua et al, 2014). Dietary folate 
is metabolised into 5-methyltetrahydrofolate (5-MTHF) in the intestine and / or 
liver before it is polyglutamated for cellular retention (Lamprecht & Lipkin, 
2003). Folic acid consists of a hetero-bicyclic pteridine ring, para-
aminobenzoic acid and glutamic acid (Bourassa & Tajmir-Riahi, 2015, as 
shown in Fig 1.6), and is transported into cells by the reduced folate carrier, 
the proton-coupled folate transporter (PCFT) and folate receptors. In cells, it is 
reduced to dihydrofolate (DHF) and subsequently tetrahydrofolate (THF) 
(Zhao et al, 2009a).  
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Figure 1.6  Chemical structure of folic acid (from Bourassa & Tajmir-
Riahi, 2015) 
 
 
 
 
Evidence from rodent studies suggest folic acid is converted first into 5-MTHF 
in intestinal mucosa and transported via the hepatic portal vein before further 
metabolism in the same way as dietary folate (Tani & Iwai, 1983). Under the 
action of DHF reductase (DHFR), 5-MTHF is reduced to DHF and 
consequently to THF. However, data from humans indicate that the expected 
increase in 5-MTHF in the hepatic portal vein after folic acid ingestion does not 
occur (Wright et al, 2007). Furthermore, DHFR activity in human liver is 
significantly reduced and is more variable compared with rats which results in 
unmetabolised folic acid appearing in plasma and urine (Bailey & Ayling, 
2009). This is in consensus with recent finding from Patanwala et al (2014) 
that folic acid supplementation enters into the human hepatic portal venous 
circulation largely unreduced and the low 5-MTHF content in human mucosal 
cells is most likely due to insufficient DHFR activity in enterocytes.    
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As illustrated in Fig 1.7, in human gut, both folic acid and the 5-
formyltetrahydrofolic acid (5-FormylTHF) enter mucosal cells from gut lumen 
via PCFT with a similar affinity (shown in blue arrow with identical weight). In 
the presence of DHFR, folic acid is biotransformed into THF and then 5-MTHF 
before being transport out into the hepatic portal vein. This is similar for 5-
FormylTHF although the transformation into 5-MTHF is less efficient in the 
case of folic acid (shown in blue arrow with a lighter weight) (Patanwala et al, 
2014). Expression of multidrug resistance protein 3 (MRP3) in the mucosal 
membrane suggests it might have a role in the movement of folate out of 
mucosal cells (Zhao et al, 2009a). This means of transport is more efficient for 
the reduced tetrahydrofolate (shown by the blue arrow in heavier weight) (Zeng 
et al, 2001). As a result, approximately double amount of labelled folate was 
found in the portal vein after 5-FormylTHF than after folic acid ingestion 
(Patanwala et al, 2014). 
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Figure 1.7  Folic acid handling in the human gut lumen, its metabolism 
in mucosal cells and possible transport mechanism into the hepatic 
portal vein (taken from Patanwala et al (2014), PCFT=proton-coupled folate 
transporter, DHFR=dihydrofolate reductase, THF=tetrahydrofolate, 5-
MTHF=5-methyltetrahydrofolic acid, 5-FormyTHF=5-formyltetrahydrofolic 
acid, MRP3=multidrug resistance protein 3) 
 
 
 
 
Folate is a key intermediate in the 1-carbon cycle and is responsible for the 
synthesis of the universal methyl donor S-adenosyl methionione (SAM), which 
is essential for DNA methylation. During the 1-carbon cycle, folate acts as a 
co-enzyme and is reduced to 5,10-methyltetrahydrofolate (5,10-MTHF) and 
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subsequently 5-MTHF, whereas homocysteine is recycled back to methionine 
and acts as the precursor of SAM – the major methyl donor involved in DNA 
methylation catalysed by DNMTs (as shown in Fig. 1.8) (Crider et al, 2012; 
Kim, 2005). Hence sub-optimal dietary folate intake can affect DNA 
methylation. 
 
Figure 1.8  Simplified schematic diagram of Folate / Folic acid 
Metabolism (source from: Crider et al 2012) 
 
 
 
Note: DHF = dihydrofolate, DHFR = dihydrofolate reductase, DNMT = DNA 
methyltransferase, dTMP = thymidylate, dUMP = deoxyuridine monophosphate, MS 
= methionine synthase, MTHFR = methylene tetrahydrofolate reductase, SAH = S-
adenosylhomocysteine, SAM = S-adenosylmethionine, SHMT = serine 
hydroxymethyltransferase, THF = Tetrahydrofolate, TS = thymidylate synthase 
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1.4.3  Folate and neural tube defects 
Inadequate folate intake at conception and during the first weeks of human 
pregnancy increases the risk of neural tube defects (NTD), especially spina 
bifida, which is due to failure of neural tube closure in the foetus (SACN, 2006). 
NTD is apparent in the human foetus between 21-28 days after conception. 
Epidemiological studies revealed worldwide prevalence of NTD varies 
between 1 to 10 in every 1000 births or established pregnancies (Au et al, 
2010). Since the 1990s, there were approximately 550-630 reported cases of 
pregnancies affected by NTD in the UK every year (SACN, 2006). Carefully-
conducted randomised controlled trials (RCTs) in the UK and elsewhere 
showed that supplement of folic acid before, and in early pregnancy, reduced 
the risk of NTD in women with low, normal and high risk (Berry et al, 1999; 
Czeizel & Dudás, 1992; MRC Vitamin Study Research Group, 1991). To 
reduce the incidence of NTD, mandatory folic acid fortification of cereals and 
grains was introduced in 1998 in the U.S. Following the introduction of the folic 
acid fortification program, NTD rates fell rapidly (De Wals et al, 2007). This 
programme has significantly increased the folate status of the population 
(Pfeiffer et al, 2005) and has reduced the number of NTD affected pregnancies 
in the U.S. to around 3,000 cases every year (Centers for Disease Control and 
Prevention, 2014).  
The current UK recommendations for folate intake for adults and pregnant 
women are listed in Table 1.3, with a general guidance of 1mg/day as the 
tolerable upper limit for the population with the exception of pregnant women 
who had previous history of NTD-affected pregnancies. At present, folic acid 
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supplements are taken in around 50% of planned pregnancies in the UK. Since 
planned pregnancies are less likely in young mothers and women from the 
most deprived social-economic groups, these two groups are most at risk of 
NTD (SACN, 2009). Furthermore, because inadequate blood folate status has 
been found in groups of women aged between 19-24 years and 25-34 years 
(around 8 and 4% respectively), there might be a need to increase folate intake 
in this particular group (NDNS, 2011). Pregnant mothers with low folate status 
had a higher risk of pre-term births and lower birth weight in babies. Because 
of the possible adverse effects caused by low folate status in pregnancies, the 
Scientific Advisory Committee for Nutrition (SACN) (2011) recommended 
compulsory folic acid fortification of 300µg per 100g of flour within the U.K. to 
reduced NTD affected pregnancies. This recommendation is currently under 
consideration and to date the U.K. government has not implemented this 
recommendation. 
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Table 1.3  Daily recommendations for folate (folic acid) intake in the 
UK adult population *note: µg=micrograms (adapted from the British Dietetic 
Association, 2013). 
Population group Recommended folate/FA intake 
Adult and children over 11 years 200µg 
Any women considering pregnancy 200µg + 400 µg supplementation 
Pregnant women 
300µg + 400µg supplementation for 
the first 12 weeks of pregnancy 
Lactating women 260µg 
 
 
Folate deficiency in adults can lead to megaloblastic anaemia (Golding, 2014). 
In the U.K., data from the National Diet and Nutritional Survey (NDNS, 2011) 
has revealed that the average folate intake for all age categories was above 
the reference nutrient intake (RNI, which provides sufficient nutrition intake for 
95% of the population). However, inadequate blood folate status was found in 
certain groups of individuals, e.g. 16% and 8% for institutionalised and free-
living individuals aged 65 years and over, and in women aged between 19-24 
years and 25-34 years the rates were approximately 8 and 4% respectively. 
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1.5  Developmental Origins of Health and Disease 
The Developmental Origins of Health and Disease (DOHaD) hypothesis 
argues that sub-optimal nutritional intake in utero  leave marks on the 
developing organism which contribute to elevated risk of disease later in life 
(Barker, 2004). In support of the DOHaD hypothesis, poor nutrition during early 
development in animals has been linked with increased risk of several 
diseases in adulthood including diabetes, cardiovascular disease and obesity 
(Hanson et al 2011). However, the biological mechanism underlying the 
DOHaD hypothesis and the nature of these marks remains unclear. Over the 
past decade, this laboratory has developed the hypothesis that epigenetic 
mechanisms are candidate mechanisms through which early life nutritional 
exposures may influence lifelong health based on: i) the key role of epigenetic 
marks and molecules in regulating gene expression (discussed in section 1.1 
above), ii) the centrality of gene expression patterns in determining phenotype 
and iii) the plasticity of epigenetic marks in response to environmental 
(including dietary) exposures (Mathers et al, 2010; Mathers & McKay, 2009; 
Mathers, 2007; McKay et al, 2004). In addition, work in other laboratories has 
suggested gene-specific epigenetic modifications at individual CpG sites in the 
offspring during development as a result of disturbed maternal nutrition is a 
possible mediating mechanism (Hanson et al, 2011; Dolinoy et al, 2007). This 
is because some environmental (nutritional) exposures are “received” and 
“recorded” as epigenetic marks which are “remembered” across cell 
generations and may be “revealed” as altered gene expression patterns later 
in the life-course (Mathers, 2008). The importance of this plasticity of 
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epigenetic marks in early life in response to nutritional exposures (Fraga & 
Esteller, 2007) is discussed in section 1.6. 
 
 
1.6  Folate, DNA methylation and gene expression 
During embryonic and early fetal development, when epigenetic marks are 
being established, they may be particularly susceptible to modification. 
Therefore, inadequate maternal nutrition in this critical window, especially low 
intakes of methyl donors such as folate, can have effects on global and gene 
specific DNA methylation in the offspring and, subsequently, on risk of disease 
in later life (Barua et al, 2014; Haggarty et al, 2013; Kobayashi et al, 2013; 
Steegers-Theunissen et al, 2013).  
 Genomic DNA methylation was significantly elevated in colon of folate 
supplemented compared with folate depleted ageing rats (Choi et al, 2003). 
This observation suggests that dietary folate intake could potentially interact 
with the ageing process to reverse effects of ageing on genomic DNA 
methylation (Jang et al, 2005). However, these data on changes in DNA 
methylation do not provide any indication of biological relevance, which would 
require an understanding of effects on gene-specific methylation and 
expression of the corresponding genes and on physiological functions during 
ageing (Akinota & Parrish, 2010).  
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1.6.1  Effects of folate status during gestation and early life on 
DNA methylation and gene expression in offspring  
Increased global DNA methylation was observed in the colon of male mouse 
offspring supplemented with folic acid (5mg/kg) in utero and after weaning until 
31 weeks of age. These offspring born from folic acid-supplemented dams 
appeared to be protected against the development of colorectal cancer in adult 
life which could due to the reduced proliferation and DNA damage in the 
colorectum epithelium found in these offspring (Sie et al, 2011). Interestingly, 
a similar study by the same group reported reduced global DNA methylation 
and hypo-methylation of Ppar-ɣ, ER-α, p53 and Apc genes in liver DNA from 
newborn pups whose mothers were supplemented with folic acid during 
lactation. When combined with maternal high folic acid intake during 
pregnancy, post-weaning folic acid supplementation in offspring induced 
hyper-methylation of Ppar-ɣ, p16 and p53 in the liver at 14 weeks (Sie et al, 
2013). Additionally, low maternal folate supply pre-conception and during 
pregnancy and lactation decreased global DNA methylation in the small 
intestine of adult progeny (McKay et al, 2011). Recently, Jing-Bo et al (2013) 
reported promoter hypo-methylation of GR, PPARα and PPARɣ (genes 
involved in energy metabolism) and increased expression of the corresponding 
genes in livers of intrauterine growth-restricted piglets. These changes were 
reversed when piglets were supplemented with 5mg/kg folic acid from weaning 
until 35 days of age. This implies the effect of folate supplementation on global 
DNA methylation could be life-stage and / or tissue specific, and that folic acid 
supplementation after birth can alter gene-specific DNA methylation patterns.  
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In the agouti mouse model, maternal supplementation with dietary methyl 
donors including folic acid, vitamin B12, choline, and betaine altered 
methylation of several CpGs with the Avy gene and changed offspring 
phenotype by shifting away from the yellow colour coat and obese agouti 
phenotype to the leaner pseudo agouti phenotype with brown colour coat 
(Waterland & Jirtle, 2003). A recent study by Cho et al (2013) has found that, 
at birth, male Wistar pups born to mothers exposed to a high maternal folate 
intake displayed an obesogenic phenotype including higher food intake, body 
weight and glycaemic response to glucose load. However, the obesogenic 
phenotype displayed in rat offspring appeared to be rectified when the pups 
were continued on the high folate diet until 29 weeks of age. Expression of the 
neuropeptide pro-opiomelanocortin (Pomc) is regulated by circulating leptin 
and insulin and has a role in food intake and body weight (reviewed in Morton 
et al, 2006). High folate intake in mouse offspring causes hypo-methylation 
and expression of the Pomc gene promoter and this could contribute to the 
reversal of the obesogenic phenotype caused by high maternal folate supply 
in male pups (Cho et al, 2013). These data suggest that the effects of altered 
folate supply on phenotypic outcomes may depend on the life stage at which 
the intervention occurs.  Intriguingly, Bermingham et al, (2013) reported that 
post-weaning supplementation with adequate levels of selenium and folate in 
female offspring of mice fed high-fat diets inadequate in selenium and folate 
during gestation and lactation can alter global DNA methylation and lead to 
reduced expression of Slc2a4 (encodes the glucose transporter GLUT4 and 
has a role in diabetes) in mouse liver. 
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A possible interaction between maternal folate supply and high fat intake has 
been reported. Delaney et al (2013) found that supplementing ApoE-/- dams 
with methionine, B12, choline, betaine and folate during pregnancy diminished 
atherosclerotic plaques in the offspring that were fed a high fat diet from 
weaning. Carlin et al (2013) reported reversal of global DNA hypo-methylation 
in mouse offspring when the maternal high fat diet was supplemented with 
methyl donors. Furthermore, Langie et al (2013) observed that low folate 
intake during gestation and lactation, when combined with high fat feeding 
from weaning, decreased base excision repair (BER) activity in cortex, 
cerebellum, hippocampus and subcortical regions in mouse offspring. This 
altered DNA repair activity was associated with changes in methylation and 
expression of BER-related genes. 
In humans, a study of T cells from healthy individuals between 22 to 81 years 
of age revealed that global DNA methylation is more susceptible to low folate 
and methionine levels in ageing (>50 years old) than in young cells (Li et al, 
2010). Hyper-methylation of the imprinted gene IGF2, and hypo-methylation of 
PEG3 (another imprinted gene) and of LINE-1 in red blood cells was 
associated with the use of folic acid supplements after week 12 of gestation in 
pregnant mothers and similar changes were  also observed in cord blood at 
birth (Haggarty et al, 2013). There was a significant positive association 
between red cell folate status and SFRP1 promoter methylation in the human 
rectal mucosa in males (Tapp et al, 2013). On the other hand, N33 methylation 
in the rectal mucosa was negatively associated with plasma folate status in 
males while for females the correlation between N33 methylation and plasma 
folate was positive (Tapp et al, 2013).  
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In some of the studies summarised above, a number of methyl donors were 
included in the supplemented diet and it is not clear whether the change in 
global and gene-specific DNA methylation is the effect of supplemental folate 
per se or is a generic effects of a combination of methyl donors.   
 
1.7 Hypotheses, Aims and Objectives 
1.7.1  Hypotheses  
 Dietary folate depletion in utero affects the methylation status of a panel 
of genes in the fetal mouse gut and in the adult mouse colon and 
proximal small intestine; 
 Aberrant DNA methylation caused by folate depletion in utero combined 
and high fat feeding after weaning will alter expression of candidate 
genes in the adult (6 months) mouse small intestine and colon;  
 In humans, folate status and age affect gene-specific DNA methylation 
and gene expression in the colo-rectal mucosa.   
 
1.7.2  Aims and Objectives 
The aims of this project were to test the above hypotheses by undertaking the 
following specific objectives:  
 Quantify DNA methylation in a panel of genes viz. Igf2-DMR1, Esr1, 
Slc39a4-CGI1 and –CGI2 and p16 in DNA from the fetal mouse gut 
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using samples from mothers that were subjected to either a folate 
deplete or folate adequate diet pre-conception and during pregnancy 
(details in Chapter 2 and Fig 2.1); 
 Conduct a multistep in silico bioinformatic analysis of genome wide 
microarray expression data to identify additional candidate genes that 
have been differentially expressed in response to low folate and during 
ageing;  
 Design and validate mouse-specific pyrosequencing assays for 
quantification of methylation at selected CpG sites within the two 
candidate genes identified in the above objective viz. Obfc2a and 
Ppm1k;  
 Apply the Obfc2a and Ppm1k DNA methylation assays to DNA 
extracted from the fetal mouse gut tissues whose mothers were fed 
either a folate depleted or folate adequate diet during pregnancy; 
 Design and validate real-time qPCR assays for genes that had shown 
differential methylation in mouse tissues;  
 Quantify DNA methylation and expression of the corresponding genes 
for the panel of candidate genes in adult mouse small intestine and 
colon from a mouse model in which offspring were exposed to normal 
or depleted folate status in utero and during lactation and then offspring 
were randomised to a low or high fat diet from weaning;  
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 Design and validate human-specific pyrosequencing assays for 
measurement of gene-specific methylation in genes that had shown 
differential methylation in the mouse; 
 Design and validate real-time qPCR assays for quantification of 
expression of the corresponding genes in human; 
 Quantify promoter DNA methylation and gene expression using 
colorectal mucosal biopsies from individual selected to i) have lower or 
higher folate status and ii) be younger or older. 
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CHAPTER 2 
 
Materials and Methods 
 
2.1  Ethical Statement 
2.1.1   Mouse studies 
The animal procedures used in this project were carried out under the Home 
Office Project licence no. 60/3979 and ethical approval was obtained from the 
Newcastle University Ethics Review Committee.  
 
2.1.2   Human colo-rectal mucosal biopsies 
Human colo-rectal mucosal biopsies were taken from the biobank which were 
collected for the Biomarkers of Risk in Colorectal Cancer (BORICC) 1 study 
(Mathers, 2010). Ethical approval for this study was obtained from the 
Northumberland Local Research Ethics Committee (project reference 
04/Q0902/6/2004). 
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2.2 Mouse studies 
2.2.1   Animal housing, husbandry and dietary intervention 
The mice used in this study were housed in the Newcastle University 
Comparative Biology Centre (CBC) at 20–22 ºC, with 12 hour light and dark 
cycles, and fresh water was provided ad libitum. After delivery to the CBC, 
mice were fed standard rodent chow for 2 weeks to allow them to adapt to their 
new surroundings. 
Female C57BL/6J mice were randomised to either a folate depleted (FD; 0.4 
mg folic acid/kg) or folate adequate (FA; 2 mg folic acid/kg) diet and offered 6 
g/day (g/d) for 4 weeks prior to mating (McKay et al, 2011b). Two female mice 
and one male (C57BL/6J) mouse were then grouped as mating trios and were 
provided with 6 g/day per mouse of the designated diet. When pregnancy was 
confirmed by the presence of a vaginal plug, this was recorded as day 0. Once 
pregnant, female mice were re-caged and were offered 10 g/d of designated 
diet until day 17.5 of gestation, when dams were killed and foetuses were 
removed and weighed (study and sampling of tissues carried out previously by 
McKay et al, 2011a). Gut tissue was removed from foetuses, weighed and 
labelled, snap frozen in liquid nitrogen and stored at ̵ 80ºC prior to DNA 
extraction (Fig 2.1). 
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Figure 2.1 Folate depleted mouse model used to obtain fetal gut tissue 
 
 
 
 
2.2.2   Adult mouse colon and proximal small intestine 
The same animal procedures as stated in 2.2.1 were repeated and female 
mice were fed 10 g/d the assigned diet throughout pregnancy and lactation. 
The quantity of diet offered to lactating dams was increased to 20g/d. After 
weaning (aged 22-25 days), offspring were re-housed and randomised to 
either a low-fat diet (LF; 5% anhydrous milk fat, TD.09506; Harlan 
Laboratories, Indianapolis, IN, USA) or a high-fat diet (HF; 20% anhydrous milk 
fat; TD.09507) until 6 months of age when offspring were killed and weighed 
(Fig 2.2). The colon and small intestine were removed from the offspring. Small 
intestine was divided equally in length into two separate sections – proximal 
and distal small intestine. Contents from both colon and small intestine were 
discarded, washed, weighed, placed in labelled foil, snap frozen in liquid 
nitrogen and stored at  ̵80˚C prior to DNA and RNA extraction.  
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Figure 2.2 Study overview for adult mouse colon and proximal small 
intestine sampling 
 
 
 
 
2.3 Processing of adult mouse tissues 
To enhance sampling and tissue lysis of adult mouse colon and small intestine, 
a cryogenic technique was used for grinding the tissue. In brief, a metal mortar 
and pestle, spatula and scraper were placed in liquid nitrogen prior to tissue 
grinding. Labelled empty Eppendorf tubes were pre-weighed and placed on 
dry ice. Biological samples were removed from freezer storage at ̵ 80˚C and 
put on dry ice until use. The mortar and pestle were taken out of liquid nitrogen 
using pincers and a tissue sample was placed inside the mortar (one sample 
at a time). The pestle was then placed on top of the sample in the mortar and 
tapped 3 to 4 times with a hammer to pulverise the tissue. The ground tissue 
was scraped out of the mortar and into an Eppendorf tube using the spatula 
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and scraper, and the Eppendorf tube was re-weighed. The mortar, pestle, 
spatula and scraper were cleaned thoroughly and put back in liquid nitrogen 
ready for the next sample. Aliquots of homogenised tissue were stored in ̵ 80˚C 
until use. Ground tissue was used for extraction of DNA and RNA (as 
described in 2.5.2 and 2.7.1 respectively) from both adult mouse colon and 
proximal small intestine.  
 
 
2.4 Origin of human colorectal mucosal biopsies 
Human colon mucosal biopsies were collected from healthy volunteers in 
2004/2005. All volunteers were recruited through endoscopy lists at Wansbeck 
General Hospital within Northumbria Healthcare NHS Foundation Trust. 
Details of potentially suitable patients were reviewed at least five days prior to 
scheduled endoscopy appointment. Patients who appeared to satisfy the 
participation criteria (as listed in Table 2.1) were sent study information by post 
and invited to consider joining the BORICC1 Study when they came to out-
patients clinic for their scheduled endoscopy of the large bowel (using flexible 
sigmoidoscopy or colonoscopy). During this visit, potential recruits were 
offered the opportunity to ask questions about the study and written informed 
consent was obtained for each study participant. Colorectal mucosal biopsy 
samples were collected from macroscopically normal bowel at 10 cm from the 
anorectal margin, snap frozen in liquid nitrogen and stored at ̵ 80˚C until use.  
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Table 2.1  Criteria for participation in the BORICC 1 study 
 
 
 
For the present project, 34 human colorectal mucosal biopsies were selected 
based on information in the BORICC1 Study phenotypic database. These 
biopsies were obtained from both younger (aged 26 – 48 years) and older 
(aged 50 – 78 years) participants and participants with lower and higher red 
cell folate concentrations (see Chapter 6 for further details).  
 
 
Participation Criteria
Age ≥ 16 or ≤ 85 years 
No familial adenomatous polyposis (FAP)
No Hereditary non-polyposis colorectal cancer (HNPCC)
No known CRC
No previous colorectal surgery
Non-pregnant
No chemotherapy within the last six months
Not taking aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs)
Not on immunosuppressive medication or therapy
No active colonic inflammation at endoscopy
Complete left sided examination 
No CRC found during endoscopy or on histology
No iatrogenic perforation at endoscopy
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2.5  DNA extraction and bisulphite modification in preparation for 
quantification of DNA methylation  
2.5.1  Fetal mouse gut  
Fetal mouse gut tissues were removed from the ̵ 80ºC freezer and weighed 
prior to DNA extraction. DNA was extracted from tissues using the Omega EZ 
tissue DNA extraction kit according to manufacturer’s specifications. In brief, 
up to 30mg of tissue from each fetal mouse gut sample was minced by scalpel 
and kept overnight at 56°C with protease in lysis buffer to allow digestion of 
tissue. The lysate was loaded into columns for DNA binding and centrifuged 
briefly. The column was washed twice using the buffer provided in the kit and 
centrifuged for 1 min to dry the column membrane. DNA was incubated at room 
temperature for 1 min and subsequently eluted in 30µl of elution buffer. DNA 
elutions were repeated until DNA concentration fell below 80ng/µl. All eluted 
DNA was stored at -20ºC until use. DNA was extracted from 10 fetal gut tissue 
samples and added to the DNA archive from 24 fetal gut tissues which had 
been obtained previously (Wong, 2010).  
 
2.5.2  Bisulphite modification of DNA 
Following bisulphite treatment of genomic DNA, pyrosequencing allows 
quantitative measurement of DNA methylation at specific loci. Upon sample 
preparation, successful PCR amplification and assay validation, DNA 
methylation data can be generated within a day. Under bisulphite modification, 
un-methylated cytosines were converted to uracil whereas methylated 
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cytosines remained unchanged. Bisulphite converted DNA allows CpGs with 
differential methylation to be investigated as simulated C/T polymorphism and 
a percentage of methylation is obtained for individual CpGs (Tost & Gut, 2007). 
The concentration and integrity of eluted DNA were measured using a 
Nanodrop ND-1000 spectrophotometer. The concentrations of DNA and 
number of aliquots obtained for each tissue sample were recorded and used 
to calculate the amount of DNA template required for bisulphite modification 
(BM) using the Zymo DNA Gold kit according to the manufacturer’s 
instructions. Briefly, 900ml of CT conversion reagent was mixed with 1 µg of 
genomic DNA and incubated at 98ºC for 10 mins, 64ºC for 2.5 hrs and held at 
4ºC. After incubation, DNA was washed, desulphonated and purified in a spin 
column. Finally 10µl of BM DNA was eluted into an Eppendorf tube.   
 
2.5.3  Adult mouse colon and proximal SI  
The same protocol and extraction kit as stated in 2.5.1 was used to extract and 
prepare DNA from adult colon and proximal small intestine with the addition of 
tissue grinding step (as described in section 2.3) prior to tissue digestion. 
Between 15-25mg of ground tissue from each biological sample was used for 
DNA extraction. DNA was extracted from 48 adult mouse colon and 48 
matched adult mouse proximal small intestine. 
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2.5.4   Human colo-rectal mucosal biopsies 
DNA was extracted from human colorectal mucosal biopsies using Qiagen’s 
Mini Prep DNA/RNA kit. In brief, 10µl of β-mercaptoethanol (β-met) was added 
to 1ml of Buffer RLT Plus, 600µl of this mixture was put into a 2ml tube together 
with 5 X 3mm glass bead and shaken in an amalgamator for 1 min. After 
centrifugation for 3 mins at 4°C, the supernatant was placed in an AllPrep DNA 
column and centrifuged for 30 seconds to allow binding of DNA. Flow-through 
from the AllPrep DNA column was then kept on ice and used for simultaneous 
RNA extraction as stated in section 2.7.2. The AllPrep DNA column was then 
washed twice in buffers AW1 and AW2 respectively. DNA bound to the AllPrep 
column was incubated at room temperature and eluted in 30-50µl of elution 
buffer initially. After measuring the concentration and purity of DNA using the 
Nanodrop ND-1000 spectrophotometer, elution was repeated for each 
biological sample until the DNA concentration fell below 20ng/µl. 250ng of 
human genomic DNA from each biological sample was used for BM using the 
Zymo DNA Gold kit (as described in section 2.5.2). 
 
 
2.6  Pyrosequencing assay development 
2.6.1  Promoter analysis and candidate gene selection 
Please refer to Chapter 3 for details of the selection of candidate genes (Igf2-
DMR1, Esr1, Slc39a4, p16, Obfc2a and Ppm1k) for DNA methylation 
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quantification, CpG island identification and gene promoter region analysis for 
each candidate gene. 
 
2.6.2   Mouse-specific pyrosequencing assay design 
Four mouse-specific pyrosequencing assays: Igf2-DMR1, Esr1, Slc39a4-CGI1 
and -CGI2 were developed and validated previously (Wong, 2010). To develop 
an assay for p16, pyrosequencing primers were taken from Maegawa et al 
(2010). 
Further mouse-specific pyrosequencing assays were designed for Obfc2a and 
Ppm1k using the Biotage PSQ Assay design software (version 1.0.6). Due to 
the location of CpGs required for methylation quantification and the length of 
fragment that could be analysed in each pyrosequencer assay, three mouse-
specific pyrosequencing assays were designed for Obfc2a (primer set 1 
sequence 1 – amplicon 1, primer set 1 sequence 2 – amplicon 2, and primer 
set 2 – amplicon 3) and two assays for Ppm1k (primer set 1 – amplicon 1, and 
primer set 2 – amplicon 2) promoters. 
 
2.6.3   Human-specific pyrosequencing assay design and 
optimisation 
One human-specific pyrosequencing assay for SLC39A4 was designed using 
the Biotage PSQ Assay design software (version 1.0.6). Two PyroMark CpG 
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assays were optimised for ESR1 and one assay for OBFC2A (Qiagen, cat. no. 
PM00024612 & PM00024619, and PM00012005 respectively).  
 
2.6.4   Bisulphite modification of genomic DNA 
Mouse tail DNA samples were BM using the EZ DNA Gold methylation kit 
(Zymo Research; as stated in 2.5.2) and used for PCR protocol optimisation 
of pyrosequencer primers. 
 
2.6.5   Polymerase Chain Reaction (PCR) optimisation 
2.6.5.1  Pyrosequencer primers for mouse intestinal samples 
Pyrosequencing PCR primer sets were optimised using BM mouse tail DNA in 
4 different PCR master mixes (MM1 – MM4, Appendix 2A) each at 3 different 
annealing temperatures (55ºC, 60ºC and 65ºC, x 50 cycles). In brief, 200ng of 
BM DNA was included as template in a 25 µl PCR reaction volume containing 
12.5 µl of HotStar Taq mastermix (Qiagen). Negative controls containing 
molecular biology grade water (dH2O) instead of DNA were included in each 
master mix to check for contamination in each set of PCR amplifications. PCR 
amplification was carried out in a G-storm thermocycler (GRI Ltd), PX2 
Thermal cycler (Thermo Fisher Scientific) or Bio-Rad G1000 Thermal Cycler. 
When amplicons of the expected size for each primer set were obtained, the 
master mix and annealing temperature that generated the cleanest and 
strongest PCR product (as visualised on 1% agarose gel electrophoresis, 
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example shown in Figure 2.3) were selected as the protocol for 
pyrosequencing PCRs for that particular primer set. Details of optimised PCR 
conditions, primer sequences and pyrosequencing specifications are provided 
in Appendix 2B.   
 
 
Figure 2.3  Agarose gel illustrating PCR products from Slc39a4-CGI1 
pyrosequencing primers optimisation for mouse samples 
 
 
 
 
 
From left to right, 100bp DNA ladder, MM1 annealing @ 55, 60 
& 65˚C, -ve control, MM2 annealing @ 55, 60 & 65˚C and -ve 
control, 100bp DNA ladder 
From left to right, 100bp DNA ladder, MM3 annealing @ 55, 60 
& 65˚C, -ve control, MM4 annealing @ 55, 60 & 65˚C and -ve 
control, 100bp DNA ladder  
54 
 
2.6.5.2 Pyrosequencing primers for human colorectal mucosal 
samples  
The same procedures as stated in 2.6.5.1 were followed for the optimisation 
of all four human-specific pyrosequencing PCR primer sets as listed in section 
2.6.3 except the amount of BM DNA template used in each PCR reaction was 
20ng.   
 
2.6.5.3  Pyrosequencer controls for mouse samples 
For each gene, one primer set (“control primers”) was designed to amplify 
flanking regions of amplicons using the Primer3 software to generate 0% and 
100% methylated pyrosequencer controls. The PCR optimisation protocol for 
pyrosequencer primers was repeated for control primers optimisation using 
unmodified mouse tail DNA. Similar to pyrosequencer primer optimisation, the 
master mix and annealing temperature that generated the cleanest and 
strongest PCR product was used as 0% unmethylated control. This 0% 
unmethylated control was then in-vitro methylated using the New England 
Biolabs CpG Methyltransferase (M.SssI) kit (Schubeler et al, 2001) to generate 
100% methylated control.    
Finally, both controls (0% and 100%) were BM using the Zymo DNA Gold kit 
to generate BM 0% and 100% methylated DNA for each gene. 
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2.6.5.4 Pyrosequencer controls for human samples 
The EpiTect PCR Control DNA set (Qiagen) including unmodified human 
genomic DNA, unmethylated (0%) and methylated (100%) BM human DNA 
were used as pyrosequencer controls for human samples. Both 0% and 100% 
controls were used to optimise PCR conditions for all three PyroMark CPG 
assays (as listed in section 2.6.3). All three controls: unmodified genomic DNA, 
0% and 100% methylated DNA were included in each PCR run. 
 
2.6.5.5  Validation of Pyrosequencer assays using Pre- and Post 
PCR serial dilutions (Mouse) 
To check for integrity of pyrosequencing primer sets, 0% and 100% methylated 
controls was serially diluted pre-PCR amplifications to produce pre-PCR 
dilution curves. Additionally, to ensure reliability of pyrosequencing data, PCR 
amplified 0% and 100% controls were serial diluted to generated post-PCR 
dilution curves as detailed below (Chung et al, 2008).  
Pre-PCR serial dilutions were carried out in duplicate to generate 0, 5, 10, 25, 
50, 75, 90, 95 and 100% methylated BM DNA. Each of the diluted samples 
was PCR amplified according to previously-optimised conditions. All PCR 
products were checked by 1% agarose gel electrophoresis to confirm the 
appropriate size of the product and the absence of contamination in the water 
controls. Similarly, a post-PCR dilution series (5, 10, 25, 50, 75, 90 and 95%) 
was generated using 0% and 100% methylated pyrosequencer PCR products. 
The methylation status of each CpG in both the pre-PCR and post-PCR 
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dilutions was measured quantitatively using the Biotage Pyromark MD 
Pyrosequencer as described in Section 2.6.6. An example of a set of validation 
curves is shown in Fig 2.4, with details of the regression coefficients for 
individual CpGs within each assay in Table 2.2 (full details of dilution curves 
validated for mouse specific pyrosequencing assays for this project are in 
Appendix 2C). 
Ten mouse-specific pyrosequencing assays were used to quantify methylation 
at Esr1, Igf2-DMR1, p16, two CpG islands at Slc39a4 (-CGI1 and -CGI2), three 
genomic regions within Obfc2a (amplicons 1, 2 and 3) and two loci at Ppm1k 
(amplicons 1 and 2) in fetal mouse gut, adult mouse colon and proximal small 
intestine.  
Please note: Assays for Esr1, Igf2-DMR1 and Slc39a4 were validated 
previously (Wong, 2010).  
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Figure 2.4 Expected and observed percentage DNA methylation for 
Obfc2a-amplicon 1 CpG site 1 obtained from A): pre-PCR and B) post-
PCR dilution series 
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Table 2.2  Regression coefficients obtained for the six mouse-specific 
pyrosequencing assays validated for DNA methylation quantification 
 
Locus 
Total no. of 
CpGs 
Range of regression coefficients (R2) 
for all CpGs within assay 
Pre-PCR dilution Post-PCR dilution 
Obfc2a-amp1 9 0.98 – 0.95 0.99 – 0.97 
            -amp2 8 0.99 – 0.98 0.99 – 0.97 
            -amp3 9 0.99 – 0.95 0.99 – 0.96 
Ppm1k-amp1 4 0.99 – 0.97 0.99 – 0.99 
           -amp2 7 0.99 – 0.98 0.99 – 0.97 
         p16 5 0.99 – 0.99 0.98 – 0.97 
 
 
 
2.6.5.6  Validation of Pyrosequencer assays using Pre- and Post 
PCR serial dilutions (Human) 
Pre- and Post-PCR serial dilutions (0, 25, 50, 75 and 100%) in duplicate were 
created using the 0% and 100% BM human DNA from the Epitect control DNA 
set (Qiagen) as described in 2.6.5.3. After confirmation of PCR product and 
non-existence of contamination in negative controls on 1% agarose gel, 
methylation quantitation was carried out using the pyrosequencer (as 
described in section 2.6.6). Regression coefficients for all three assays listed 
in Table 2.3, and full details of dilution curves for all three human-specific 
pyrosequencing assays (ESR1-amp1, ESR1-amp2 and OBFC2A) are 
provided in Appendix 2D. Quantification of SLC39A4 methylation proved 
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problematical. For this assay, unmethylated DNA contained measurable 
amounts of methylation at certain CpGs (i.e. 17, 11 and 27% for CpG sites 1, 
2 & 3 respectively) and fully methylated controls did not measure as 100% 
methylation (i.e. 77, 56 & 84% for CpG sites 1, 2 & 3 respectively). For this 
reason, validation curves for this gene were not generated. However, because 
the DNA methylation data obtained from the experimental samples were within 
the range of percentage DNA methylation of both unmethylated and 
methylated controls, the measured data from samples were used for 
comparing treatment effects. It should be noted that the reported values may 
not represent absolute DNA methylation values at this locus.  
 
 
Table 2.3  Regression coefficients obtained for the three human 
pyrosequencing assays 
 
Locus 
Total no. of 
CpGs 
Range of regression coefficients (R2) 
for all CpGs within assay 
Pre-PCR dilution Post-PCR dilution 
ESR1-amp1 4 0.99 – 0.98 0.99 – 0.99 
           -amp2 4 0.99 – 0.96 0.99 – 0.99 
OBFC2A 5 0.99 – 0.99 0.99 – 0.99 
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2.6.6   Quantification of CpG methylation by Pyrosequencing 
2.6.6.1  Fetal mouse gut and adult mouse colon and proximal small 
intestine  
Pyrosequencing primers and sequencing regions for candidate genes Obfc2a 
and Ppm1k were designed using the Biotage PSQ Assay design software 
(version 1.0.6). For p16, the sequencing primer was taken from Maegawa et 
al (2010).  
Briefly, 10µl of PCR products were mixed with 2µl of streptavidin sepharose 
beads and 38µl of binding buffer and placed on a shaker (1400 r.p.m.) at room 
temperature for 10 minutes to allow the binding of the biotin labelled PCR 
product to the beads. Beads were then captured using a Pyrosequencing 
Vacuum Prep Tool (Qiagen) and the resultant single stranded PCR product 
was added to 0.5µl of 10µM sequencing primer and 11.5µl of annealing buffer. 
Samples were then placed on a heating block at 80ºC for 2 min, and left at 
room temperature to cool to allow the annealing of pyrosequencer primer to 
the PCR product. Pyrosequencing was then carried out using a Pyromark MD 
system to assess methylation status of each CpG which was quantified by Pyro 
Q-CpG 1.0.6 software.  
 
2.6.6.2  Human colo-rectal mucosa 
A sequencing primer for the targeted region of SLC39A4 was designed using 
the Biotage PSQ Assay design software (version 1.0.6). Sequencing primers 
(and details of the sequencing regions) for ESR1-1, ESR1-2 and OBFC2A 
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were provided by QuantiTect primer assays (Qiagen). Preparation work for 
pyrosequencing for human samples was the same as described in 2.6.6.1 
above, except that 3µl of 1X QuantiTect sequencing primer (provided with 
assay) was mixed with 9µl of annealing buffer.   
 
 
2.7  RNA extraction 
2.7.1  Adult mouse colon and proximal small intestine  
Aliquots of ground mouse colon or proximal small intestine (as described in 
2.3) were used for RNA extraction using TRIzol Plus RNA Purification kit 
(Ambion) using previously optimised protocol (Lisanti, 2013). Briefly, 20-30mg 
of ground tissue were homogenised in 1ml of Trizol reagent using a hand-held 
homogeniser and incubated at room temperature for 5 mins to allow digestion 
of tissue. After centrifugation, 100µl of 1-bromo-3-chloropropane (BCP, Sigma 
Aldrich) were added to the lysate to facilitate phase separation and to minimise 
DNA contamination. After centrifugation (12,000g, 10mins, @ 4˚C), the clear 
aqueous phase was recovered, 200µl of lysis solution and 300µl of 100% 
ethanol were added and mixed gently. The lysate was then loaded into a 
column (provided in the kit) to allow RNA binding.  
The manufacturer’s recommendations were followed from this point onwards. 
Briefly, the column was washed using the buffer provided and RNA was eluted 
in 50µl of RNA storage solution (Ambion, 1 mM sodium citrate, pH 6.4 +⁄- 0.2 
buffer) for better RNA stability. Concentration (ng/µl) and purity (260/280 and 
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260/230 ratio) of RNA were measured using a Nanodrop spectrophotometer. 
If the 260/280 or 260/230 ratio was ≤1.9, further cleaning of the RNA was 
carried out using a new column and the washer buffer provided in the kit. 
Elutions were repeated until RNA concentration fell below 60ng/µl.   
All RNA extracted was diluted to 100ng/µl and divided into 8µl of aliquots and 
stored at ̵ 80˚C. 500ng of RNA extracted from each biological sample was used 
to check for RNA integrity in 1% agarose gel with a 1kb DNA ladder (confirmed 
by 2 clear bands representing 18s and 28s rRNA; example shown in Fig 2.5).    
 
 
Figure 2.5  Confirmation of mRNA presence and integrity by gel 
electrophoresis  
 
 
 
 
 
 
 
1kb DNA 
ladder 
2 bands 
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2.7.2  Human colo-rectal mucosal biopsies  
RNA was extracted from mucosal biopsies using Qiagen’s Mini Prep 
DNA/RNA kit. The flow-through from the AllPrep DNA column (see section 
2.5.4) was used for RNA purification for each biological sample. Briefly, one 
volume of 70% ethanol was mixed with flow-through before transferring to an 
RNeasy spin column for RNA binding. Each column was then washed once in 
RW1 buffer and twice in RPE buffer before RNA elution. After drying the 
membrane for 1 minute, RNA storage solution (Ambion) was used to elute the 
RNA. Concentration and purity of RNA were measured using the Nanodrop 
spectrophotometer (described in section 2.7.1). Further elutions were carried 
out for each sample until RNA concentration was less than 25ng/µl. Aliquots 
of RNA were stored at  ̵ 80ºC freezer until use. 
Integrity of RNA was checked in a random selection of samples (5 out of 27 
samples) using the procedures described in section 2.7.1. 
 
 
2.8  Reverse transcription PCR in preparation for RNA quantification 
In preparation for RNA quantification by real-time qPCR, mouse total RNA was 
reverse transcribed into single-stranded complementary DNA (cDNA) using 
the QuantiTect Reverse transcription kit (Qiagen) according to manufacturer’s 
recommendation. Genomic DNA (gDNA) removal was carried out on all 
samples using DNase digestion before reverse transcription to remove 
residual DNA contamination as follows: 500ng of total RNA was mixed with 2µl 
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of gDNA wipeout buffer, and nuclease-free water to a total reaction volume of 
14µl. After incubated at 42°C for 2 mins, samples were cooled immediately on 
ice.  
For reverse transcription of mRNA into cDNA, each sample was added to 4µl 
of RT buffer mix containing Mg2+ and dNTPs, and 1µl of RT primer mix. After 
adding 1µl of reverse transcriptase to the reaction mix, samples were 
incubated at 42°C for 30 mins followed by 95°C for 3 mins to inactivate 
transcriptase. 
Reverse transcriptase negative (RT-ve) and no template negative controls 
(NTC) were included in each RT qPCR. Control PCR amplification was 
performed using a GAPDH primer set (Fermentas) using a previously 
optimised protocol (Lisanti, 2013). Briefly, after first-strand cDNA synthesis, 
the reaction product from a randomly picked sample and the RT-ve control 
were diluted 1:1000 and PCR amplified x35 cycles with annealing temperature 
at 58˚C. When a 496bp PCR product was present for the sample and no PCR 
product was visible for RT-ve control on 1% agarose gel, cDNA samples were 
ready to proceed to real-time quantitative PCR (qPCR) as described in 2.9 
below. 
The same protocol and reagents described above were used for the synthesis 
of cDNA from total RNA extracted from human colo-rectal mucosal biopsies 
as described in 2.7.2. 
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2.9  Real-time quantitative PCR  
The StepOnePlus qPCR system (Applied Biosystem) was used for relative 
gene expression quantification using the standard qPCR program (annealing 
at 60˚C for 1 min, x40 cycles). Raw cycle threshold (CT) values were quantified 
using StepOne software version 2.2.2 (Applied Biosystem). QuantiFast SYBR 
Green PCR kit (Qiagen) was used for all qPCRs. For each reaction, 7.5µl of 
SYBR Green with ROX dye was mixed with 0.5µl of 10µM forward and reverse 
primers plus 3µl of diluted cDNA (15ng of cDNA template in 15µl reaction 
volume). Melt curves were obtained for each qPCR as follows: 
95˚C for 15 seconds 
60˚C for 1 minute 
From 60˚C to 95˚C, with temperature increment of +0.3˚C per second 
The Minimum Information for publication of Quantitative real-time PCR 
Experiments guidelines (MIQE guidelines, Bustin et al, 2009) was followed in 
the design and execution of qPCRs as described here and below in 2.10.  
 
 
 
 
 
 
66 
 
2.10  Real-time qPCR assay development  
2.10.1  Adult mouse colon and proximal small intestine 
2.10.1.1  Selection and validation of appropriate reference 
(housekeeping) genes  
Reference (housekeeping) genes were used as endogenous controls to obtain 
relative gene expression values in gut samples. Two housekeeping genes: 
beta glucuronidase (Gusb) and TATA Box Binding Protein (Tbp) were selected 
for qPCR according to current evidence from the literature (Wang et al, 2010). 
These 2 genes have been shown to be stably expressed in mouse gut tissues 
and there is no evidence that expression of these genes is influenced by diet. 
To test for the suitability of these two reference genes, two samples from each 
treatment group (as illustrated in Fig 2.2) were randomly selected for pilot 
qPCR to check for the possibility of treatment effects on expression of these 
genes in both colon and proximal small intestine. This showed no significant 
treatment effects (two-way ANOVA, p>0.05) found for either of the reference 
genes (data in Appendix 2E).  Therefore both Gusb and Tbp were deemed to 
be suitable as endogenous controls (reference genes) for quantification of 
mouse-specific relative gene expression in the present study. 
 
2.10.1.2 Primer design 
Primer sets for qPCR were designed using the Primer3 website 
(http://primer3.ut.ee/). The cDNA sequences for all five target genes (Esr1, 
p16, Slc39a4, Obfc2a and Ppm1k) and the two reference genes (Gusb and 
67 
 
Tbp) were obtained from NCBI and checked on BLAST. Primer sets were 
designed with melting temperatures between 59-61˚C, product size ranges 
from 90-110bp and PCR products that include at least one exon-exon splice 
junction (Pfaffl, 2001). This allowed the amplified products to be differentiated 
from genomic DNA contamination on electrophoresis. 
Each set of primers was checked for its specificity in in silico PCR using the 
UCSC online Genome Browser software. The potential for formation of 
duplexes and of hairpins was tested through the REviewer™ sequence 
analysis tools (Thermo Scientific) for each set of primers. The full list of primer 
sequences for the RT-qPCR assays is provided in Appendix 2F. 
  
2.10.1.3  Serial dilution curves for mouse qPCR primer sets 
Serial dilutions were created for cDNA in triplicate using QuantiFast SYBR 
Green PCR kit (Qiagen). Reagents and materials for each qPCR reaction were 
the same as described in 2.9. Dilution curves were created using five serial 
dilution points with dilution factors of either 5 or 3, i.e. 1:1, 1:5, 1:25, 1:125 and 
1:625; or 1:1, 1:3, 1:9, 1:27 and 1:81. Technical triplicates within 0.5 CT values 
were included and averaged for each serial dilution point. Standard curves for 
adult mouse colon were obtained successfully for Esr1, Slc39a4, Obfc2a and 
Ppm1k. Standard curves for Slc39a4, p16, Obfc2a and Ppm1k were generated 
for adult mouse proximal small intestine. Examples of a standard curve, a melt 
curve and an amplification plot are shown in Fig 2.6. Standard curves for the 
two reference genes (Gusb and Tbp) were obtained for both adult mouse colon 
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and small intestine. Standard curves, melt curves and amplification plots for all 
targets and reference genes in both mouse tissues are shown in Appendix 2G.  
 
Figure 2.6  A) Standard curve, B) amplification plot and C) melt curve 
for p16 expression in adult mouse proximal SI  
 
 
 
 
note: serial dilution in factor of 3, i.e. the five points are 1:1, 1:3, 1:9, 1:27 & 1:81 
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Legend: 
 
C = 1 in 1 dilution 
D = 1 in 3 dilution 
E = 1 in 9 dilution 
F = 1 in 27 dilution 
G = 1 in 81 dilution 
 
B 
C 
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2.10.2  Human colo-rectal mucosa biopsies 
2.10.2.1  Selection of reference genes  
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 18S ribosomal 
RNA (18s rRNA) were selected as endogenous controls (reference genes) for 
human samples based on the literature (Bas et al, 2004; Zampieri et al, 2010). 
To further examine the suitability of both GAPDH and 18s as reference genes 
in the present study, one sample from each of the high folate and low folate 
groups, and one sample from each of the younger and older groups were used 
as pilots to check for possible effects of folate status and / or age on expression 
of both reference genes. According to CT values obtained in the amplification 
plot, no effects of treatment group were found for either gene, and so both 
were used as endogenous controls (reference genes) for human-specific 
qPCRs in the present study. 
 
2.10.2.2  qPCR assays for quantification of gene expression 
QuantiTect expression primer assays (Qiagen) were used for quantification of 
expression for three target genes (SLC39A4, ESR1 and OBFC2A) and the two 
reference genes (GAPDH and 18s) for the human colo-rectal mucosal 
samples.  
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2.10.2.3  Serial dilution curves for human qPCR primer sets 
The same reagents and dilution protocols as described in 2.10.1.3 were used 
to generate standard curves for the human-specific qPCR analysis. The FAST 
program in StepOnePlus qPCR system (Applied Biosystem) was used to 
obtain raw CT values (annealing at 60˚C for 30sec, x 40 cycles) using the 
StepOne software version 2.2.2 (Applied Biosystem). Melt curves were 
performed for all qPCRs as described in 2.9. All standard curves, melt curves 
and amplification plots for all three targets and two housekeeping genes for 
human colon are reported in Appendix 2H. 
 
 
 
2.11  Statistical Analysis 
2.11.1  Gene-specific methylation in mouse and human 
All pyrosequencing data were exported to Microsoft Excel; technical replicates 
that exceeded the 5% threshold were discarded and the analysis was 
repeated. Methylation values for each sample were averaged and used to 
create a data file in SPSS Statistics software for data analysis. 
‘Microsoft SPSS Statistics 17’ and ‘Minitab’ software were used to investigate 
the effect of maternal dietary folic acid supply on the percentage methylation 
at Igf2-DMR1, Esr1, Slc39a4-CGI1 and –CGI2, p16, Obfc2a-amp1, -amp2 & -
amp3 and Ppm1k-amp1 & -amp2 loci. The Kolmogorov-Smirnov test was used 
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to test for normal distribution of each dataset and it was found that all data 
were normally distributed. For methylation of each individual CpG and mean 
methylation of all CpG sites within each locus, analysis of variance (ANOVA) 
was used to examine the effect of the dietary interventions. Further details of 
the statistical analysis methods are provided in Chapters 4 and 5. 
Possible influences of fetal weight (FW), placental weight (PW), fetal gut 
weight, serum 5-methyltetrahydrofolate (5-MTHF) and serum 5,10-
methyltetrahydrofolate (5, 10-MTHF) concentrations of dams and placental 
efficiency (data obtained from McKay et al, 2011a) on methylation at each CpG 
site and on mean of all CpG within each locus were examined using linear 
regression.   
 
2.11.2  Gene-specific methylation in adult mouse proximal small 
intestine and colon  
‘Microsoft SPSS Statistics 19’ was used for data analysis. The Kolmogorov-
Smirnov test was used to test for normal distribution and ANOVA was used to 
examine the effects of maternal folate depletion and/or high fat diet after 
lactation. Phenotypic data from studies of these adult mice have been reported 
previously (McKay et al, 2014). 
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2.11.3  Gene-specific methylation in human colon 
‘Microsoft SPSS Statistics 19’ was used for analysis of data derived from 
analysis of the human colo-rectal mucosal samples (see Chapter 6 for further 
details of the statistical analysis approach used). Phenotypic data from the 
volunteers in the BORICC 1 study were provided by Prof JC Mathers. 
  
2.11.4  Gene expression in mouse proximal small intestine and 
colon 
All data generated from qPCR were exported to Microsoft Excel. The means 
of raw CT values for all three technical replicates for each biological sample 
were calculated. Expression of the reference genes was tested for potential 
treatment effects using two-way ANOVA and no significant effects (p>0.05) 
were observed. The geometrical means (geomeans) for both reference genes 
were used to calculate relative expression of each target gene in 
corresponding samples using the  2-ΔCT method (2–(CT value of sample – CT value of 
geomean of HKG)). One-Sample Kolmogorov-Smirnov Test was used to test for 
normal distribution of each data set and a probability plot was used to illustrate 
the normality of data (example shown in Fig 2.7).  
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Figure 2.7  Probability plot for geomean of housekeeping genes in 
adult mouse proximal small intestine 
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Log transformation or Box-Cox transformation (Minitab 16 Statistical software) 
was applied to datasets that were not normally distributed. Where such 
transformations were unsuccessful in normalising the data, the original non-
transformed data were analysed using the non-parametric Mann-Whitney U 
test. 
 
2.11.5  Gene expression in the human colo-rectal mucosa 
For the human colo-rectal mucosal sample, the same approaches for the 
analysis of gene expression data, including validation of reference genes, and 
the formula used for the relative expression calculation were similar to those 
applied in the analysis of expression data for the mouse tissues.  
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CHAPTER 3 
 
Identification of candidate genes for quantification of gene-
specific DNA methylation  
3.1  Introduction 
Folate acts as a methyl-donor in one-carbon metabolism through SAM (as 
discussed in section 1.4.2) and therefore altered folate supply can cause 
epigenetic changes and contribute to phenotypic changes. In addition, altered 
folate supply may modulate the carcinogenic and ageing processes (as 
illustrate in Fig 3.1 below).  
Figure 3.1 Interactions between ageing and folate deficiency during 
cancer development (taken from Kim et al, 2009) 
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Based on the evidence that aberrant methylation can influence gene 
expression at the transcriptional level (Feil & Fraga, 2012; Gibney & Nolan, 
2010), the main aim of the work described in this chapter was to identify 
candidate genes for quantification of promoter methylation and gene 
expression in subsequent studies in mice (see Chapters 4 and 5).  
Epigenetic changes are all hallmark of ageing (López-Otín et al, 2013) and 
arise in most tumours. In particular, aberrant gene-specific DNA methylation is 
one of the features of both ageing and of age-related disease such as cancer 
(Psofaki et al, 2010; Irizarry et al, 2009). Hyper-methylation of Igf2-DMR1, Esr1 
and p16 has been reported in both the normal ageing human colon and in 
colorectal cancer (reviewed in Lao & Grady, 2011). Because of the uncertainty 
whether this observation is exclusive to the human colon, Maegawa et al 
(2010) compared DNA methylation in a variety of both young and old (3 and 
35 months old respectively) mouse tissues. All three genes displayed 
differential methylation with age in mouse intestine, and tissue-specificity was 
found for both Esr1 and Igf2-DMR1. Age-related hyper-methylation of ESR1 
and IGF2 has been observed in the human colon, and of p16 in mouse colon 
(reviewed in Kim et al, 2009). Age-related decline in Slc39a4 methylation was 
observed in the mouse intestine (Maegawa et al, 2010) – this would be 
expected to increase Slc39a4 expression. Interestingly, energy restriction 
(which can increase lifespan in a number of species, Daniel & Tollefsbol, 2015; 
Mattison et al, 2012) led to down-regulation of SLC39A4 in human intestinal 
cell line (Ions, 2011).  
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A literature search was carried out to investigate the biological characteristics 
of these four genes and of their gene products and of their involvement in age-
related diseases.  
 
3.1.1  Igf2-DMR1  
Insulin-like growth factor II (Igf2) is one of the most extensively studied genes 
with respect to DNA methylation. Igf2 is an imprinted gene which is transcribed 
from the paternal allele only and whereas the maternal allele is heavily 
methylated (Calvanese et al, 2009; Ferguson-Smith & Surani, 2001; Waterland 
et al, 2006). In mice, Igf2 is located at the distal end of chromosome 7 (Kaffer 
et al, 2001) whereas in humans IFG2 is located on chromosome 11 at position 
11p15.5 (http://ghr.nlm.nih.gov/gene/IGF2). The gene  encodes the growth 
promoting hormone insulin-like growth factor 2, which promotes cell 
proliferation and growth in many tissues including brain, liver, colon and 
placental. Because Igf2 is highly active during embryonic development, it is 
essential for normal fetal progression, including placental growth (Christiansen 
et al, 2009).  
Loss of imprinting (LOI) at the IGF2 locus has been reported in Wilms tumour 
from human fetal kidneys (Ogawa et al, 1993) and in colorectal cancers (CRC) 
(Lahm et al, 1992). In the apparently normal human colon mucosa from 
individuals with CRC, loss of IGF2 imprinting was found in approximately 30% 
of cases compared with only 10% of disease-free subjects (Cui et al, 2003). 
Increased IGF2 expression occurs with IGF2 LOI as a result of expression 
from the maternal allele, possibly through mutation or silencing of a CCCTC 
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binding factor that binds to the unmethylated differentially methylated domain 
in the maternal allele (Nie et al, 2012).  
Igf2 expression is regulated by methylation at four differentially methylated 
regions (DMRs) in the mouse (Fig 3.2, Lopes et al, 2003). DMR1 is a silencer 
element upstream of the IGF2 promoter region and has been found to be 
hyper-methylated in normal human ageing colon tissues and in colon cancer 
(Woodson et al, 2005; Xu et al, 2004; Issa et al, 1996). Conversely, Maegawa 
et al (2010) recently reported Igf2-DMR1 hypo-methylation in older compared 
with younger mouse small intestine. Igf2 methylation appears to be plastic in 
response to folate supply. For example, Igf2 hypo-methylation was observed 
at specific CpG sites in Igf2-DMR1 in liver, kidney and blood from folate-
depleted compared with normal post-partum mice (McKay et al, 2011a). 
Higher IGF2-DMR methylation has been reported in infants whose mothers 
received pre-conceptional folic acid supplementation (Steegers-Theunissen et 
al, 2009). In summary, Igf2 methylation appears to be altered in ageing and in 
the development of cancers, including CRC, and to respond to folate supply. 
These changes in methylation, and in particular LOI, are likely to induce 
changes in expression of Igf2 but this has been less intensively investigated.  
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Figure 3.2  Location of the four differentially methylated regions of 
Igf2 in mouse chromosome 7: 142,650,766-142,666,816 (adapted from 
Lopes et al, 2003) Please note: black box denotes active expression while 
white box denotes inactive expression  
 
 
 
3.1.2   Esr1  
In mice, the Esr1 gene is located on chromosome 10 (from MGI, 
http://www.informatics.jax.org/marker/key/45360) whereas the human 
homolog ESR1 is found on chromosome 6 (6q25.1) 
(http://ghr.nlm.nih.gov/gene/ESR1). ESR1 encodes the intracellular nuclear 
receptor oestrogen receptor α protein (Tsiambas et al, 2011), and contains 
several domains including DNA-binding, transcription activating, dimerization 
and hormone-binding domains (Osborne et al, 2005). The ESR1 gene product 
belongs to oestrogen receptor protein family that is activated by the hormone 
17β-oestradiol and can regulate gene expression by functioning as a 
transcription factor (Tsiambas et al, 2011). ESR1 has a role in signal 
transduction and the regulation of transcription and cell growth (Osborne et al, 
2005). Furthermore, it is essential for mammalian breast development 
(Macaluso et al, 2007).  
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ESR1 promoter hyper-methylation was first reported by Issa et al (1994) in 
normal ageing human colorectal mucosa, and subsequently in human 
colorectal cancer (Kondo & Issa, 2004). Increased Esr1 hyper-methylation was 
also observed in the normal ageing mouse small intestine (Maegawa et al, 
2010). ESR1 methylation in normal colon mucosa is higher in older compared 
with younger humans (Kaz et al, 2014; Worthley et al, 2010). In disease free 
individuals aged 65 years or less, ESR1 methylation was lower in both the 
distal and proximal colon than in individuals aged > 65 years (Hiraoka et al, 
2010). As observed for other genes, ESR1 methylation differs between tissues 
(McKay et al, 2011a). For example, in human leukocytes, ESR1 was 60% less 
methylated than in normal colon from the same person (Ally et al, 2009). 
Furthermore, Al-Ghnaniem et al (2007) observed higher ESR1 methylation in 
normal-appearing colorectal mucosa from colorectal cancer patients and 
subjects with hyperplastic polyps or adenoma compared with disease free 
individuals. Interestingly, Hiraoka et al (2010) reported that as the stage of 
neoplasia increased, ESR1 methylation in the apparently-normal mucosa 
decreased.  In summary, ESR1 methylation in the normal colon mucosa 
increases with age and is raised in colorectal cancer but, curiously, ESR1 
methylation in the normal colon mucosa appears to fall with disease 
progression.  
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3.1.3  p16 
In humans, the tumour suppressor gene cyclin-dependent kinase inhibitor 2A 
(CDKN2A), also known as p16INK4A, is located on chromosome 9 (9p21.3) 
(http://ghr.nlm.nih.gov/gene/CDKN2A) whilst in mouse its homolog is located 
in chromosome 4 (http://www.informatics.jax.org/marker/key/24976). The 
protein product, p16INK4A, binds to and inhibits cyclin-dependent kinases CDK4 
and CDK6, leading to the hypo-phosphorylation of pRb and inhibition of cell-
cycle progression and cell proliferation (Bazarov et al, 2010; Sherr, 2001).  
Aberrant p16 methylation has been observed in various ageing tissues. For 
example, So et al (2006) reported promoter hyper-methylation of p16INK4A 
(together with LOX, RUNX3 and TIG1) in ageing human gastric mucosa, and 
normal human ageing colon tissues (Kondo & Issa, 2004). Inactivation of p16 
by promoter hyper-methylation has been observed in both colorectal 
adenomas and human colon cancer (Rashid et al, 2001; Guan et al, 1999). 
p16 promoter hyper-methylation is an early event during oncogenesis in 
morphologically normal cells (Holst et al, 2003; Nuovo et al, 1999) and Psofaki 
et al (2010) reported a positive correlation between p16 promoter methylation 
and polyp progression to lesions of greater tumourigenic potential. Recently, 
serum methylated p16 has been investigated as a potential prognostic 
biomarker in gastric cancer (Wu et al, 2014). While the use of p16 as a 
prognostic biomarker in some cancer is still controversial, a meta-analysis by 
Lou-Qian et al (2013) showed that p16 methylation correlated with poorer 
survival in non-small cell lung cancer. On the other hand, chronic expression 
of p16 INK4A can induce cellular senescence as a protective mechanism against 
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carcinogenesis (reviewed in LaPak & Burd, 2014). This suggests meticulous 
regulation of p16 is required in order to achieve a balance between 
suppression of tumourigenesis and ageing (LaPak & Burd, 2014). 
Promoter p16INK4A hyper-methylation has been associated with the silencing 
of p16INK4A in human mammary epithelial cells and has been shown to increase 
lifespan in vitro (Hinshelwood et al 2009; Holst et al, 2003; Noble et al, 1996). 
In addition, Janzen et al (2006) reported inhibition of p16INK4a expression 
diminished age-related apoptosis in stem cells in mice, and improvement in 
stress tolerance and repopulation of injured tissue was observed. This implies 
transcriptional silencing of p16 could have different effects among cells and 
species. 
 
3.1.4  Slc39a4  
The Slc39a4 gene, also known as ZIP4, is one of the solute carrier family 39 
(Slc39/ZIP) families of zinc transporter proteins. In humans, ZIP4 is located on 
the long arm of chromosome 8 (8q24.3, http://ghr.nlm.nih.gov/gene/SLC39A4) 
wheras in mice the homolog Slc39a4 is located on chromosome 15 (MGI, 
http://www.informatics.jax.org/marker/key/56007). The encoded transporter 
protein is expressed at the apical membrane of enterocytes in the mouse. ZIP4 
is involved in dietary zinc absorption within the duodenum and jejunum and is 
responsible for the maintenance of cellular zinc homeostasis (Fairweather-Tait 
et al, 2008). Mutation in the ZIP4 gene is responsible for the genetic disorder 
acrodermatitis enteropathica (Dufner-Beattie et al, 2003).  
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McKay et al (2011a) reported CpG site and CGI specific Slc39a4 hypo-
methylation in livers, kidney and blood of post-partum dams that were fed 
folate-depleted diets pre-implantation and during pregnancy compared with 
normal dams. Slc39a4 is hypo-methylated during ageing in the mouse small 
intestines (Maegawa et al, 2010). In addition, hypo-methylation of Slc39a4 was 
observed in 4 human colorectal cancer (CRC) cell lines (HCT116, DLD1, RKO 
and SW480) (Kim et al, 2009a).   
Age-dependent epigenetic effects on ZIP genes may have a role in decline 
zinc homeostasis and/or higher dietary zinc requirements with increasing age 
(Fairweather-Tait et al, 2008). Interestingly, recent evidence suggests reduced 
intracellular zinc status in mouse immune cells was associated with enhanced 
inflammation in vitro with increasing age.  
 
 
3.2  Selection of additional candidate genes 
To increase the probability of finding genes that respond to the effect of folate 
supply and/or age, databases of gene expression from studies carried out in 
the Mathers laboratory were searched. In addition, bioinformatics tools were 
used to identify the promoter regions of these “new” candidate genes, CpG 
islands within those promoter regions and, finally, transcription factor binding 
sites which might be influenced by promoter methylation.   
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3.2.1   Rationale for bioinformatics approach and in silico analysis 
I hypothesised that folate status and ageing would alter gene expression 
through effects on promoter methylation. Although the mechanisms 
responsible for the (usually) inverse relationship between promoter 
methylation and gene expression are not known with certainty, it has been 
assumed that methylation of regulatory regions of the genome can prevention 
binding by regulatory proteins and/ or the transcriptional machinery. In general, 
initiation of transcription is the most significant and stringently regulated stage 
of gene expression. For higher eukaryotic organisms, such regulation of genes 
is governed combinations of regulatory proteins known as transcription factors 
(TF). TFs recognise and bind to specific regulatory sequences – TF binding 
sites (TFBS) - which are typically situated in the promoter region of genes 
(Marsman & Horsfield, 2012; Moss et al, 2007; Suzuki et al, 2001). Gene 
transcription is repressed when the binding of transcription factors to 
promoters is prohibited by DNA methylation (Du et al, 2012; Wrzodek et al, 
2012; Watt & Molloy, 1988).  
Bioinformatic tools such as Entrez Gene, MGI, Nucleotide, NCBI Blast, UCSC 
genome browser and RefSeq which are freely available online databases can 
provide useful and practical information about gene expression such as 
genomic sequences, coding sequences and locations of genes. In addition, 
gene promoters can be located using these databases and associated tools. 
Some of the information in these databases is based on experimentally verified 
5’ transcript ends and in these cases the data identified using these tools is 
usually reliable. However the information listed in each database and its format 
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are diverse and can be contradictory (Hosseinpour et al, 2013; Malkaram et 
al, 2012; Kel et al, 2005), so their use for promoter identification can be 
cumbersome. In contrast, Genomatix software (GmbH) draws on a more 
extensive database that provides substantial information on species and gene-
specific promoter locations (Gene2Promoter), tissue-specific TFBS and 
locations (ModelInspector). Whilst powerful, these tools generate a vast 
amount of output for each gene, so vigilant filtering and interpretation of output 
is essential for a meaningful outcome.  
The development of gene expression microarrays allows genome-wide 
scanning to identify gene(s) differentially expressed in response to 
environmental stimuli or ageing factors (Mensaert et al, 2014; Kobayashi et al, 
2013). To investigate the effect of maternal folate depletion during 
development, and also of ageing, on gene-specific methylation in adult murine 
offspring, three-sets of genome-wide microarray expression data were 
subjected to in silico analysis to select candidate genes for this project.  
Details of the strategy and steps used for choosing additional candidate gene 
are provided in section 3.2.2 below. 
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3.2.2   Microarray data 
In addition to genes identified using the criteria listed in section 3.1, extra 
candidate genes were identified using the following criteria:  
i) genes that were differentially expressed in fetal liver in response to 
reduced maternal folate supply, and  
ii) genes that showed age-related changes in expression.  
For this reason, genes were initially located from two sets of whole genome 
microarray expression data: 17.5 day old livers of male fetuses born from dams 
that were fed normal or folate depleted diets before mating and during 
pregnancy and lactation, and 6 months old offspring mice from the same 
maternal folate depletion model (the protocols for the mouse studies are 
reported  in McKay et al, 2011b and 2014 respectively, and microarray data 
sets were provided by JA McKay, D Ford and JC Mathers, in preparation). 
Genes that were ± ≥1.2 fold differentially expressed in both microarray 
datasets (17.5 day and 6 months old livers in response to low maternal folate, 
with p values of < 0.05) were selected. Ingenuity Pathway Analysis (IPA, 
Ingenuity Systems Inc., Redwood City, CA) software was then used to find 
genes that appeared in both sets of microarray expression data. Secondly, 
gene IDs that were not recognised by the IPA software were checked manually 
and added on to the preliminary candidate gene list. This preliminary gene list 
(n=18, Appendix 3A) was then  used to find genes that were also differentially 
expressed (± ≥ 2.0 fold) in young versus senescent human MRC5 lung 
fibroblast based on genome wide expression array data (Lisanti, 2013). Finally, 
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genes that appeared in all three sets of genome-wide microarray expression 
data were selected as the final candidate gene list (n=2, Fig 3.3).  
 
 
Figure 3.3  Selection of candidate genes from genome wide microarray 
expression data      
 
The two genes that overlapped in all three microarray data sets were Obfc2a 
and Ppm1k. Therefore, a literature search was carried out to discover the 
biological functions of the corresponding gene products and to determine what 
is known about the methylation status and/or expression of both Obfc2a and 
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Ppm1k in mammalian tissues in response to ageing and to altered folate 
supply. 
 
3.2.2.1 Obfc2a 
Oligonucleotide / oligosaccharide-binding fold containing 2A (Obfc2a), also be 
referred to as NABP1, encodes the nucleic-acid-binding protein 1. In humans 
this gene is located on chromosome 2 (2q32.3) 
(http://www.ncbi.nlm.nih.gov/gene/64859). The mouse homolog Obfc2a is 
located in chromosome 1 (http://www.informatics.jax.org/marker/key/59988). 
Kang et al (2006) demonstrated that is expressed at low levels in mouse brain, 
lung, liver, spleen, stomach, skeletal muscle and uterus, and is highly 
expressed in mouse heart, kidney, testis, thymus and placenta. Although the 
exact biological function of NABP1 awaits further investigation, its expression 
in double positive haematopoietic progenitor cells in thymus (number 5 of 6 
possible stages in thymocytes maturation, with CD4 and CD8 as positive 
defining cell surface markers, notable for high levels of DNA re-arrangement) 
suggests a possible role in DNA recombination or repair in thymocytes (Kang 
et al, 2006). 
The NABP1 protein binds to single-stranded DNA (ssDNA) through the 
oligonucleotide / oligosaccharide binding fold domain (Richard et al, 2008). 
ssDNA binding proteins are essential for cellular processes including DNA 
replication, recombination, transcription, damage recognition and repair and 
maintenance of genomic stability and may have a role in cancer development 
(Peters et al 2013, Won et al 2013, Broderick et al 2010). Obfc2a depletion in 
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mouse fibroblasts in vivo impaired proliferation, resulted in accumulation of 
chromosomal damage and hence elevated genomic instability (Feldhahn et al 
2012).  
To the best of my knowledge, there are no published data on the methylation 
status of the Obfc2a locus.  
 
3.2.2.2 Ppm1k 
The PPM1K gene in humans is located on chromosome 4 (4q22.1) 
(http://www.ncbi.nlm.nih.gov/gene/152926) whilst the murine homolog is 
located on chromosome 6 (http://www.informatics.jax.org/marker/key/83411). 
The gene product protein phosphatase Mg2+/Mn2+ dependent 1K is a nuclear-
encoded protein that is targeted to the mitochondria. This protein is also known 
as mitochondrial protein PP2Cm (mitochondrial matrix-targeted protein 
phosphatase 2C family member) (GeneCards, 2011; Wellcome Trust, 2011). 
It displays phosphoserine phosphatase activity and may have a role in the 
regulation of branched-chain amino acid catabolism. PP2Cm regulates the 
mitochondrial membrane permeability transition pore, which is vital for cellular 
survival, cardiac function and normal embryonic development (Lu et al, 2009; 
Lu et al, 2007). PP2Cm is expressed in several adult mouse tissues with the 
highest expression detected in brain, heart, liver, kidney and diaphragm (Joshi 
et al, 2007; Lu et al, 2007). PP2Cm deficient mitochondria are more 
susceptible to mitochondria permeability transition pore opening induced by 
excess Ca2+ influx, therefore loss of PP2Cm function has been associated with 
cell death (Lu et al, 2009).  
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Furthermore, Lu et al (2009 & 2007) demonstrated that inactivation of Pp2cm 
led to apoptosis in mouse liver in vivo, and to abnormal cardiac, digestive 
system and neural development in zebrafish embryos. In mouse, expression 
and function of PP2Cm are regulated at the transcriptional level and are reliant 
on nutrient status. Reduced PP2Cm mRNA status was found in adult mouse 
brain, heart and liver after 48 hr food deprivation (Zhou et al, 2012). In humans, 
PPM1K expression was significantly lowered in pancreatic islets from 
hyperglycaemic compared with normal glycaemic donors and was positively 
correlated with glucose-stimulated insulin secretion in transfected clonal β cells 
in rats (Taneera et al, 2012). 
No publications reporting Ppm1k methylation have been identified.   
  
 
3.3 Identification of genomic sequences, gene promoters and CpG 
islands 
3.3.1   For mouse samples 
Mouse genomic sequences for all candidate genes were obtained from Mouse 
Genome Informatics (MGI). Genomic promoter locations and promoter 
sequences for these Obfc2a and Ppm1k were obtained from the NCBI 
database (procedures listed in Appendix 3B). Gene specific promoter locations 
and promoter sequences were then checked against the promoter locations 
and sequences obtained from the Gene2Promoter output given by Genomatix 
software (available from www.genomatix.de through membership subscription 
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to NuGO – NutriGenomics Organisation). The length of each gene promoter 
was optimised to:  
- 500bp upstream from first transcription start site (TSS), and  
- 100bp downstream from last TSS. 
The locations of CpG islands (CGIs) for both genes were identified using the 
CpG island explorer 2.0 software and checked against CGI locations found 
using “MethPrimer” (Li & Dahiya, 2002) set with the following parameters: 
- length of CGI as 200bp, 
- GC content of > 50%, 
- observed/expected CpG ratio of 0.6.  
Only promoters that have a gold rating in Genomatix were selected for 
transcription factor binding site (TFBS) analysis. This is because promoter 
transcripts that have a gold rating were obtained from full length cDNAs at the 
5’ end which were verified experimentally (Genomatix, 2014). TFBS within 
gene promoters were identified using the ModelInspector tab in Genomatix 
and were mapped to genomic sequences of all candidate genes accordingly 
(Cartharius et al, 2005) (example shown in Fig 3.4).  
Overview of in silico steps carried out for assay development in Figure 3.5. 
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Figure 3.4  Genomic sequence and location of Obfc2a promoter and 
CGI in mouse (note: genomic sequence obtained from MGI – 
ENSMUSG00000026107, chr1: 51527142 – 51528635, CGI highlighted in 
yellow and promoter region in bold and within [bracket]) 
 
agttgctgcttgggacgcgggctgcgcggttggtgaacagccttgccgttttgctgtcacgtaccttccctgagcctggga
cggagggggcgcgcgcgtgtgcgtgtgttgtgtgagggacagcgggactcgggcagggccgtctcctgatcccttttcc
cttagcggaggcggcagtgcgcacgctggtttgctcgccgcccacttgggagcgggctcagggtgcggagtgcgtcttc
ggttttgttttttggttttttgttttttttgaacttgtgagag[tctttttcccctcccttttccatttttattttcttttggctccgt
gcctctagggctggtttacccggcccctgaattaccgcttcctgaccccggtcgccaatcttgccccaggttgctccccg
gctctgcccctgcccctccccgagggtgggaagccttgcctagtgggtctctgaagcgtagccgcacctgcctcagtat
gcacggggtcaacgaccctccactttttataaaagacattaaggccggactgaaaaacttaaatgtcgtctttattgtc
ctggagataggtaagtgaggtccgcagcccgccccacaccctcgagagctcggacctcttccccgcccgcgaccccac
gtgctcctggcccagaatcctacccggggacagaagtcagtcacgtagcgagccagaggagggtgaaagagctccc
tcgaatgaactccttatctaacacacctttccttctcccctttttgatttttaaatcttcacaggacgagtgaccaaaacc
aaagacggccatgaagtgagatcctgcaaagtagctgatagaacgggaagcatcactatttctgtgtgggatgagat
cggagg]gctcatacagacaggggatattattcggttgaccagagggtaggtgtgcataaattggggtaggtgtgggtt
tggccgacttcggggttctgaagttgtttggctcttccatgggccacttcaagaagggagctgttttagtggacctcactg
ggagcagctcaccttcacagctaatttgttttaggtagggatttaactcccctccaattttaaaggttaattttatttttgag
aataccgtgtggaagtcagtgagcatttatcagtgaggctgataaaagatcacattaccctttccaccctttcttggaga
ctgggtttttctgtgtagccctggttgtcctggaacaattctatagactagtctgtcctcgaactcacagagatatacctgg
aaatcagttctgtgtgccacaccagttggacacatttcctttttaatcagttcgtgtatgaagtataatgtcttccacccctt
tccttttttggtacctttttttgtactcaatactcatcgttgtgatatggacatgaatgaatatctggaatactcattcttgaa
aatgatttcatctgtaagatcagagtttcacaaaacccaaaat 
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Figure 3.5   Overview of multiple In silico steps for assay 
development 
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3.3.2  Selection of genomic regions for development of 
pyrosequencing assays for human samples 
The strategy described above in section 3.3.1 was repeated to locate the gene 
promoter and CGI in SLC39A4 and for use in the design of pyrosequencing 
assay for human samples. One CGI was identified within the SLC39A4 
promoter region. 
For ESR1 and OBFC2A, pyrosequencing assays were purchased from Qiagen 
and the primer sets were provided as QuantiTect primer assays in which the 
sequences of the PCR primer set were not known. However, the location of 
genomic region for pyrosequencing for both genes was identified by locating 
the pyrosequencing primers within genomic sequences for each of the three 
assays (example shown in Fig 3.6). Therefore the procedures listed in Fig 3.5 
were followed for both ESR1 and OBFC2A with the exception of the second 
last step where PCR primer sets for pyrosequencing were provided by Qiagen.   
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Figure 3.6  Genomic sequence and location of OBFC2A promoter and 
CGI in human (note: sequence obtained from NCBI reference sequence 
NC_000002.11, chr 2, 192542000 – 192544000, CGIs highlighted in yellow, 
promoter region in bold and within [bracket], sequence analysed in 
pyrosequencer underlined) 
 
GTTCCCACTGCTGTTGAATAATTAATTCCTTTTAGATGTACAAAAGCAAGTGCAAAGTAAAAGAAGAA
AAGCTAAATGGGGAAGGTGTGTAATATGAGAGGCAGGGGGTAAGGAAAAATGAGAAGTCTGCAAAGGA
ATTTACGTCCTATCTGCTTAGCATTACACAGTGGAAGCCCACGTCAGACATTTGTGTTGCAGTCCTGC
CTGCTCAGGGGTTGCTGGGTGACCTTCTGCAAATTACCTCATCTTTCTGGGTTTCAATTTAAGTATGC
CTGAAATGAGGCGGTTGAATTG[ATCTCCAAATTCCCTTCTGGTGCTAAACTTCCAGCCTTGTAGCCA
CTGACGCCTTCACCATCCCAGCCTGTTTTCCCTTGGTACCGGACCAGCTGCCCTTGCCCGAACCCTGT
TCTTCCTCGACTGCGAACTTTCTAACGTACTCACAGGTTCTAAACTCTACCGTTCCTCGTGACCGAGG
GACTAAAGGGCCCGGGCAGGGGCTCAACTCTGAGAGAAAAAAAGGCAAGAAAACTCCAAAGTTGGACA
GCAAGCGTCAAAAGACTGCACAGCAGGAAGGCGAAACCGAACAGAACTGCTGCTGCGCGGCGACAGCT
GAAGTGGGTGGAGAACGGGAGGGCGGGGGAGGCGGGGCCGAGAGCGATTGGAAGGACGAGGGGGCGGA
GCCCGCGCTGACAGCCCCCGGGGAGGAGCGAGGGAAGCTCTGCGGGCTGCGGCGGCCGGGTCCCGCCC
CTTTGCTTCCCCTCCCCAGCACCAGGCGGGCGTGGCAGCAGGCGTGCCGACGCAGCGTGACTTCACAA
GGGGAGGGGCGGGCCGAGGGTCCTGCCGGCGCGCGGGCGTGTTCATCAGTCGCTGTTTGGGACGCTGG
GTGTGCGGTGTTCTGTCTCCGCTCCCGTTTCGCTGTCACAGCCCGTTCCTTCCCGGAGCCCGGGACAG
GCTGGGCGCGCGCCCGTGTGAGTGAGCGGGACTCAGGGCAGAAGTGTCCCCTCACTGCGTTTTTTTTT
CCTTTTATCCAAAGAACGGGGCAGTTAGTACGCTTGCCTTCCTGTCGCCCGGTTGGGAGCGGGGTTGG
TGTGCGGAGTGGTTCGCCTTTTTTTCTTTAGAACTTGTGAGCCTTTTTTTTTTTTTTTTTTTTTTTTC
TTTTTTTAGGCTCAGTGCTGTCCGGGCTGGTTTGCCCGGTCCCTGACTAACGGCTTTCTGCCCCTTCT
CTCGCCACCCCTGCCCAAGGTCGCCCCTCTGCCTTCGCCCCTGTCCCGGGAGGGTGGGAAGCTTTGAC
CCCGCCCTGCCCACTCGCGTCTCCGCAGCCGTAGCCGCGCCTGTCCCAATATGAATAGGGTCAACGAC
]CCACTTATTTTTATAAGAGATATTAAGCCCGGACTGAAAAACTTAAATGTCGTCTTTATTGTCCTGG
AGATAGGTAAGTGGGGTTTGCAGCCTACTCCACCGCCCGCTGTGCCTCCCGGGGCGGGAGACAGGGGC
GCCGGCCGCTGCGCGCCCGGGGCTCCCCTCCTCCTCCCTCCCCTCCCCCACCCACGTGGCTCTAGTGG
CCTCCGCCCGAGATCGGATCCTACCTGAGGCGGGAGCCCTGGGCTTGGTCACTTCCCACCTTCCAGAT
GTATTAAAATACCGGAGGAGGAGTTAGCCTTTCTGGATGTCCTCATTATCTAACAACCCCTCCCTTTG
ATTTTTAAATCCTCACAGGACGCGTGACCAAAACCAAAGACGGCCATGAAGTGAGATCGTGCAAAGTA
GCAGATAAAACGGGCAGCATCACTATTTCCGTGTGGGATGAGATCGGAGGTCTTATACAGCCAGGGGA
TATTATTCGGTTGACCAGAGGGTAGGTGTGCAAAAAAGTCGGGGGACCTAACAGTCTGCAGAATCGGG
ATTGGCCGGCTCCTGGGATCTTGGCAAGCCCTGAAGTCCCCCGCCTTTTCTGTGGGCCACTCTTGAGG
AGTTTTGAACTCCTTTGGTGTTAACTTTGGG 
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CHAPTER 4 
 
DNA methylation in the gut of mouse fetuses from dams fed 
diets with normal or low folate content 
 
4.1  Introduction 
Folate is involved in the synthesis of purines and thymidylate (Nazki et al, 
2014) therefore is essential for cell division, DNA replication and DNA repair 
(Bailey & Gregory, 1999). Maternal folate supply has major effects on fetal 
development and on the health of the next generation (reviewed in van Uitert 
& Steegers-Theunissen, 2013). Inadequate folate intake during gestation is 
associated with a higher risk of spina bifida, cleft lip and palate and 
complications in late pregnancy (Blom & Smulders, 2011). High serum folate 
concentrations, use of folic acid supplements and higher dietary folate intake 
are associated with reduced risk of low birth weight (Charles et al, 2005) and 
of small for gestational age neonates (Baker et al, 2009). Currently, folic acid 
supplementation during early pregnancy and pre-conception is recommended 
worldwide to reduce the incidence of neural tube defects (van Uitert & 
Steegers-Theunissen, 2013). 
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Increasing evidence from both human and animal studies supports the 
hypothesis that environmental exposures during development affect the risk of 
disease in adult life (reviewed in Dolinoy et al, 2007a) – the so-called 
Developmental Origins of Health and Disease (DOHaD) hypothesis. Maternal 
dietary intake (especially of those nutrients involved in one-carbon metabolism 
such as folate, choline and vitamin B12) has been linked to epigenetic 
modulation of gene expression (Haggarty et al, 2013). In addition, sub-optimal 
folate status in adulthood is associated with higher risk of cardiovascular and 
other age-related diseases (Blom & Smulders, 2011). Alterations in DNA 
methylation has consequential effects on gene expression and is one probable 
mechanism that explains the connection between nutritional supply in utero, 
fetal programming and disease phenotype in the offspring (Dolinoy et al, 
2007a). Because of its key role as a one-carbon donor for synthesis of S-
adenosyl methionine (SAM, the universal methyl donor), folate status can have 
an effect on DNA methylation in the promoter region of genes and thus 
modulate gene expression (Jirtle & Skinner, 2007).  
The roles of Esr1, Igf2 and p16 methylation in ageing and in age-related 
diseases have been identified (see Sections 3.1.1, 3.1.2 & 3.1.3 respectively 
for overview) but, prior to the start of this project, the DNA methylation patterns 
of these three genes in foetuses has not been reported. Similarly, although 
hypo-methylation of Slc39a4 has been reported in the aged mouse intestine 
(in section 3.1.4), the effect of maternal folate supply on Slc39a4 methylation 
in mouse foetuses and in the dams has not been established. Furthermore, 
whole genome gene expression studies using microarray-based approaches 
(McKay et al, unpublished data), revealed differential Obfc2a and Ppm1k 
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expression in fetal (17.5d) mouse livers in response to low folate intake (details 
in Fig 3.3) but to date no studies have reported the methylation status of these 
two genes in fetal gut from mouse. 
 
 
4.2 Hypothesis, aims and objectives 
The main aim of this chapter is to test the hypothesis that dietary folate 
depletion in utero affects DNA methylation of a panel of genes in the fetal 
mouse gut. To test this hypothesis, a panel of genes namely Igf2-DMR1, Esr1, 
Slc39a4, p16, Obfc2a and Ppm1k were selected. Gene specific DNA 
methylation was quantified at several CpG sites within each of these genes by 
Pyrosequencing using DNA from fetal gut tissues of offspring born from mouse 
dams that were subjected to either a folate adequate or folate depleted diet 
pre-conception and during gestation (details of the origin of the fetal gut tissue 
are described in Fig 2.1 and in section 2.2.1). 
 
 
4.3 Overview of experimental approach 
DNA was extracted from fetal gut tissue according to the procedures described 
in Section 2.5.1. Pyrosequencing to quantify DNA methylation at selected CpG 
sites was carried out on bisulphite-modified DNA using the procedures 
described in section 2.6. DNA methylation data were obtained from 2, 3, 9, 3, 
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5, 9, 9, 8, 4, 7 CpGs for Igf2-DMR1, Esr1, Slc39a4-CGI1 & –CGI2, p16, 
Obfc2a-amp1, -amp2 & -amp3, and Ppm1k-amp1 & -amp2 respectively. 
Statistical analysis was carried out as outlined in Sections 2.6 and 2.11 
respectively. 
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4.4  Results: 
4.4.1  Levels of DNA methylation at the ten loci studied in fetal gut  
When data for all foetuses were pooled (i.e. considering offspring from folate-
depleted and control dams as a single group), mean methylation in DNA from 
fetal gut differed considerably across the genes loci investigated. Mean DNA 
values were greater than 50% for Igf2-DMR1 (n=34, 52.6% SEM 3.74), 
Slc39a4-CGI1 (n=34, 69.2% SEM 4.86) and for Slc39a4-CGI2 (n=34, 63.8% 
SEM 6.01). The only other gene locus for which mean methylation was greater 
than 10% was p16 (n=34, 11.3% SEM 7.63). Mean DNA methylation for all 
genes examined are shown in Fig 4.1.  
Note that the SEM values for each of the genes were relatively small indicating 
only modest inter-individual differences in DNA methylation at these loci. 
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Figure 4.1  Mean DNA methylation for each of the target genes in DNA 
from murine fetal gut tissue in offspring from dams fed diets with normal 
or low folate content (Note: data are the means of both dietary groups 
combined (n=34), error bars represent SEM)  
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4.4.2  Effect of maternal folate depletion on gene-specific DNA 
methylation 
There was no detectable effect of maternal dietary folate depletion on locus-
specific DNA methylation of Igf2-DMR1, Esr1, p16 and Slc39a4-CGI2 in DNA 
from murine fetal gut (ANOVA, p>0.05, n=18 for normal diet and n=16 for low 
dietary folate groups). In contrast, DNA methylation at CpG sites 3, 5, 6, 8, 9 
and overall mean of all CpGs across the Slc39a4-CGI1 locus was reduced 
significantly in DNA from the fetal gut from progeny of folate depleted dams 
(p<0.05, data shown in Fig 4.2 A). Similarly, significantly lowered DNA 
methylation was observed at CpG sites 1, 2, 4 and overall mean of all 4 CpGs 
at Ppm1k-amp1 in fetal gut DNA from the low maternal folate group (p<0.05, 
Fig 4.2 B). 
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Figure 4.2  DNA methylation at specific CpG sites in: A) Slc39a4-CGI1 
and B) Ppm1k-amp1 in fetal gut tissues from dam fed either a low or 
normal folate diet during pregnancy (*denotes p<0.05, error bars represent 
SEM, red represent low folate and yellow represent normal folate content of 
maternal diet) 
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4.4.3  Effect of sex on gene-specific DNA methylation 
Previous studies have reported effects of gender on DNA methylation at 
specific loci (Boks et al, 2009; Sarter et al, 2005) so in this study it was of 
interest to investigate the effect of gender (n=18 for male and n=16 for female) 
on DNA methylation at all ten loci studied. DNA from males was more highly 
methylated than that from females at the Esr1 locus for all 3 CpG sites and 
when expressed as an overall mean (ANOVA, p<0.05, Fig 4.3 A). For Slc39a4-
CGI1, levels of methylation were higher in females than in males at CpG site 
4 and when expressed as an overall mean across all 9 CpG sites investigated 
(p<0.05, Fig 4.3 B). Similarly, higher methylation was observed in females at 
CpG site 1 and overall mean across all four CpGs at Ppm1k-amp1 (p<0.05, 
Fig 4.3 C). No effects of sex on DNA methylation were observed at other loci 
measured in this study (p>0.05, data not shown). 
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Figure 4.3 Sex specific DNA methylation at CpG sites in: A) Esr1, B) 
Slc39a4-CGI1 and C) Ppm1k-amp1 loci. Data are pooled across both 
maternal dietary treatments (* denotes p<0.05, error bars represent SEM)  
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4.4.4  Investigation of possible maternal diet * offspring gender 
interactions on DNA methylation in fetal gut 
Given the evidence shown above of differences between males and females 
in DNA methylation at some loci, two-way ANOVA was used to test for possible 
dietary * gender interactions on DNA methylation at all ten loci in Igf2-DMR1, 
Esr1, p16, Slc39a4, Ppm1k and Obfc2a investigated here. However, no 
significant dietary and gender interaction effects were found on DNA 
methylation at all ten loci investigated (ANOVA, p>0.05, n=34, data not 
shown).  
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4.4.5  Effect of maternal dietary folate on fetal weight, fetal gut 
weight, placental weight and placental efficiency 
Low birth weight coupled with heavier placental weight has been associated 
with higher blood pressure and risk of hypertension in later life in humans 
(Barker et al, 1990). In this study, fetal body weight was significantly higher in 
the offspring from dams fed the folate depleted diet (p=0.006, Table 4.1, 
McKay et al, 2011b) but fetal gut weight, placental weight and placental 
efficiency were not affected by maternal folate supply (ANOVA, p>0.05, Table 
4.1).  
 
Table 4.1  Weight of fetal gut tissue, placental weight and placental 
efficiency of offspring from dams fed either a low or normal folate diet 
(data expressed as mean ± SEM) 
 
 
Low maternal folate 
supply (n=16) 
Normal maternal 
folate supply 
(n=18) 
Weight of foetuses (g) 0.854 (0.023) 0.779 (0.022) 
Weight of fetal gut (g) 0.269 (0.004) 0.267 (0.004) 
Weight of placenta (g) 0.104 (0.005) 0.104 (0.004) 
Placental efficiency* 8.373 (0.342) 7.691 .312) 
Note: * placental efficiency was calculated by dividing weight of foetuses by 
placental weight in each individual mouse offspring (De Paepe et al, 2015; 
Molteni, 1984) 
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4.4.6  Sex differences in fetal weight, fetal gut weight, placental 
weight and placental efficiency  
There were no differences between male and female foetuses in weight or gut 
weight (ANOVA, p>0.05, Table 4.2). However, placental weight was higher in 
male pups than in female pups (ANOVA, p=0.026, Table 4.2). This outcome is 
consistent with a lower placental efficiency in males but the lower mean value 
observed for males did not reach statistical significance (ANOVA, p>0.05, 
Table 4.2).  
  
 
Table 4.2  Differences in fetal weight, fetal gut weight, weight of 
placental and placental efficiency between the two sexes (data expressed 
as mean ± SEM) 
 
 Male (n=18) Female (n=16) 
Fetal weight (g) 0.835 (0.022) 0.796 (0.023) 
Weight of fetal gut (g) 0.269 (0.004) 0.266 (0.004) 
Placental weight (g) 0.111 (0.004) 0.098 (0.004) 
Placental efficiency* 7.745 (0.319) 8.325 (0.331) 
Note: *placental efficiency was calculated by dividing fetal weight by placental 
weight in each individual mouse offspring (De Paepe et al, 2015; Molteni, 
1984) 
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4.4.7  Interaction between maternal dietary folate and sex of 
offspring on fetal weight, fetal gut weight, placental weight and placental 
efficiency 
Due to the higher fetal weight observed in pups from folate depleted dams, 
and a higher placental weight in male offspring, two-way ANOVA was used to 
examine possible interactions between maternal dietary folate and sex of 
offspring on fetal weight, fetal gut weight, placental weight and placental 
efficiency. There were no significant interactions for any of the four phenotypic 
outcome variables (ANOVA, p>0.05, n=34, data not shown). 
 
4.4.8  Relationship between placental weight and locus specific 
DNA methylation in fetal gut 
Relationships between placental weight and methylation of Esr1, Ppm1k-amp2 
and Obfc2a-amp1 in fetal gut, regardless of maternal dietary regime, were 
examined using linear regression. This showed that for all CpG sites within 
Esr1, Ppm1k-amp2, higher placental weights were correlated with higher 
methylation (positive correlations) (Table 4.3). These relationships were 
significant for 4 out of the 11 CpG sites investigated and for overall mean 
methylation at each gene locus (Linear Regression, p<0.05, n=34, Table 4.3). 
In contrast, placental weight was negatively correlated with each methylation 
at each CpG site within Obfc2a-amp1, significantly so for 6 out of the 9 CpG 
sites investigated and for overall mean methylation at this gene locus (p<0.05, 
Table 4.3). No significant correlations were found between placental weight 
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and DNA methylation of CpG sites within any other loci including those of Igf2-
DMR1, Slc39a4-CGI, -CGI2 and p16 (p>0.05, data not shown).  
 
Table 4.3 Relationships between placental weight and CpG 
methylation at: A) Esr1, B) Ppm1k-amp2 & C) Obfc2a-amp1 loci 
investigated by linear regression (*denotes statistically significant 
correlations) 
 
Esr1 p value Correlation 
S1 0.108 +ve 
S2  0.012* +ve 
S3 0.060 +ve 
mean  0.038* +ve 
 
Ppm1k-amp2 p value Correlation 
S1  0.017* +ve 
S2 0.116 +ve 
S3 0.458 +ve 
S4  0.032* +ve 
S5 0.005* +ve 
S6 0.287 +ve 
S7 0.461 +ve 
mean  0.039* +ve 
 
Obfc2a-amp1 p value Correlation 
S1  0.014* -ve 
S2 0.079 -ve 
S3  0.032* -ve 
S4 0.066 -ve 
S5  0.029* -ve 
S6  0.014* -ve 
S7  0.011* -ve 
S8 0.123 -ve 
S9  0.019* -ve 
mean  0.011* -ve 
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For each gene separately, the relationships between placental weight and 
overall DNA methylation at that gene locus are illustrated in Figure 4.4. 
Multivariate regression analysis suggests when sex was added as a 
confounding factor, the relationship between placental weight and CpG 
methylation for each gene locus was not affected. (p>0.05, n=34, Figure 4.4) 
 
 
Fig 4.4 Relationships between sex, placental weight (g) and overall 
CpG methylation (%) at A) Esr1, B) Ppm1k-amp2 and C) Obfc2a-amp1 
(Note: values for Esr1 mean, Ppm1k-amp2 mean & Obfc2a-amp1 mean are % 
methylation and placental weight are in grams. Blue and green circles 
represent males and females respectively) 
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4.5 Discussion 
4.5.1   Effects of maternal folate depletion 
For the first time, this study has revealed lower DNA methylation at several 
CpG sites at Slc39a4 and Ppm1k-amp1 in gut tissue of foetuses from folate-
depleted mothers, compared with foetuses from mothers fed a diet containing 
normal levels of folate was observed in this study. In the current study, serum 
concentrations of 5-MTHF and 5,10-MTHF were used as biomarkers of folate 
status (Smith et al, 2006) and this analysis showed the expected reduction in 
maternal folate status following dietary folate depletion (p˂0.05 for both 5-
MTHF and 5, 10-MTHF; data published by McKay et al, 2011b). Thus it is 
reasonable to attribute effects of the dietary intervention on DNA methylation 
at various CpGs within Slc39a4-CGI1 and Ppm1k-amp1 loci in fetal gut to 
reduced maternal and, as a consequence, fetal folate status. The fact that 
there were no maternal dietary effects on DNA methylation at the other 8 loci 
investigated suggests that CpGs in DNA in murine fetal gut differ in their 
susceptibility to the effects of altered maternal folate status. Moreover, 
quantification of methylation status in DNA from blood, kidney and liver of the 
dams from the same study showed significantly lower methylation at specific 
sites within Esr1, Igf2-DMR1 and Slc39a4-CGI1 loci in the folate depleted post-
partum mice (McKay et al, 2011a). DNA methylation measurements for the 
remaining loci in this gene panel (i.e. p16, Obfc2a and Ppm1k) in dams are not 
known because methylation assays for these remaining six loci had not been 
validated at time of publication of McKay et al, (2011a).   
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In addition to requirements for optimal fetal growth and development, higher 
folate intake during pregnancy is needed to satisfy the physiological 
adjustments made by mothers, including blood volume expansion and tissue 
growth (Stamm & Houghton, 2013). The current observations, and those from 
McKay et al (2011a), indicate that the establishment of differential DNA 
methylation patterns in fetal gut tissue and in blood, kidney and liver from dams 
in response to maternal low folate intake could be tissue-specific (Thompson 
et al, 2010). A recent study of murine offspring whose mothers were exposed 
to an environmental insult (addition of lead to the drinking water) showed that 
effects on DNA methylation were sex- and tissue-specific (Sánchez-Martín et 
al, 2015). In the latter study, genome-wide methylation analysis identified 1623 
CpG sites, corresponding to 117 unique genes, which were differentially 
methylated following maternal lead exposure (Sánchez-Martín et al, 2015). 
This observation aligns with the present study in showing that not all gene loci 
in offspring are affected similarly (in respect of changes in DNA methylation) 
by maternal exposures. The molecular mechanisms responsible for such 
specificity in methylation responses to maternal folate depletion are not known. 
Since availability of SAM for methylation is, presumably, equal for all loci within 
a given cell, other factors including genetic architecture which affect the fidelity 
of the methylation machinery may be candidate mechanisms. 
The long-term health consequences of differences in Slc39a4 and Ppm1k-
amp1 methylation caused by maternal dietary folate depletion during 
development are likely to depend on the durability of the altered methylation 
patterns into adulthood, and whether these methylation changes are 
accompanied by changes in expression of the corresponding genes. In 
115 
 
addition, it is possible that the insult of maternal folate depletion will alter the 
ability of the offspring to cope with other dietary and environmental exposures 
in later life. These issues were addressed in the current study by investigating 
the possible influence of post-weaning dietary fat intake on these folate-
modifiable CpG sites, and on DNA methylation of additional genes, in DNA 
from the gut of adult mice (details in Chapter 5). In addition, changes in gene 
expression in the adult gut tissue were investigated (please refer to Chapter 
5).   
Published observations are consistent with the idea that altered Slc39a4 DNA 
methylation may be linked with ageing and / or disease. For example, reduced 
Slc39a4 DNA methylation was observed in murine ageing intestine and in 
human CRC cell lines (Maegawa et al, 2010; Kim et al, 2009a), and Slc39a4 
expression was elevated  in human hepatocellular, and both human and 
murine pancreatic carcinoma cells (Weaver et al, 2010; Zhang et al, 2010; Li 
et al, 2009). According to the current belief that DNA hypo-methylation is 
generally associated with up-regulation of the corresponding gene, the 
reduced Slc39a4 methylation observed here in fetal mouse gut may lead to 
increase in Slc39a4 expression. Furthermore, dietary restriction (which 
enhances lifespan in several species) has been shown to down-regulate 
SLC39A4 in human intestinal cell line (Ions, 2011). Determining if the 
differences in DNA methylation of Slc39a4 that we measured are associated 
with differences in expression of the gene may lead to a better understanding 
of their possible implications for health and / or ageing.   
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4.5.2   Sex differences in DNA methylation 
Sex specific differences in DNA methylation at Esr1, Slc39a4 and Ppm1k was 
observed in gut tissue from offspring regardless of the mother’s dietary folate 
intake. For Slc39a4-CGI1 and Ppm1k-amp1 DNA methylation was higher in 
females but methylation was higher in males for the Esr1 locus. The observed 
differences were relatively small but were statistically significant. These 
observations add to a growing body of information on sex-specific methylation 
at specific loci reported in mouse (Kobayashi et al 2013; Takasugi et al, 2013) 
and human studies (Edelman et al, 2012; Boks et al, 2009; Sarter et al, 2005). 
If these DNA methylation differences translate into differences in expression 
of the corresponding genes, this raises the likelihood of possible sex-specific 
phenotypic differences arising from differential DNA methylation. Furthermore, 
given the fact that Esr1 hyper-methylation has been found in ageing human 
colorectal mucosa and murine small intestine (Issa et al, 1994; Maegawa et al, 
2010), and Slc39a4 hypo-methylation has been found in ageing murine small 
intestine (Maegawa et al, 2010), our observations of a higher Esr1 but lower 
Slc39a4 methylation in the male fetal gut suggests male mice might be more 
vulnerable to the effects of restricted folate in utero. If such sex-specific 
methylation differences persist into adulthood, they may contribute to 
accelerated ageing, and increased risk of age-related diseases, in males. 
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4.5.3   Maternal folate supply, placental efficiency and DNA 
methylation 
Foetuses from dams fed the folate depleted diet were heavier than those with 
adequate folate supply but there was no effect of the dietary intervention on 
fetal gut weight. It follows that the weight of other fetal tissues and / or organs 
must have been affected by maternal folate supply but these differences were 
not explored systematically in the present study. Fetal liver were weighed and 
there was no significant difference between fetal liver weights in the normal 
and low folate groups (McKay et al, 2011b).  
The relationship between intrauterine environment and risk of disease in adult 
life has been documented in both human and animal models with the placenta 
commonly suggested as one of the contributors to fetal programming (Barker 
et al, 1990; Jaquet et al, 2000; Ozanne et al, 2005; Simmons et al, 2001). In 
this study, male foetuses had heavier placentas than female foetuses (Table 
4.2) but there was no effect of maternal folate intake on placental weight (Table 
4.1). Interestingly, I observed positive associations between placental weight 
and CpG methylation at Esr1 and Ppm1k-amp2 in DNA from the fetal gut, 
whereas for Obfc2a methylation the corresponding association was negative 
(but statistically significant). There was no evidence that these relationships 
were affected by sex (Figure 4.4). Several studies have investigated 
relationship between DNA methylation in the placenta and maternal dietary 
intake (Zhao et al, 2014; Gabory et al, 2012; Ferreira et al, 2011) but the 
present study appears to be unique in study effects on DNA methylation in the 
fetal gut. The higher Esr1 methylation observed in foetuses with heavier 
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placentas in the present study adds to current data that pups born from heavier 
placenta might contribute to the susceptibility of the ageing phenotype in later 
life since Esr1 methylation increases with age and in age-related diseases 
(Horii et al, 2008; Kwabi-Addo et al, 2007).  
It appears that the present study is the first to examine CpG methylation at 
Ppm1k and Obfc2a under any conditions. Therefore, it is of interest to examine 
effects of other nutritional insults such as high dietary fat intake from weaning 
on DNA methylation of these genes and to determine whether changes in DNA 
methylation are associated with changes in expression of the corresponding 
genes. This information is reported and discussed in Chapter 5. 
 
 
4.6 Chapter summary 
In summary, maternal folate depletion pre-conception and in utero altered DNA 
methylation at specific CpG sites within Slc39a4-CGI and Ppm1k-amp1 in the 
fetal mouse gut. Additionally, differential DNA methylation between the two 
sexes was observed at Esr1, Slc39a4-CGI1 and Ppm1k-amp1. Male offspring 
had heavier placentas than female offspring, and there was a positive 
correlation between Ppm1k methylation in gut tissue from foetuses and 
placental weight. On the other hand, Obfc2a methylation was negatively 
correlated with placental weight.   
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CHAPTER 5 
 
Effects of maternal folate depletion and high-fat diet post-
weaning on DNA methylation and gene expression in adult 
mouse colon and proximal small intestine 
 
5.1  Introduction 
The Developmental Origins of Health and Disease (DoHAD) hypothesis 
proposes that sub-optimal nutritional intake in utero disrupts early life 
programming and contributes to increased risk of disease in later life (Barker, 
2004). In particular, increasing evidence from animal studies supports the 
hypothesis that nutritional insults during development can lead to adverse 
health outcomes throughout life. However, the biological mechanism(s) 
underlying the DoHAD hypothesis is not clear. DNA methylation is one 
potential epigenetic mechanism for this developmental programming effect. 
DNA methylation describes the addition of methyl groups to the 5’ position in 
cytosine residues within CpG dinucleotides (CpG sites) which, typically, are 
clustered within CpG islands (CGIs) in the promoter regions of genes. 
Generally DNA methylation is considered as a gene silencing mark. Therefore 
early life methyl donor depletion could affect the availability of S-adenosyl 
methionine (SAM) and, as a consequence, patterns of DNA methylation and 
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gene expression thus altering cell function in the developing organism 
(reviewed in Jones, 2012).  
Dietary folate is one of the major methyl contributors which play a part in DNA 
methylation through increased intracellular SAM availability (Nijhout et al, 
2006). As reviewed in Antony (2007), adequate maternal folate supply is vital 
for fetal development in the offspring. Sub-optimal folate intake at conception 
and in early pregnancy increases the risk of neural tube defects (NTD) in 
children hence the mandatory folate fortification of staple foods in the United 
States and Canada (Forges et al, 2007). However, excessive folic acid 
supplementation intake may be harmful e.g. through the promotion of 
colorectal neoplasm (Mathers, 2009).  
Waterland et al (2008) demonstrated that dietary supplementation with methyl 
donors (folic acid, vitamin B12, choline and betaine) leads to hyper-methylation 
and subsequently silencing of the obesogenic Avy allele in agouti mice, and 
prevented the trans-generational amplification of offspring body weight. Global 
and gene-specific promoter hypo-methylation were observed in the brain of 
mouse offspring from mothers fed a high-fat diet, with decreased methylation 
observed in dopamine and opioid related genes which were associated with 
increased expression of these genes (Vucetic et al, 2012). When the diet of 
dams was supplemented with methyl donors (folic acid, choline, betaine, 
vitamin B12 and methionine), it diminished the adverse effects in mouse 
offspring caused by the consumption of a maternal high fat diet (Carlin et al 
2013). Furthermore, Langie et al (2013) observed that low maternal folate 
intake during pregnancy and lactation, combined with high fat feeding from 
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weaning, decreased base excision repair (BER) activity in the cortex, 
cerebellum, hippocampus and subcortical regions in mouse offspring. This 
altered DNA repair activity was associated with changes in methylation and 
expression of BER-related genes.  
On the other hand, the male offspring born from dams fed a high folic acid diet 
(40mg/kg) during pregnancy had higher risk of obesity, glucose intolerance 
and insulin resistance when fed a high fat diet for eight weeks. These mice 
also had reduced adiponectin mRNA level but increased global DNA 
methylation in white adipose tissue (Huang et al, 2014).  
A recent study by Dahlhoff et al (2013) revealed reduced methyltransferase 3b 
expression but no change in Cbs promoter (cystathionine β-synthase, one of 
the genes involved in the hepatic trans-sulfuration pathway) and global DNA 
methylation in livers from mice in which obesity was induced by feeding a high 
fat diet. Similarly, Jiang et al (2011) investigated the effect of high fat feeding 
induced obesity on hepatic glucokinase (Gck) and L-type pyruvate kinase 
(LPK) methylation in Wistar rat livers. They observed hyper-methylation of both 
gene promoters and down-regulation of transcription of the corresponding 
genes in livers from the high fat-fed group. 
These observations suggest that the adequacy of folate provision in early 
development and the quantity of fat provided from weaning may influence 
patterns of methylation in the offspring.  In addition, earlier studies from this 
laboratory have shown that maternal folate depletion may exacerbate the 
adverse effects of high dietary fat intake on the capacity for DNA repair in the 
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mouse brain (Langie et al. 2013). The present experiment aimed to extend 
these observations to studies in both the small and large intestines. 
 
 
 
5.2 Hypothesis, aims and objectives 
As described in Chapter 4, maternal folate depletion during pregnancy affected 
gene-specific methylation in the fetal mouse gut. These observations raised 
several questions including: 
i) Are the DNA methylation effects of altered maternal folate supply seen 
in the fetal gut of offspring maintained into adulthood? 
ii) Do these DNA methylation changes result in altered expression of the 
corresponding genes? 
iii) Are there differential effects of the dietary interventions in the small and 
large intestine? N.B. The very small amount of gut tissue available in 
fetal mice meant that the whole gut was analysed. 
iv) Are effects of the primary insult (inadequate maternal folate supply) 
amplified by a second nutritional insult i.e. feeding a high fat diet from 
weaning?  
Here I hypothesised that:  
 Dietary folate depletion during pregnancy and lactation in mice affects 
gene-specific DNA methylation in the proximal small intestine (prox SI) 
and in the colon of the adult offspring; 
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 Feeding a high fat diet from weaning affects gene-specific DNA 
methylation in the prox SI and colon of the adult offspring; 
 There are interactions between maternal folate supply and dietary fat 
feeding from weaning on gene-specific DNA methylation in the prox SI 
and colon of the adult offspring; 
 Differences in DNA methylation patterns will correspond with 
differences in gene expression. 
 
The aim of this chapter was to test these hypotheses using adult mouse 
tissues. To do so, I undertook the following objectives: 
1. Collected prox SI and colon tissue from adult mice exposed to altered 
maternal folate supply during pregnancy and lactation followed by 
feeding low or high fat diets from weaning (please see Fig 2.2 for 
overview of study protocol); 
2. Quantified DNA methylation at all ten loci in six candidate genes (Igf2-
DMR1, Esr1, p16, Slc39a4, Ppm1k and Obfc2a) in DNA from the prox 
SI and colon from adult (6 months old) mouse offspring. 
3. Quantified expression of the six candidate genes (Igf2-DMR1, Esr1, 
p16, Slc39a4, Ppm1k and Obfc2a) in RNA from the prox SI and colon 
from adult mouse offspring. 
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5.3 Overview of experimental approach 
DNA and RNA were extracted from proximal SI and colon of six months old 
mice according to the protocols which are described in sections 2.5.3 and 2.7.1 
respectively. Pyrosequencing for quantification of DNA methylation of specific 
CpG sites in DNA from both colon and proximal SI was carried out as 
described in section 2.6. Reverse transcription of mRNA and real-time 
quantitative PCR to measure gene expression was carried out as described in 
sections 2.8 and 2.9 respectively. The resulting data were analysed statistically 
as summarised in section 2.11. 
 
 
 
Results: 
5.4 Adult mouse proximal small intestine 
5.4.1  Effect of folate depletion during pregnancy and lactation on 
gene-specific DNA methylation in mouse intestine from adult offspring 
As described in Chapter 4, low maternal folate supply reduced Slc39a4-CGI1 
(McKay et al, 2011b) and Ppm1k methylation in the fetal gut. In this Chapter 
proximal SI from 48 offspring from dams fed either a folate adequate (FA) or 
folate depleted (FD) diet were used to investigate the effect of maternal low 
folate intake on DNA methylation in ten loci within this gene panel. Values of 
DNA methylation for each individual CpG sites within each locus were 
averaged and expressed as overall mean for that locus. Mean values of DNA 
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methylation for each gene locus in each dietary group and probabilities of 
effects of maternal folate supply and dietary fat intake from weaning are 
summarised in Table 5.1. Although DNA methylation values were very different 
for each of the target gene loci, for any given gene mean DNA methylation 
values were very similar for offspring of mice fed the low or normal folate diets 
during pregnancy and lactation (Table 5.1). There was no significant effect of 
maternal folate supply on methylation at any of the ten loci investigated 
(ANOVA, p>0.05, n=24 for FA and FD diet groups respectively, data 
summarised in Table 5.1).  
 
5.4.2  Effect of dietary fat content from weaning on locus-specific 
DNA methylation in adult mouse proximal intestine 
Methylation at all nine CpG sites and overall mean methylation across all 9 
CpGs in Slc39a4-CGI1 were significantly lower in proximal SI DNA from mice 
fed the high fat (HF) compared to low fat (LF) diets (ANOVA, p<0.05, n=24 for 
LF, n=24 for HF diet, Fig 5.1 A). In contrast to effects on Slc39a4 methylation, 
for all the other loci investigated, high fat feeding from weaning resulted in 
higher DNA methylation. Higher DNA methylation was found at CpG sites 2, 4 
and mean methylation across all five CpGs in p16 from mouse SI DNA in the 
HF dietary group (p<0.05, Fig 5.1 B). Methylation at CpGs 3, 4, 5 and mean 
methylation across all nine CpGs at Obfc2a-amp1, CpGs 1, 4, 6 and overall 
mean across all nine CpGs at Obfc2a-amp2 were higher in proximal SI DNA 
from mice fed the HF diet (p<0.05, Fig 5.1 C&D). Likewise, methylation at 
CpGs 1, 2, 4 and overall mean across all four CpGs in Ppm1k-amp1, CpGs 2, 
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5, 7 and mean methylation across all seven CpGs in Ppm1k-amp2 were higher 
in the HF dietary group (p<0.05, Fig 5.1 E&F). 
Although the effects of HF diet from weaning were significant only at some 
CpG sites in p16, Obfc2a and Ppm1k, at every CpG site, mean methylation 
was higher in proximal SI DNA from mice fed the HF diet. 
 
 
Figure 5.1 Impact of feeding a high fat diet from weaning on DNA 
methylation of A) Slc39a4-CGI1, B) p16, C) Obfc2a-amp1, D) Obfc2a-
amp2, E) Ppm1k-amp1 and F) Ppm1k-amp2 in prox SI DNA from offspring 
aged 6 months (*denotes p<0.05, data are expressed as mean ± SEM) 
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5.4.3  Impact of low folate supply during pregnancy and lactation 
and high dietary fat intake from weaning on locus-specific DNA 
methylation in prox SI from 6 months old offspring 
The mouse feeding trial from which tissues used in this study were obtained 
was designed as a 2*2 factorial design to test the hypothesis that the effects 
of the primary insult (inadequate maternal folate supply) would be amplified by 
a second nutritional insult i.e. feeding a high fat diet from weaning. Therefore, 
the next step was to test for interactions between maternal folate supply during 
gestation and lactation, and high fat feeding from weaning on DNA methylation 
of all six target genes. There were no significant interactions between 
nutritional treatments for methylation at any of the CpG sites within all ten loci 
investigated (ANOVA, p>0.05, n=48; Table 5.1). For Obfc2a-amp1, the 
interaction was close to significant (P=0.063). 
F 
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Table 5.1  Impact of maternal folate supply during pregnancy and 
lactation and of dietary fat content from weaning on mean methylation at 
10 loci in DNA from the proximal small intestine of adult offspring (data 
expressed as overall mean % methylation at each locus, SEM= standard error 
of mean – pooled values based on the Mean Square for Error in the ANOVA, 
values in bold denotes statistically significant outcome) 
Gene 
locus 
Maternal folate 
supply 
Dietary fat from 
weaning 
Probabilities of effects 
Low 
(SEM) 
Normal 
(SEM) 
Normal 
(SEM) 
High 
(SEM) 
Folate Fat 
Folate*fat 
interaction 
Igf2-
DMR1 
37.2 
(0.33) 
37.7 
(0.33) 
37.9 
(0.33) 
37.1 
(0.33) 
0.300 0.103 0.861 
Esr1 
22.5 
(0.28) 
22.0 
(0.28) 
22.5 
(0.28) 
22.0 
(0.28) 
0.284 0.195 0.297 
p16 
7.2 
(0.11) 
7.3 
(0.11) 
7.1 
(0.11) 
7.4 
(0.11) 
0.574 0.042 0.529 
Slc39a4-
CGI1 
80.4 
(0.32) 
80.0 
(0.32) 
81.2 
(0.32) 
79.3 
(0.32) 
0.404 <0.001 0.888 
Slc39a4-
CGI2 
84.2 
(0.24) 
84.3 
(0.24) 
84.5 
(0.24) 
84.0 
(0.24) 
0.954 0.107 0.209 
Obfc2a-
amp1 
2.6 
(0.13) 
2.4 
(0.13) 
2.1 
(0.13) 
2.8 
(0.13) 
0.441 0.001 0.063 
Obfc2a-
amp2 
0.7 
(0.12) 
0.9 
(0.12) 
0.6 
(0.12) 
1.0 
(0.12) 
0.160 0.031 0.678 
Obfc2a-
amp3 
1.9 
(0.09) 
2.0 
(0.09) 
1.8 
(0.09) 
2.0 
(0.09) 
0.589 0.092 0.772 
Ppm1k-
amp1 
3.5 
(0.09) 
3.5 
(0.09) 
3.2 
(0.09) 
3.8 
(0.09) 
0.699 <0.001 0.406 
Ppm1k-
amp2 
3.1 
(0.17) 
3.1 
(0.17) 
2.9 
(0.17) 
3.3 
(0.17) 
0.755 0.012 0.157 
Note: For details of experimental protocol, including dietary treatments, 
please see section 2.2.2 and Fig 2.2.  
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5.4.4  Sex specific DNA methylation in proximal SI of adult 
offspring from all dietary groups  
Data from fetal gut in mouse indicated differential DNA methylation at Esr1, 
Slc39a4 and Ppm1k between the two sexes (please see section 4.4.8 and Fig 
4.4 for details). Here in prox SI DNA from adult mouse offspring, methylation 
at CpG sites 1, 2 and overall mean methylation across all 3 CpGs at Esr1 was 
higher in male compared with female mice regardless of dietary regime 
(ANOVA, p<0.05, Fig 5.2 A, n=24 for male and n=24 for female). Conversely, 
DNA methylation at CpG sites 2, 3 and overall mean at the Slc39a4-CGI2 were 
lower in male than in female mice (p<0.05, Fig 5.2 B). The significantly different 
Slc39a4 and Esr1 methylation patterns between both sexes in prox SI 
observed here was similar to previous observations in the fetal gut. For the 
remaining eight loci, no effect of sex on gene-specific DNA methylation was 
observed in the adult mouse proximal SI (p>0.05, data not shown). 
 
 
 
 
 
 
 
 
 
132 
 
Figure 5.2 Sex-specific methylation at A) Esr1 and B) Slc39a4-CGI2 in 
prox SI DNA from weaned mouse offspring (*denotes p<0.05, data 
expressed as mean ± SEM) 
 
 
 
 
 
 
 
A 
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5.4.5   Associations between methylation of Esr1 and Slc39a4 
methylation in DNA from proximal SI and body weight of adult mouse 
offspring 
Feeding the high fat diet from weaning increased body weight and body fat 
content in the adult mouse offspring investigated in this study (McKay et al, 
2014). Therefore it is of interest to investigate whether DNA methylation of the 
gene loci examined here in the prox SI correlated with the weight of the mice 
at six months when the tissue was collected. Using data for all mice regardless 
of treatment group, linear regression analysis showed that adult mouse body 
weight correlated positively with overall mean methylation across all three 
CpGs at the Esr1 locus in prox SI DNA (p<0.05, n=48, example shown in Fig 
5.3 A). In contrast, for Slc39a4, DNA methylation at CpGs 1, 2 and overall 
mean across all nine CpGs at –CGI1, and CpGs 1, 2, 3 and overall mean 
across all three CpGs at –CGI2 were negatively associated with mouse body 
weight (p<0.05, example shown in Fig 5.3 B). 
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Figure 5.3  Relationship between mouse body weight and mean 
methylation (%) of: A) Esr1 and B) Slc39a4-CGI2 in proximal SI DNA from 
adult offspring 
 
 
 
 
    
 
 
A 
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5.4.6   Association between Esr1, Slc39a4 and Ppm1k methylation 
in proximal SI and weight of proximal SI from adult mouse offspring 
The evidence that mouse body weight was associated with DNA methylation 
at some gene loci (see section 5.4.5 above) suggested the possibility that 
mass of the target tissue (in this case the proximal SI) might be related to DNA 
methylation. Further linear regression analysis showed that methylation of 
CpG site 3 at the Esr1 locus in proximal SI DNA was positively associated with 
proximal SI weight (Linear Regression, p<0.05, n=48, Fig 5.4 A). On the other 
hand, methylation at CpG sites 1, 2 and overall mean across all 9 CpGs at 
Slc39a4-CGI1 were negatively associated with the weight of proximal SI 
(p<0.05, example shown in Fig 5.4 B). For Ppm1k-amp2, methylation of CpG 
site 1 and mean methylation across all seven CpGs at this locus were 
positively correlated with mouse SI weight (p<0.05, example shown in Fig 5.4 
C). 
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Figure 5.4  Relationship between weight of proximal SI in adult 
offspring and methylation at: A) Esr1 CpG 3, B) overall mean at Slc39a4-
CGI1 and C) overall mean at Ppm1k-amp2 in proximal SI DNA  
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5.4.7   Effects of maternal folate intake, dietary fat content post-
weaning and sex on expression of p16, Slc39a4, Obfc2a and Ppm1k in 
the proximal SI from adult offspring 
In the sections above, I have shown that dietary fat content from weaning, sex 
and body and tissue weights were associated with changes in DNA 
methylation at loci within the Slc39a4, p16, Obfc2a and Ppm1k genes. Since, 
in some cases, there is an inverse relationship between promoter methylation 
and expression of the corresponding gene, it was important to discover 
whether the changes in methylation which I observed were related to changes 
in gene expression. Therefore, I quantified expression at the mRNA level for 
these four genes only using real-time quantitative PCR (qPCR).   
In adult mouse proximal SI, there were no differences in p16, Slc39a4, Obfc2a 
and Ppm1k expression at the mRNA level in offspring from folate adequate 
and folate depleted dams (ANOVA, p>0.05, n=24 for FA and FD groups 
respectively, Table 5.2). However, high-fat feeding from weaning decreased 
p16, Obfc2a and Ppm1k expression compared with offspring that were fed the 
low-fat diet (p<0.05, n=24 for HF and LF dietary groups respectively, Table 
5.2). There was no difference in expression of this gene panel between the 
two sexes (p>0.05, n=24 for male and n=24 for female, data not shown). No 
interaction between the effects of maternal low folate supply and high fat 
feeding after lactation on expression of these four genes at mRNA level in prox 
SI from adult offspring was observed (ANOVA, p>0.05, Table 5.2). 
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Table 5.2 Impact of maternal folate supply during pregnancy and 
lactation and of dietary fat content from weaning on expression of 4 
genes in the proximal small intestine of adult offspring (expression values 
are presented relative to the geomean of Gusb and Tbp, data expressed as 
mean ± SEM, values in bold denotes statistically significant outcomes) 
 
 
Gene 
locus 
Maternal folate 
supply 
Dietary fat from 
weaning 
Probabilities of effects 
Low 
(SEM) 
Normal 
(SEM) 
Low 
(SEM) 
High 
(SEM) 
Folate Fat 
Folate*fat 
interaction 
p16 
8.3 
(0.98) 
7.8 
(0.98) 
9.5 
(0.97) 
6.6 
(0.97) 
0.722 0.04 0.308 
Slc39a4 
14.8 
(0.75) 
13.2 
(0.75) 
14.6 
(0.75) 
13.4 
(0.75) 
0.127 0.284 0.196 
Obfc2a 
8.2 
(0.33) 
8.1  
(0.33) 
9.0 
(0.33) 
7.2 
(0.33) 
0.906 0.001 0.451 
Ppm1k 
28.1 
(1.31) 
29.3 
(1.31) 
33.3 
(1.27) 
24.2 
(1.27) 
0.498 <0.001 0.060 
Note: For details of experimental protocol, including dietary treatments, 
please see section 2.2.2 and Fig 2.2.  
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5.4.8   Associations between DNA methylation and expression of 
the corresponding genes for p16, Slc39a4, Obfc2a and Ppm1k in adult 
mouse proximal SI 
Higher DNA methylation at CpG sites 1, 4 in amplicon 2 and CpG sites 4 in 
amplicon 3 of Obfc2a was inversely correlated with expression of the Obfc2a 
gene in the prox SI from adult offspring (Linear Regression, p<0.05, Fig 5.5 A-
C). Similar relationships were also observed between methylation of CpG sites 
1, 2, 4 and overall mean at Ppm1k-amp1 and expression of this gene (Linear 
Regression, p<0.05, Fig 5.5 D-G). No significant correlations between DNA 
methylation at individual CpGs and corresponding expression of p16 and 
Slc39a4 was observed (p>0.05, data not shown). 
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Figure 5.5  Association between gene expression and CpG methylation 
at: A-B) sites 1 & 4 of Obfc2a-amp2, C) Obfc2a-amp3 site 4, D-G) Ppm1k-
amp1 sites 1, 2, 4 and overall mean at this locus in adult mouse prox SI 
(note: X-axis represents CpG site-specific methylation, Y-axis represents 
expression of the corresponding gene) 
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5.5 Adult mouse colon 
5.5.1  Effect of folate depletion during pregnancy and lactation on 
gene-specific methylation in colon DNA from adult offspring 
As observed for the proximal SI, there was no significant effect of maternal 
folate supply on DNA methylation at any of the CpGs within the ten loci 
investigated (ANOVA, p>0.05, n=24 for FA and FD diet groups respectively, 
Table 5.3).  
 
5.5.2  Effect of dietary fat intake from weaning on locus specific 
methylation in DNA from the colon of adult offspring mice 
Methylation at CpG site 1 and overall mean across all three CpGs at Esr1 were 
higher in colon DNA from mice fed the HF diet compared with the LF diet from 
weaning (ANOVA, p<0.05, n=24 for LF, n=24 for HF diet, Fig 5.6 A). Similar to 
the effects observed for the prox SI, DNA methylation at CpG sites 1, 2, 3, 5, 
7, 9 and overall mean methylation across all 9 CpGs in Slc39a4-CGI1; and 
CpGs 2, 3 and mean methylation across all 3 CpGs in Slc39a4-CGI2 was 
reduced in colon DNA from adult offspring mice fed the HF diet (p<0.005, Fig 
5.6 B&C).In contrast, methylation at CpG sites 4, 5 and mean methylation 
across all 9 CpGs at Obfc2a-amp2 were higher in DNA of colon from mice fed 
the HF diet (p<0.05, Fig 5.6 D). 
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Figure 5.6 Effect of high fat diet post-weaning on DNA methylation at: 
A) Esr1, B) Slc39a4-CGI1, C) Slc39a4-CGI2 and D) Obfc2a-amp2 in colon 
DNA from adult mouse offspring (*denotes p<0.05, data expressed as mean 
± SEM) 
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5.5.3   Impact of low folate supply during pregnancy and lactation 
and high dietary fat intake from weaning on locus-specific DNA 
methylation in colon from adult offspring 
As reported in prox SI, there were no significant interactions between 
nutritional treatments for methylation at any of the CpG sites within all ten loci 
investigated in colon DNA from mouse offspring (ANOVA, p>0.05, n=48; Table 
5.3).  
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Table 5.3  Impact of maternal folate supply during pregnancy and 
lactation and of dietary fat content from weaning on mean methylation at 
10 loci in DNA from the colon of adult offspring (data expressed as overall 
mean % methylation at each locus, SEM=standard error of mean,  values in 
bold denotes statistically significant outcome) 
Gene 
locus 
Maternal folate 
supply 
Dietary fat 
from weaning 
Probabilities of effects 
Low 
(SEM) 
Normal 
(SEM) 
Normal 
(SEM) 
High 
(SEM) 
Folate Fat 
Folate*fat 
interaction 
Igf2-
DMR1 
52.3 
(0.30) 
52.5 
(0.296) 
52.1 
(0.296) 
52.7 
(0.296) 
0.626 0.151 0.969 
Esr1 
23.8 
(0.30) 
24.4 
(0.30) 
23.6 
(0.30) 
24.5 
(0.30) 
0.178 0.037 0.338 
p16 
8.9 
(0.19) 
8.7 
(0.19) 
8.8 
(0.19) 
8.8 
(0.19) 
0.417 0.770 0.815 
Slc39a4
-CGI1 
66.0 
(0.45) 
65.9 
(0.45) 
66.8 
(0.45) 
65.2 
(0.45) 
0.908 0.017 0.489 
Slc39a4
-CGI2 
68.3 
(0.45) 
68.3 
(0.45) 
69.4 
(0.45) 
67.2 
(0.45) 
0.958 0.002 0.517 
Obfc2a-
amp1 
6.4 
(0.48) 
6.3 
(0.46) 
6.0 
(0.48) 
6.7 
(0.46) 
0.909 0.276 0.976 
Obfc2a-
amp2 
5.8 
(0.51) 
5.1 
(0.52) 
4.6 
(0.51) 
6.3 
(0.52) 
0.340 0.027 0.060 
Obfc2a-
amp3 
1.9 
(0.10) 
1.8 
(0.10) 
2.0 
(0.10) 
1.8 
(0.10) 
0.417 0.244 0.174 
Ppm1k-
amp1 
3.1 
(0.14) 
2.9 
(0.14) 
2.9 
(0.14) 
3.2 
(0.14) 
0.341 0.126 0.743 
Ppm1k-
amp2 
7.5 
(1.35) 
6.4 
(1.35) 
5.9 
(1.35) 
8.0 
(1.35) 
0.547 0.275 0.434 
Note: For details of experimental protocol, including dietary treatments, 
please see section 2.2.2 and Fig 2.2 
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5.5.4    Impact of sex on locus-specific methylation in DNA from the 
colon of adult offspring regardless of dietary regime 
DNA Methylation at CpG site 2 and mean of both sites at Igf2-DMR1 was lower 
in male than in female mice (ANOVA, p<0.001, n=24 for male and female 
respectively, Fig 5.7 A). Moreover, there was significantly lower methylation in 
the males at both -CGI1 and -CGI2 in Slc39a4 in DNA from the adult mouse 
colon (p<0.005 for both loci, Fig 5.7 B&C respectively). On the other hand, 
male showed higher DNA methylation than female at CpG sites 1, 3 and overall 
mean at Esr1 locus (p<0.05, Fig 5.7 D). 
 
 
Figure 5.7 Sex-specific DNA methylation at: A) Igf2-DMR1, B) Slc39a4-
CGI1, C) Slc39a4-CGI2 and D) Esr1 in DNA from adult offspring colon 
(*denotes p<0.05, data expressed as mean ± SEM) 
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5.5.5   Interactions between maternal folate intake and sex for DNA 
methylation in colon DNA from adult offspring 
Significant interactions between maternal folate supply and sex of the offspring 
were observed for DNA methylation at CpG sites 1, 2, 4, 5, 6, 7 and overall 
mean methylation at Obfc2a-amp1 in mouse colon from adult offspring 
(ANOVA, p<0.05, Fig 5.8 A-G). In every case, methylation was lower with the 
folate adequate diet than for the low folate diet for males whereas the opposite 
was true for females where the offspring had higher methylation if their dams 
had been fed the normal folate diet. The interaction between sex and low 
maternal folate supply was not observed in any other CpGs in the remaining 
nine loci investigated in colon DNA from mouse offspring (p>0.05, data not 
shown). 
 
Figure 5.8 Interaction plots between low maternal folate intake and sex 
at CpG sites: A=1, B=2, C=4, D=5, E=6, F=7 and G=mean methylation at 
Obfc2a-amp1 in colon DNA from weaned adult mouse (data expressed as 
mean % methylation) 
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5.5.6   Association between gene specific DNA methylation in 
colon DNA and adult mouse body weight 
As reported above, I observed significant associations between mouse body 
weight and methylation at some gene loci in DNA from the proximal SI and so 
the same putative relationships were investigated for the colon. Methylation of 
CpG sites 1, 2 and overall mean across all two CpGs at Igf2-DMR1 in colon 
DNA were negatively associated with the body weight of the adult offspring 
mice (Linear Regression, p<0.05, n=48, example shown in Fig 5.9 A).In 
contrast, the body weights of adult mice were positively associated with DNA 
methylation at CpG sites 1, 2, 3 and overall mean methylation across all three 
CpGs at the Esr1 locus (p<0.05, example shown in Fig 5.9 B). For Slc39a4, 
methylation at CpGs 1, 2, 3, 5, 6, 8 and overall mean across all nine CpGs at 
CGI1 was negatively associated with the body weight of the adult mice 
(p<0.05, example shown in Fig 5.9 C). For the remaining seven loci, the 
correlations between each CpG sites and body weight of mouse offspring was 
not significant (p>0.05, data not shown). 
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Figure 5.9  Relationships between adult offspring mouse body weight 
and overall methylation at: A) Igf2-DMR1, B) Esr1 and C) Slc39a4-CGI1 in 
colon DNA   
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5.5.7   Association between DNA methylation in weaned mouse 
colon DNA and weight of colon from adult mouse offspring 
The next step was to investigate possible relationships between colon tissue 
weight and methylation of target genes in colon DNA. Methylation of CpG sites 
1, 2 and overall mean across both CpGs at Igf2-DMR1 locus in colon DNA 
were negatively associated with weight of colon in adult offspring mice (Linear 
Regression, p<0.05, n=48, example shown in Fig 5.10 A). Conversely, 
methylation at CpG site 3 at Esr1 was positively associated with colon weight 
of the adult mice (p<0.05, Fig 5.10 B). No significant associations was 
observed between CpG methylation and mouse colon weight in the remaining 
eight loci (p>0.05, data not shown). 
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Figure 5.10  Relationships between the weight of colon in adult offspring 
and methylation of: A) overall mean at Igf2-DMR1 and B) Esr1 CpG site 3 
in colon DNA  
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5.5.8   Effects of maternal folate intake, dietary fat content post-
weaning and sex on expression of Esr1, Slc39a4, Ppm1k and Obfc2a in 
the colon from adult offspring 
In section 5.5.2, altered Esr1, Slc39a4 and Obfc2a methylation was observed 
in mouse colon from adult offspring from the high fat dietary group compared 
with the low fat group. Therefore it is of interest to quantify the corresponding 
expression of these three genes, together with Ppm1k expression in the 
mouse colon.   
There were no differences in Esr1, Slc39a4 and Obfc2a expression at the 
mRNA level in the colon of offspring from folate adequate and folate depleted 
dams (ANOVA, p>0.05, n=24 for FA and FD groups respectively, Table 5.4). 
Furthermore, methylation at Esr1, Slc39a4 and Obfc2a loci differed between 
the HF and LF dietary groups, high-fat feeding from weaning did not affect 
expression of Esr1, Slc39a4 and Obfc2a compared to the offspring that were 
fed the low-fat diet (p>0.05, n=24 for HF and LF dietary groups respectively). 
No interaction was found between the effects of maternal low-folate intake and 
high-fat feeding after lactation on expression of these three genes in colon 
from adult mouse offspring (two-way ANOVA, p>0.05, Table 5.4).  
However, when data for all dietary treatments were pooled, expression of 
Obfc2a was significantly lower in males than in females (p<0.001, n=24 for 
male and n=24 for female, Table 5.5).  
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Table 5.4 Impact of maternal folate supply during pregnancy and 
lactation and of dietary fat content from weaning on expression of 4 
genes in the colon of adult offspring (expression values are presented 
relative to the geomean of Gusb and Tbp, data expressed as mean ± SEM) 
 
Gene 
locus 
Maternal folate 
supply 
Dietary fat from 
weaning 
Probabilities of effects 
Low 
(SEM) 
Normal 
(SEM) 
Low 
(SEM) 
High 
(SEM) 
Folate Fat 
Folate*fat 
interaction 
Esr1 
11.6 
(0.75) 
11.1 
(0.75) 
10.8 
(0.75) 
11.8 
(0.75) 
0.601 0.344 0.729 
Slc39a4 
16.6 
(2.02) 
17.1 
(2.02) 
15.2 
(2.02) 
18.6 
(2.02) 
0.872 0.244 0.914 
Obfc2a 
4.1 
(0.25) 
3.8  
(0.25) 
4.1 
(0.25) 
3.7 
(0.25) 
0.378 0.258 0.847 
Ppm1k 
29.0 
(2.87) 
29.7 
(2.87) 
30.4 
(2.87) 
28.3 
(2.87) 
0.874 0.617 0.451 
Note: For details of experimental protocol, including dietary treatments, 
please see section 2.2.2 and Fig 2.2.  
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Table 5.5 Gene expression at the mRNA level in the colon of male and 
female adult offspring (data pooled across dietary treatment groups) 
(expression values are relative to geomean of Gusb and Tbp, data expressed 
as mean ± SEM, value in bold denotes statistically significant outcome) 
 
 
Gene Male (SEM) Female (SEM) p values 
Esr1 9.32 (0.73) 7.90 (0.73) 0.177 
Obfc2a 3.35 (0.21) 4.60 (0.21) 0.000 
Ppm1k 26.00 (2.9) 32.77 (2.9) 0.102 
Slc39a4 17.81 (2.02) 16.03 (2.02) 0.536 
 
 
 
 
 
 
5.5.9   Associations between methylation of specific CpG sites in 
target genes and expression of the corresponding genes in adult mouse 
colon 
In mouse colon from adult offspring, expression of the Obfc2a gene was 
positively correlated with CpG methylation at sites 2, 4, 5 and 8 in Obfc2a-
amp3 (Linear Regression, p<0.05, Fig 5.11). The relationship between each 
individual CpGs and their corresponding expression was investigated in Esr1, 
Ppm1k and Slc39a4, however no significant correlations was found in colon 
from adult offspring (p>0.05, data not shown). 
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Figure 5.11  Relationship between gene expression and DNA 
methylation at CpG sites 2, 4, 5 and 8 (panels A – D respectively) at 
Obfc2a-amp3 (note: X-axis represents CpG site-specific methylation within 
this locus, Y-axis represents Obfc2a expression) 
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5.6   Patterns of locus-specific DNA methylation and 
corresponding gene expression in fetal mouse gut, and in the adult colon 
and prox SI  
5.6.1   Mean DNA methylation at Igf2-DMR1, Esr1, p16, Slc39a4, 
Obfc2a and Ppm1k in fetal gut, adult colon and proximal SI in mouse 
When mean DNA methylation at each gene locus was estimated for all 
available mice regardless of dietary treatment, there were remarkably similar 
patterns in inter-gene methylation differences between the adult colon and 
prox SI (n=48 for colon and prox SI respectively) and the fetal gut (n=34) (as 
shown in Fig 5.12). For all tissues, the highest levels of methylation (66-84%) 
were observed at Slc39a4, with intermediate values (37-52%) for Igf2-DMR1 
and values of 10% or less for the remaining gene loci (Fig 5.12). For Esr1, 
DNA methylation in the fetal gut was less than half of that in the adult colon 
and prox SI (9% in fetal gut compared with 22-24% in both adult tissues). For 
Slc39a4, DNA methylation was higher in the prox SI compared with the fetal 
gut and adult colon (80-84%, 63-69% and 66-68% respectively) (Fig 5.12).  
Since the proximal SI and colon tissue were obtained from the same animals, 
paired t-tests were used to compare methylation of the target genes in the 
colon and prox SI of adult offspring. This analysis showed that overall mean 
DNA methylation at all loci except Obfc2a-amp3 differed significantly between 
the two adult mouse tissues (p<0.001, n=48, Table 5.6). In most cases, 
methylation was higher in the colon but the notable exception was Slc39a4 for 
which methylation was considerably higher at both CGIs investigated in the 
adult prox SI DNA (Table 5.6). 
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Figure 5.12    Patterns of locus-specific DNA methylation in the fetal gut, 
and colon and proximal SI of adult mice at Igf2-DMR1, Esr1, p16, Slc39a4-
CGI1 & -CGI2, Obfc2a-amp1, -amp2 & -amp3 and Ppm1k-amp1 & -amp2 
in mouse (data expressed as overall mean % methylation for each locus 
regardless of dietary regime, error bar represent SEM, n=34 for fetal gut and 
n=48 for both adult colon and prox SI respectively) 
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Table 5.6  Comparison of overall mean methylation at each of the ten 
loci investigated in paired samples of adult mouse colon and proximal SI 
DNA irrespective of dietary treatment (SEM = standard error of mean) 
 
 % methylation 
Gene 
locus 
Prox SI (SEM) Colon (SEM) P≤ 
Igf2       
-DMR1 
37.5 (0.24) 52.4 (0.28) 0.001 
Esr1 22.3 (0.22) 24.1 (0.23) 0.001 
p16  7.2 (0.08)   8.8 (0.13) 0.001 
Slc39a4
-CGI1 
80.2 (0.26) 66.0 (0.39) 0.001 
Slc39a4
-CGI2 
84.2 (0.19) 68.3 (0.39) 0.001 
Obfc2a 
-amp1 
 2.5 (0.11)  6.3 (0.35) 0.001 
Obfc2a 
-amp2 
 0.8 (0.08)  5.5 (0.38) 0.001 
Obfc2a 
-amp3 
 1.9 (0.06)  1.9 (0.07) 0.569 
Ppm1k -
amp1 
 3.5 (0.08)  3.0 (0.10) 0.001 
Ppm1k -
amp2 
 3.1 (0.12)  6.9 (0.94) 0.001 
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5.6.2    Comparison of Slc39a4, Obfc2a and Ppm1k expression in 
adult colon and proximal SI in adult mouse offspring 
Since I had quantified expression of Slc39a4, Obfc2a and Ppm1k by real-time 
qPCR expression in both colon and prox SI from mouse offspring, this provided 
an opportunity to compare expression of this gene panel in paired samples of 
both adult mouse tissues from the same animals. This analysis showed that 
Obfc2a expression in the colon was only half of that in the proximal SI (paired 
t-tests, p<0.001, n=27, Table 5.7). Borderline higher Slc39a4 expression was 
observed in adult colon compared with the prox SI (p=0.069, Table 5.7) but 
expression of Ppm1k was very similar in both tissues (p>0.05, Table 5.7) 
 
 
 
Table 5.7 Gene expression in paired samples of proximal SI and colon 
from adult offspring regardless of dietary treatment (expression values are 
relative to geomean of Gusb and Tbp, data expressed as mean ± SEM, value 
in bold denotes statistically significant outcome) 
 
Gene Prox SI (SEM) Colon (SEM) p values 
Slc39a4 14.1 (0.55) 16.9 (1.41) 0.069 
Obfc2a 8.2 (0.26) 4.0 (0.18) <0.001 
Ppm1k 28.8 (1.15) 29.4 (1.99) 0.783 
 
 
 
 
168 
 
5.7 Discussion 
5.7.1   Inter-tissue comparisons of DNA methylation in fetal and 
adult gut and expression of the corresponding genes in the adult mouse 
colon and proximal SI regardless of dietary regime 
When data were pooled across all dietary treatments, there was remarkable 
similarity in DNA methylation patterns between fetal gut and the two regions of 
adult gut for the ten loci examined in this study (Fig 5.12). The observations 
suggest that, broadly speaking, for these specific genes, methylation patterns 
established in utero, are maintained well into adulthood (adult samples 
collected at age 6 months). However, for the adult mice only, because both 
tissues came from the same 48 mice, it was possible to compare methylation 
between tissues using paired t-tests. This statistical analysis revealed 
significant inter-tissue differences in mean methylation at all ten loci 
investigated except for Obfc2a-amp3 (Table 5.6). In addition, since expression 
of Slc39a4, Obfc2a and Ppm1k was quantified in the same paired samples of 
adult prox SI and colon, these data was used to investigate inter-tissue 
associations between the mean methylation of each loci within this gene panel 
and expression of the corresponding genes. The lower Slc39a4 methylation at 
both CGIs in the colon compared with the proximal SI corresponded with 
higher expression of this gene in the colon than in the proximal SI. Similarly, 
higher Obfc2a (except –amp3) methylation but lower corresponding 
expression was observed in colon than in the proximal SI. These observations 
are in agreement with the current belief that higher promoter methylation 
corresponds with down-regulation of gene expression. For Ppm1k, there were 
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relatively small inter-tissue differences in either expression or DNA methylation 
(Table 5.6 and Table 5.7).      
To my knowledge, the data presented in this chapter are unique and that this 
is the first study which has compared methylation profiles for these (or any 
other genes) in the fetal gut and in paired samples of adult proximal SI and 
colon. Ivanova et al (2012) observed that methylation of several imprinted 
genes including Igf2-DMR1 was mostly unchanged in mouse liver obtained in 
post-natal week 3 and week 12 from offspring which were exposed to maternal 
protein restriction during gestation and lactation. However, reduced expression 
of Gnas was detected at week 3 and this down-regulation of Gnas in liver was 
sustained to a lesser extent at week 12 after birth (Ivanova et al, 2012). This 
suggests that methylation of imprinted genes can be influenced by dietary 
factors. Indeed, in humans, individuals whose mothers were subjected to 
famine pre-conception or in early pregnancy during the Dutch Hunger Winter 
period had reduced Igf2 methylation six decades later compared to unexposed 
same-sex siblings. In this study, Igf2 methylation was not measured in early 
childhood (Heijmans et al, 2008) so that it is not possible to determine when 
the observed alterations in Igf2 methylation occurred. However, a randomized 
controlled trial of peri-conceptional micronutrient supplementation in The 
Gambia reported differential methylation in response to the intervention for 2 
out of 12 imprinted genes in cord blood (Cooper et al, 2012). This supports the 
idea that early life nutrition influences methylation of some imprinted genes 
and that these changes are apparent at birth. As observed here for the fetal 
gut and for the colon and prox SI of 6 months old mice, methylation patterns 
established early in life appear to be maintained in gut tissues into adulthood. 
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However, although the methylation patterns in adult colon and prox SI were 
similar, there were subtle but significant differences between tissues in mean 
methylation patterns at most of the ten loci studied. This supports previous 
finding from this lab showing differential methylation patterns for Esr1, Igf2 
DMR1, Igf2 DMR2, and Slc39a4 between tissues in the mouse dams from the 
same study (McKay et al, 2011a).  However there were notable differences in 
methylation between age groups. For example, mean methylation at Esr1 in 
the adult SI was approximately twice the methylation observed in fetal gut 
(~20% methylated compared to ~10% respectively). This is consistent with 
current beliefs that higher Esr1 methylation occurs with age (Kaz et al 2014).  
The reasons for inter-tissue differences in methylation are not known. It is 
possible that some inter-tissue differences in methylation patterns may be due 
to “epigenetic drift” (Langevin et al, 2014) as a consequences of heterogeneity 
in the fidelity with which epigenetic marks are maintained over time in specific 
tissues.  
 
5.7.2   Effect of low folate status during development on DNA 
methylation and gene expression 
Maternal low folate intake did not affect methylation at any of the ten loci 
investigated in offspring DNA from either colon or proximal SI in the adult 
offspring. Given the evidence that maternal folate supply altered methylation 
patterns in fetal mouse tissue (reported in Chapter 4), and that other early life 
interventions with methyl donors produced enduring effects on DNA 
methylation patterns (Waterland & Jirtle, 2003), this finding was unexpected.  
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The lower Slc39a4-CGI1 and Ppm1k-amp1 methylation in the fetal gut in 
response to maternal folate depletion (Chapter 4) had disappeared in the adult 
SI and colon. However, from weaning, all mice received equal amounts of 
dietary folate which suggests that maintenance of differential patterns in 
Slc39a4 and Ppm1k methylation induced by folate depletion depends on 
continued differences in folate supply.  
 
5.7.3   Effect of dietary fat intake from weaning on DNA methylation 
and gene expression of Slc39a4, p16, Obfc2a and Ppm1k 
DNA methylation at all nine CpGs in Slc39a4-CGI was relatively high in both 
adult mouse gut tissues (ranging from 55.4 - 90.7%). This is similar to Slc39a4 
methylation values observed in DNA from blood, liver and kidney from post-
partum dams (McKay et al, 2011a), but higher than Slc39a4 methylation in 
fetal gut tissue DNA (McKay et al, 2011b). These findings suggest that 
methylation at this locus increases with increasing age. Although the degree 
of reduced methylation in the HF group was relatively small, due to the small 
inter-animal variance for each CpG, the differences in methylation between the 
HF and control group was significant for all CpG sites at Slc39a4-CGI1.  
Slc39a4 is typically expressed at the apical enterocyte membrane (Cragg et 
al, 2005), it is involved in dietary zinc absorption in the small intestine and is 
responsible for the maintenance of cellular zinc homeostasis (Ford, 2004). 
Mutation in Slc39a4 has been linked to acrodermatitis enteropathica, an 
inherited zinc deficiency disease characterised by impaired intestinal zinc 
absorption (Ford, 2004). 
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Increased Slc39a4 expression was reported in human hepatocellular, human 
and murine pancreatic carcinoma (Weaver et al, 2010; Zhang et al, 2010; Li et 
al, 2009) while reduced Slc39a4 methylation has been reported in ageing 
mouse intestine and in human CRC cell lines (Maegawa et al, 2010 & Kim et 
al, 2009a respectively). The higher Slc39a4 methylation observed in adult 
compared with fetal gut tissue in this study is in contrast with the observation 
of reduced methylation of this gene with age in the mouse intestine reported 
by Maegawa et al (2010). A possible explanation for this divergence in findings 
could relate to differences in the ages of mice which were compared i.e. fetal 
and 6 months old adult gut in my study and 3 versus 35 months old in Maegawa 
et al (2010). Thirty-five months old is very old for a mouse and it is possible 
that the methylation patterns in Slc39a4 change in very old age or that mice 
which survive to very old age have different methylation patterns to those who 
die younger. 
Since DNA methylation is usually considered as a gene silencing mechanism, 
the effect of high fat intake on Slc39a4 expression was also investigated here. 
In both mouse colon and proximal SI, there was a weak inverse association 
between Slc39a4 methylation (across all 12 CpGs in the two CGIs) and 
expression of this gene and this effect was not statistically significant (Linear 
Regression, p>0.05, R2 values range from -0.012 to -0.022, data not shown). 
Methylation at the p16 locus was relatively low ranging from 3% to 13% among 
individual animals in both colon and proximal SI. Overall, methylation at this 
locus was significantly (p=0.04) higher in mice fed the high fat diet from 
weaning but the between-diet differences were small (7.1 and 7.5% 
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methylation for LF and HF groups respectively; Table 5.1). p16 is a tumour 
suppressor genes that binds to cyclin-dependent kinases CDK4 and CDK6 
and inhibits cell-cycle progression and cell proliferation. Commonly, p16 
promoter hyper-methylation has been observed in human ageing colon 
tissues, various human adenomas and carcinomas (Bazarov et al, 2010; 
Psofaki et al, 2010; Kondo & Issa, 2004). Generally, p16 hyper-methylation 
results in repressed expression of this tumour suppressor gene. This was 
confirmed in mouse proximal SI where the higher p16 methylation in the HF 
dietary group was associated with reduced p16 expression in this tissue. 
Obfc2a is a single-strand DNA binding protein that is essential for the 
recognition and repair of DNA damage. It is vital for normal replication and 
preservation of genomic stability. Obfc2a is expressed in mouse brain, lung, 
liver, spleen and stomach (Kang et al, 2006). Reduced Obfc2a expression has 
been reported in murine embryonic fibroblasts which leads to increased 
genomic instability (Richard et al, 2008; Feldhahn et al, 2012). In this study, I 
observed  higher Obfc2a methylation in both mouse colon and SI DNA from 
the HF group but the differences between dietary groups were small (Table 
5.1). The fact that DNA methylation of two loci in Obfc2a were affected in 
proximal SI while only one locus was affected in the colon suggests the small 
bowel may be more susceptible to the effect of high dietary fat intake. Similar 
to p16, lower Obfc2a expression was found in mouse SI from the HF group. 
To the best of my knowledge, there has been no previous report on Obfc2a 
methylation in mouse tissues. Indeed, the aberrant Obfc2a methylation 
observed here provided explanation as one potential mechanism that 
contributes to altered expression of this gene as the consequence of high fat 
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intake from weaning. Since Obfc2a is vital for the maintenance of a healthy 
genome, the lower expression found in proximal SI from the HF group 
suggests the DNA repair mechanisms in this tissue might be affected by the 
high fat diet. This finding is in line with reduced DNA repair capacity through 
BER in the brains of these animals which has been reported previously by this 
laboratory (Langie et al, 2013).  
Ppm1k encodes the mitochondrial protein PP2Cm, which exhibits 
phosphoserine phosphatase activity and contributes to the regulation of 
branched-chain amino acid catabolism and normal embryonic development 
(Zhou et al, 2012). PP2Cm is highly expressed in several mouse organs 
including brain, heart and liver (Joshi et al, 2007). As for Obfc2a, there are no 
published data on Ppm1k methylation or on its expression in mouse small 
intestine and colon. In this study, Ppm1k methylation was higher in the mouse 
prox SI from the HF group. However, DNA methylation of this gene is 
comparatively low, and although the differences between the two dietary 
groups was significant, the effect was very small (Table 5.1). Moreover, lower 
Ppm1k expression was observed in mouse proximal SI from animals that were 
fed the HF diet. This provides support to the idea that even small differences 
in DNA methylation can contribute to differential expression.  
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5.7.4   Does maternal folate depletion during pregnancy and 
lactation exacerbate the effects on DNA methylation of high fat feeding 
post-weaning?  
This mouse study was designed to test the hypothesis that a nutritional insult 
in early life (folate depletion due to low maternal folate supply) would 
exacerbate the effects of a second nutritional insult (feeding a high fat diet from 
weaning). Here I investigated potential interactions between maternal low 
dietary folate intake during pregnancy and lactation and high fat intake from 
weaning on methylation and expression of six genes in the small and large 
bowels of 6 months old offspring in mice. No significant interaction between 
the two dietary insults was observed for either DNA methylation or expression 
of the corresponding genes. This is in contrast with a previous report which 
found interactions between low maternal folate supply and the high fat diet on 
promoter methylation of Ogg1 and Neil1 (both base excision repair (BER)-
related genes) in the cortex region in adult offspring from the same study 
(Langie et al, 2013). These observations support the hypothesis that the 
effects of dietary interventions on DNA methylation are gene and tissue-
specific (McKay et al, 2011a). For the genes investigated here, the adult 
mouse colon and proximal small intestine appears to be less susceptible to the 
combined effect of these two nutritional insults than is the brain.  
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5.7.5   Effect of sex on gene-specific methylation and expression 
in the colon and proximal SI of adult mice 
The present study was designed to avoid any confounding of dietary effects 
by sex by including identical numbers of male and female mice in each dietary 
group (McKay et al, 2014). This design then allowed investigation of 
differences between males and females in DNA methylation and gene 
expression when averaged across all dietary treatments. The higher 
methylation found in males at Esr1 in both adult proximal SI and colon was 
consistent with my previously finding in fetal mouse gut (McKay et al, 2011b). 
Although difference between the two sexes in methylation status in DNA from 
the adult colon was less prominent than in proximal SI, these differences were 
statistically significant due to lower variation between samples.  
Expression of Obfc2a in colon from adult female mice was higher than that in 
males but there were no significant differences between the sexes in 
methylation at any of the three loci within Obfc2a. This suggests that factors 
other than DNA methylation are responsible for the differences in Obfc2a 
expression between males and females in the colon. However, because so 
little is known about epigenetic regulation of this gene, it is also possible that 
there is altered methylation at other CpG sites (not analysed in this study) 
which contribute to the sex differences in expression of Obfc2a.   
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5.7.6   Relationships between adult mouse body weight and gene-
specific methylation in the colon and proximal SI  
A meta-analysis of randomised controlled trials (RCT) in humans by Fekete et 
al (2012) found a significant, positive dose-response relationship between 
folate intake and birth weight (P=0.001). For the animals studied here, birth 
weight was not measured but, at weaning, pups whose mothers were fed the 
low folate diet were significantly lighter than pups from the control group 
(McKay et al, 2014). By 6 months of age, there were no significant effects of 
maternal folate supply on the body weight or body fat content of the offspring 
(McKay et al, 2014). However, as expected the mice fed the high fat diet from 
weaning were significantly heavier and had higher body fat than those fed the 
low fat diet post weaning (McKay et al, 2014). These diet-related differences 
in body weight were reflected in difference in gene methylation. For example, 
Slc39a4 methylation was lower in both the colon and proximal SI in animals 
from the HF dietary group. In addition, methylation at a number of CpGs within 
Slc39a4 in both mouse tissues was inversely correlated with body weight. 
Since Slc39a4 hypo-methylation is considered to be undesirable and has been 
reported in ageing mouse intestine (Maegawa et al, 2010) and human CRC 
cell lines (Kim et al, 2009a), it is reasonable to hypothesise that if the high 
dietary fat intake continues into older life, it could enhanced the effect of age 
on Slc39a4 methylation and therefore increased susceptibility to age-related 
diseases. 
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5.8 Chapter summary 
For the ten loci investigated here, similar DNA methylation patterns were 
observed in fetal gut, adult colon and prox SI. However, despite this similarity, 
there were significant differences in percentage methylation between the two 
gut tissues in adult mice. In addition, the lower methylation of Slc39a4 but 
higher methylation of Obfc2a in the colon was associated with higher and lower 
expression of these two genes respectively. This provides support for current 
belief that DNA methylation is one of the major epigenetic mechanisms 
involved in the regulation of gene transcription. High-fat feeding of offspring 
from weaning altered methylation of Esr1, Slc39a4 and Obfc2a-amp2 in the 
colon and methylation of Slc39a4-CGI1, p16, Obfc2a-amp1 & -amp2, and 
Ppm1k in the proximal SI. This effect in mice appeared to be CpG, locus and 
tissue specific in mice. This is similar to the recent observation of tissue and 
locus specific effects of maternal nutrition on methylation of the IGF2/H19 
locus in multiple tissues in newborn human twins (Loke et al, 2013). The 
differences between males and females in Esr1 and Slc39a4 methylation 
observed in the fetal gut (Chapter 4) were replicated in the proximal SI and 
colon from adult offspring. For the fetal gut, the sex effect was significant for 
Slc39a4-CGI1 methylation whereas in the prox SI of adult mice it was 
significant for Slc39a4–CGI2. In the adult colon, sex differences were 
observed in both CGIs in Slc39a4, Esr1 and Igf2-DMR1. These observations 
suggest that sex-specific differential DNA methylation patterns acquired early 
in life remain stable into adulthood in mice.   
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There were no effects of maternal folate supply on DNA methylation or 
expression of any of the 6 genes investigated in this study in either the proximal 
SI or colon of adult offspring. However, in mice fed the high fat diet from 
weaning, methylation of Slc39a4-CGI1 was significantly lower than in mice 
randomised to the low fat diet. In contrast with effects on Slc39a4 methylation, 
for all the other loci investigated, high fat feeding from weaning resulted in 
higher DNA methylation in the adult mouse proximal SI. Similar effects were 
observed in the colon. In addition, expression of p16, Obfc2a and Ppm1k was 
higher in the proximal SI. The novel findings from this chapter adds to current 
knowledge regarding the relationship between maternal folate supply, dietary 
fat intake from weaning, DNA methylation and gene expression in the intestine 
of adult mice. 
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CHAPTER 6 
 
Investigation of associations between folate status and age 
with DNA methylation and gene expression in the human 
colorectal mucosa 
 
6.1  Introduction 
The molecular mechanisms responsible for the progressive loss of function at 
cellular, tissue and organ levels during ageing remain unclear (Heyn et al, 
2012). Altered expression of several gene families and cellular mechanisms 
such as metabolic pathways have been suggested as potential candidates that 
contribute to ageing and longevity (Fadini et al, 2011). Current evidence 
suggests that the ageing phenotype results from the gradual accumulation of 
damage to all cell macromolecules which impair the function of multiple 
pathways and processes (reviewed in Mathers, 2015). This damage includes 
DNA mutations, oxidation and mis-folding of proteins and lipid oxidation 
(López-Otín et al, 2013). Epigenetic processes may have a role in ageing 
through silencing of genes that are involved in cellular defence such as DNA 
repair (Langie et al, 2013). Studies on monozygotic twins revealed that 
humans with identical genetic makeup can acquire differential methylation 
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patterns during the life-course and different risk of disease in later life (Fraga 
et al, 2005; Kaminsky et al, 2009). In addition, changes in methylation of some 
genomic regions are strongly linked with increasing age (Bell et al, 2012; 
Belshaw et al, 2010; Teschendorff et al, 2010).  
Folate is essential for the production of red blood cells. Sub-optimal folate 
availability can impair DNA synthesis and repair and alters genome stability 
(Hazra et al, 2010). Because folate is an important methyl donor, folate status 
can influences gene expression through epigenetic mechanisms, and such 
changes in gene expression may contribute to modulation of risk of disease 
(Barua et al, 2014). In addition to the protective effects against congenital 
defects during pregnancy, folate may contribute to the prevention of 
cardiovascular disease (CVD) in adulthood by lowering homocysteine 
concentrations (Mierzecki et al, 2014; Boushey et al, 1995). However, large-
scale RCTs testing the effects of folic acid (usually given in large doses in 
combination with other B vitamins) have produced little evidence of CVD 
reduction (Martí-Carvajal et al, 2013). Folate may also have a role in the 
development of several age-related diseases such as dementia in Alzheimer’s 
disease (Montgomery et al 2014) and cancers (Mason & Levesque, 1996). In 
addition, inadequate folate supply may induce tumour formation in the colon 
(Mathers, 2009) perhaps involving aberrant DNA methylation and DNA 
damage (reviewed in Kim, 2005). 
In previous chapters reporting work undertaken in mice, I have shown that 
alteration in folate supply during pregnancy and lactation can have effects on 
DNA methylation and gene expression in the mouse intestine (in Chapters 4 
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and 5). In this final experimental chapter of my thesis, I aimed to extend that 
work to studies in humans. For this I took advantage of samples and 
associated metadata from the BORICC Study (Biomarkers of Risk in Colon 
Cancer) (Greaves et al, 2014). In the BORICC Study, adults undergoing 
colonoscopy for gastrointestinal symptoms in which no pathology was 
observed provided biopsies of colorectal mucosa and were phenotyped 
extensively. This phenotyping including assessment of folate status based on 
both red cell and serum folate concentrations. This provided an opportunity to 
assess relationships between folate status, DNA methylation and gene 
expression in the human colorectal epithelium. In addition, because the 
BORICC Study included participants over a wide range of adult ages, I had the 
opportunity to assess whether such relationships differed between younger 
and older people. 
 
 
6.2 Hypothesis, aims and objectives 
In Chapters 4 and 5 I have shown that maternal folate status during pregnancy 
and lactation affected promoter methylation and expression of selected genes 
in the mouse gut. This work has been extended to humans in the present 
chapter. Here I hypothesised that:  
 folate status would affect DNA methylation in a panel of three genes in 
DNA from the human colorectal mucosa; 
  the relationship between folate status an DNA methylation would differ 
in younger v. older people; 
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 differences in DNA methylation would be associated with changes in 
expression of the corresponding genes. 
The main aim of the work reported in this chapter was to test these hypotheses 
using samples and associated meta-data from the BORICC Study. The 
specific objectives of the study were: 
1. to select a panel of genes whose methylation and expression in the 
human colorectum may be influenced by folate status and / or by 
ageing; 
2. to select participants in the BORICC Study with higher and lower folate 
status and, in each case, to include matched individuals from the 
younger and older age groups. 
3. to quantify methylation for the panel of genes in DNA extracted from 
colorectal mucosal biopsies from the selected BORICC Study 
participants;  
4. to quantify expression at the mRNA level for each gene in the panel of 
genes using RNA extracted from colorectal mucosal biopsies from the 
selected BORICC Study participants;  
5. to examine effects of other factors, notably sex, on DNA methylation 
and gene expression; 
6. to examine associations between DNA methylation and gene 
expression for the selected gene panel. 
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6.3 Overview of experimental approach 
In chapter 4, differential methylation at Esr1, Slc39a4 and Obfc2a was 
observed in adult mouse colon in response to altered dietary intake and 
methylation of Esr1 and Slc39a4 in mouse colon differed between males and 
females. Additionally, methylation of Slc39a4 and Obfc2a differed between 
mouse colon and small intestine which corresponded with changes in 
expression of both genes. For these reasons, this panel of three genes was 
selected for quantification of DNA methylation and expression in human colon 
mucosa in this study. Chromosomal locations of the genes and the names and 
functions of the corresponding proteins are summarised in Table 6.1 
DNA and mRNA were extracted from human colon mucosal biopsies from the 
BORICC study as described in sections 2.5.4 and 2.7.2 respectively. 
Pyrosequencing, reverse transcription PCR, real-time qPCR and assay 
development for all three genes were undertaken as described in sections 2.6, 
2.8, 2.9 and 2.10 respectively.  
 
 
 
 
 
 
185 
 
Table 6.1  Genes selected for methylation and expression analysis; 
Chromosomal locations, type of protein encoded, and functions of 
proteins in human 
 
Gene locus ESR1 SLC39A4 OBFC2A 
Genomic 
location 
Chromosome 6q25.1 
Chromosome 
8q24.3 
Chromosome 
2q32.3 
Name of 
protein  
Oestrogen receptor α 
zinc-regulated 
transporter-like 
protein (ZIP) 
family 
nucleic-acid-
binding protein 1 
Molecular 
function 
Transcription factor  Transporter  
Nucleic acid 
binding protein 
Examples of 
functions of 
protein 
Mediates biological 
function of steroid 
hormone 17β-
oestradiol (essential 
regulator of growth 
and differentiation) 
(Al-Ghnaniem Abbadi 
et al, 2012) 
signal transduction 
and the regulation of 
transcription and cell 
growth (Osborne et 
al, 2005) 
Zinc uptake in 
duodenum and 
jejunum, maintain 
zinc homeostasis 
in intestinal cells 
(Fairweather-Tait 
et al, 2008) 
Essential for 
various DNA 
metabolic 
processes – 
replication, 
recombination, 
damage 
recognition and 
repair (Richard et 
al, 2008) 
 
Note: genomic location of genes and protein information obtained from NCBI Gene 
(http://www.ncbi.nlm.nih.gov/gene), molecular function obtained from Human Protein 
Reference Database 
(http://www.hprd.org/summary?hprd_id=00589&isoform_id=00589_1&isoform_nam
e=Isoform_1) and gene function available from Online Mendelian Inheritance in 
Man® (http://omim.org) 
 
 
186 
 
Results: 
6.4 Baseline phenotypic data of subjects in the BORICC study 
A total of 268 volunteers were recruited for the BORICC study. All participants 
were shown at endoscopy to be free from polyps or CRC and none had a 
medical history of previous polyps or cancer. Pinch biopsies of colorectal 
mucosa were collected from a site 10 cms from the anal verge and detailed 
phenotypic measures including age, anthropometry, dietary intake and folate 
status were recorded.  
Red cell and serum folate concentrations in circulating blood are used for the 
investigation of folate status (Centers for Disease Control, 1992). Red cell 
folate concentration is a measure of longer term folate status while serum / 
plasma folate concentration reflects short term / recent folate intake. Red cell 
folate concentration is the preferred measure for folate status of an individual 
(Piyathilake et al, 2007).  
Both red cell and serum folate concentrations were originally measured as 
microgram/litre (µg/l). However, to achieve normal distribution of data and thus 
allow parametric statistical analyses, both measurements of folate 
concentration were log transformed. The mean log10 red cell folate 
concentrations were 2.56 and 2.53 µg/l for all males and females respectively 
(Fig 6.1 A). For subjects under the age of 50 years, the mean log10 red cell 
folate concentration was 2.52 µg/l while for older subjects (age 50 years and 
over), the mean log10 red cell folate concentration was 2.56 µg/l (Fig 6.1 B).  
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Figure 6.1  Distribution of red cell folate concentrations according to: 
A) sex and B) age for all participants recruited into the BORICC study 
 
 
 
 
 
 
 
A 
B 
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In this project, I used thirty-four colon mucosal biopsies collected during the 
BORICC study from participants with a mean age of 50.26 years. Participants 
were divided into either younger (< 50 yrs) or older (≥ 50 yrs) age groups (n=18 
& 16 respectively, p<0.05, ANOVA, Fig 6.2 A). Participants were also stratified 
into low folate (< 2.66 µg/l) and high folate (≥ 2.66 µg/l) groups (n=16 & 18 
respectively, p<0.05, ANOVA, Fig 6.2 B) according to red cell folate 
concentrations.  
Serum folate concentrations were significantly higher in individuals from the 
older age group (ANOVA, p<0.05) while the folate concentrations in red blood 
cells did not differ between younger and older volunteers (p>0.05). Selenium 
concentration in plasma was also measured in volunteers in the BORICC study 
and did not differ between younger and older or between those in the low and 
high red cell folate groups (p>0.05).   
Participants in the older age group were lighter in weight (p>0.05) and 
significantly shorter in height (p<0.05) compared with participants from the 
younger age group. Older volunteers had a slightly smaller waist 
circumference and larger hip measurement but these differences were not 
significant. For volunteers in the high folate group, both waist and hip 
circumference were greater than for the low folate group but the mean BMI did 
not differ significantly between these two groups (p>0.05). 
There were no significant differences between the younger and older 
participants, or between the high and low red cell folate groups for aspects of  
dietary intake, including as % energy intake from red / processed meat, 
vegetables, fat, protein and carbohydrates.  
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To avoid potential effects of smoking on DNA methylation (Petersen et al, 
2014), all participants chosen for investigation were non-smokers with no 
previous smoking history. 
Baseline characteristics of volunteers from the BORICC study selected for this 
project are summarised in Table 6.2 
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Figure 6.2  Boxplots of the distribution of A) age (yrs) and B) red cell 
folate concentration (log10 µg/l) of healthy participants from the BORICC 
study included in the present project 
 
 
 
 
A 
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Table 6.2 Baseline characteristics of BORICC study participants 
included in the present project 
 
All* 
(n=34) 
Young  
age  
group 
Old  
age  
group 
p  
value 
Low  
folate 
group 
High 
folate 
group 
p 
value 
Male (n=)  14 6  9 11  
Female (n=)  4 10  7 7  
Total (n=)  18 16  16 18  
Age (years) 50.3 39.1 62.7 <0.001 50.0 50.5 0.506 
Height (m) 1.7 1.7 1.6 0.031 1.7 1.7 0.476 
Weight (kg) 79.9 82.5 76.0 0.248 74.7 83.8 0.109 
BMI (kg/m²) 27.0 26.7 26.9 0.884 24.8 28.8 0.018 
waist circumference 
(cm) 
90.5 91.1 89.2 0.632 85.6 94.7 0.028 
hip circumference (cm) 
103.0 100.2 105.7 0.128 99.8 106.1 0.081 
waist/hip ratio 0.8 0.9 0.8 0.007 0.8 0.8 0.104 
Serum folate  
(log µg/l) 
0.9 0.8 1.0 0.042 0.8 1.0 <0.001 
Red cell folate  
(log µg/l) 
2.6 2.6 2.6 0.259 2.4 2.8 <0.001 
Plasma selenium 
(µMol/l) 
1.1 1.1 1.1 0.848 1.1 1.1 0.815 
Total energy intake (kj) 12433.7 14369.2 10918.8 0.117 12636.9 12651.0 0.995 
% energy intake from 
red/processed meat 8.6 7.3 9.6 0.426 9.5 7.5 0.496 
% energy intake from 
vegetables 4.9 4.7 5.0 0.737 5.3 4.3 0.301 
% energy intake from 
fat 30.7 30.6 30.3 0.880 32.2 28.7 0.057 
% energy intake from 
carbohydrates 47.8 45.7 49.7 0.102 46.6 48.8 0.361 
% energy intake from 
protein 15.4 14.7 16.3 0.183 15.1 15.8 0.535 
% energy from alcohol 5.8 8.7 3.4 0.048 5.8 6.4 0.796 
 Note: Current and previous smokers were excluded due to its potential ability to alter 
gene-specific methylation, p values in bold denote statistically significant outcomes  
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6.5 Relationships between folate status, age, sex and DNA 
methylation of ESR1, OBFC2A and SLC39A4 in colorectal mucosa of 
healthy human volunteers 
6.5.1  Associations between red cell folate status and methylation 
of ESR1, OBFC2A and SLC39A4 DNA in human colorectal mucosa 
Two assays were used to measure DNA methylation at a total of eight CpGs 
within two genomic regions in ESR1 (-amp1 and –amp2). For all 8 CpGs 
measured in ESR1, higher mean methylation was observed in colorectal 
mucosal biopsies from the group of volunteers who had higher red cell folate 
concentrations but  none of the differences in methylation at any single CpG 
site nor the overall mean methylation across all eight CpG sites differed 
significantly (ANOVA, p>0.05, n=34, Fig 6.3 A-B). SLC39A4 DNA methylation 
was lower at every CpG site measured in volunteers from the higher folate 
group, but again there was no statistically significant difference at any single 
site or for the overall mean across all sites (p>0.05, Fig 6.3 C). For OBFC2A, 
DNA methylation at all five CpGs measured was very low and was similar 
between the high and low folate groups (p>0.05, Fig 6.3 D).  
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Figure 6.3  DNA methylation at: A-B) ESR1-amp1-2, C) SLC39A4 and D) 
OBFC2A in colon from human volunteers with low or high red cell folate 
concentrations (low and high folate group respectively) Data expressed 
as mean ± SEM; low folate and high folate groups have red cell folate 
concentrations of < log10 2.66 µg/l & ≥ 2.66 log10 µg/l respectively; n=16 for low 
folate and n=18 for high folate groups. 
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6.5.2  ESR1, OBFC2A and SLC39A4 DNA methylation in human 
colorectal mucosa from healthy older and younger volunteer groups 
DNA methylation was significantly higher in colorectal mucosal biopsies from 
the older participants compared with the younger participants at each of the 
eight CpGs measured in ESR1, and for mean methylation across all eight sites 
(ANOVA, p<0.05, n=34, Fig 6.4 A&B). For OBFC2A and SLC39A4, there were 
no significant differences in DNA methylation at any of the sites measured 
between the younger and older age groups (p>0.05, Fig 6.4 C&D).  
 
 
Figure 6.4  Effect of age on CpG methylation at A-B) ESR1-amp1 & -
amp2, C) OBFC2A and D) SLC39A4 in the colorectal mucosa from healthy 
volunteers *denotes p<0.05, **denotes p≤0.001, data expressed as mean ± 
SEM, young = age <50 years, old = age ≥50 years, n = 18 & 16 respectively 
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6.5.3  The effect of sex on ESR1, OBFC2A and SLC39A4 DNA 
methylation in the human colorectal mucosa 
The sub-set of BORICC Study participants investigated in the present study 
included 20 men and 14 women (Table 6.1). Higher DNA methylation was 
observed in women compared with men at all eight CpG sites measured at 
ESR1-amp1 and –amp2 and overall mean across all four CpGs in each locus 
at ESR1. DNA methylation at CpG sites 1, 2, 4 and overall mean across all 
four CpGs at ESR1-amp2 was significantly higher in women (ANOVA, p<0.05, 
Fig 6.5 A&B). When averaged across all eight CpG sites within both loci in 
ESR1, the difference in DNA methylation between men and women was 
borderline significant (p=0.056, data not shown). There were no differences 
between males and females in DNA methylation at all 5 CpG sites measured 
in OBFC2A (p>0.05, Fig 6.5 C). Methylation of DNA in colorectal mucosal 
biopsies from females was higher than for males at all three CpG sites and for 
the overall mean across all three sites at SLC39A4 and this difference was 
significant at CpG site 1 in SLC39A4 (p<0.05, Fig 6.5 D).    
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Figure 6.5  CpG methylation in human colon mucosa from males and 
females at A) ESR1-amp1, B) ESR1-amp2, C) OBFC2A and D) SLC39A4 
*denotes p≤0.05, data expressed as mean ± SEM, n=20 & 14 for males and 
females respectively 
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6.5.4  Relationships between age and sex on ESR1 methylation in 
human colorectal mucosa 
Owing to the high number of female from the old age group, further statistical 
analyses were carried out to test for associations between age and sex on 
ESR1 methylation. When age was added as a confounding factor, the effect 
of sex on DNA methylation at CpGs 1, 2, 4 and overall mean at ESR1–amp2 
as described in section 6.5.3 was not affected (Regression, p<0.05, n=34, 
Fig 6.6).  
 
 
Figure 6.6  ESR1 methylation in human colon mucosa from young & old 
age group between the two sexes (A to D represent CpG sites 1, 2, 4 and 
overall mean at ESR1-amp2 respectively, n = 14 & 6 for young & old male 
respectively, n=4 & 10 young & old females respectively, blue and green 
circles represent males and females respectively) 
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6.6 Relationships between folate status, age, sex and expression of 
ESR1, OBFC2A and SLC39A4 in the colorectal mucosa of healthy human 
volunteers from the BORICC study  
Out of the thirty-four biopsies of colorectal mucosa analysed, RNA of 
satisfactory integrity and sufficient quantity was obtained from twenty-seven 
participants to investigate the effects of folate status, age and sex on the 
expression of ESR1, OBFC2A and SLC39A4. 
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6.6.1  Associations between red cell folate status and ESR1, 
OBFC2A and SLC39A4 expression in the human colorectal mucosa 
Higher ESR1 and OBFC2A expression in colon was observed in the group of 
volunteers with a higher mean folate status (assessed as concentration of 
folate in red blood cells) compared to volunteer from the low folate group, 
though this is not statistically significant (ANOVA, p>0.05, n=14 and 13 for low 
and high folate groups respectively, as shown in Table 6.3). In human colon 
mucosa from individuals in the high folate group, the expression of SLC39A4 
is lower than colon from the low folate group but this is not statistically 
significant (p>0.05, Table 6.3). 
Linear Regression was used to illustrate the relationship between individual’s 
folate status and expression of ESR1, OBFC2A or SLC39A4 measured at the 
mRNA level in colorectal mucosal biopsies from participants in the BORICC 
Study (p>0.05, n=27, Fig 6.6). 
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Figure 6.7  Relationships between red cell folate status and expression 
of: A) ESR1, B) OBFC2A and C) SLC39A4 in human colorectal mucosal 
biopsies from healthy volunteers  
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6.6.2  Associations between age and expression of ESR1, 
OBFC2A and SLC39A4 in colorectal mucosal biopsies from healthy 
human volunteers 
In human colon from the older age group, expression of ESR1 and OBFC2A 
was lower than in colon from the younger age group, whereas for SLC39A4, 
gene expression between the older and younger age group was almost 
identical. No significant differences between both age groups on gene 
expression were found for either of the three genes (ANOVA, p>0.05, n=27, 
shown in Table 6.3). 
In order to illustrate the correlation between each individual’s age and 
expression of ESR1, OBFC2A and SLC39A4 in human colon, linear regression 
analysis was carried out and this is shown in Fig 6.7 (p>0.05, n=27). 
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Figure 6.8  Relationships between Age and expression of : A) ESR1, B) 
OBFC2A and C) SLC39A4 in macroscopically normal human colorectal 
mucosal biopsies (n=27) 
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6.6.3  Interaction between red cell folate status and age on 
expression of ESR1, OBFC2A and SLC39A4 in human colorectal mucosa 
For ESR1 and OBFC2A, no interaction was observed between red cell folate 
status and age on expression of both genes in human colon (ANOVA, p>0.05, 
n=27, as shown in Table 6.3). However, for SLC39A4, interaction between age 
and folate status on gene expression was observed (ANOVA, p<0.05, in Table 
6.3). Colon from older participants with low red cell folate concentration had 
lower SLC39A4 expression compare to participants with high red cell folate 
status in the same age group. Whereas for participants from the younger age 
group with low red cell folate status, SLC39A4 expression is higher than 
individuals with a higher folate status within the same age group (as illustrated 
in Fig 6.8).   
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Table 6.3  Impact of red cell folate concentration and age on ESR1, 
OBFC2A and SLC39A4 expression in human colorectal mucosa (data 
expressed as mean relative expression in each gene ± SEM, values in bold 
denotes statistically significant outcome, red cell folate concentration and age 
of volunteers are in log10 µg/l and years respectively) 
 
 
Red cell folate 
conc. 
Age Probabilities of effects 
Low 
(SEM) 
High 
(SEM) 
Young 
(SEM) 
Old 
(SEM) 
Red 
cell 
folate 
Age 
Folate* 
age 
interaction 
n = 14 13 15 12 27 27 27 
Gene locus  
ESR1 3.1 
(0.84) 
4.1 
(0.90) 
4.2 
(0.81) 
3.1 
(0.92) 
0.390 0.415 0.566 
OBFC2A 1.3 
(0.17) 
1.4 
(0.18) 
1.6 
(0.16) 
1.1 
(0.18) 
0.101 0.689 0.102 
SLC39A4 1.5 
(0.19) 
1.3 
(0.20) 
1.5 
(0.18) 
1.4 
(0.20) 
0.745 0.393 0.013 
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Figure 6.9   Interaction plot between age and folate status on expression 
of SLC39A4 in human colon mucosa 
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6.6.4  Effect of sex on expression of ESR1, OBFC2A and SLC39A4 
in colorectal mucosal biopsies from healthy human participants 
Sufficient quantities of good quality RNA were obtained from colorectal 
mucosal biopsies from 16 male and 11 female participants in the BORICC 
Study. Quantitative qPCR analysis showed almost identical SLC39A4 
expression between the two sexes. OBFC2A expression was slightly higher in 
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males than in females. On the other hand, ESR1 expression in females was 
slightly higher than in males. None of the differences between males and 
females in expression of ESR1, OBFC2A and SLC39A4 were statistically 
significant (ANOVA, p>0.05, n=27, Fig 6.9). 
 
 
Figure 6.10  ESR1, OBFC2A and SLC39A4 expression in colorectal 
mucosal biopsies from male and female participants in the BORICC 
Study. Note: data presented as mean of relative expression in each sex group 
± SEM; x-axis represents relative expression, y-axis represents gene names; 
n=16 and n=11 for males and females respectively   
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6.6.7 Correlations between DNA methylation at single CpG sites in 
ESR1, OBFC2A and SLC39A4 and expression of the corresponding 
genes in the human colorectal mucosa 
There was an inverse association between the percentage methylation of 
ESR1 at CpG site 8 and ESR1 mRNA abundance (Linear Regression, p<0.05, 
n=27, Table 6.4). No other significant associations between DNA methylation 
at any of the individual CpG sites measured in ESR1, OBFC2A or SLC39A4, 
or between mean DNA methylation across all sites within each gene, and 
corresponding mRNA levels were observed (p>0.05, n=27, Table 6.4). One 
example of a scatter plot for each gene is shown in Fig 6.10 A-C. 
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Table 6.4 Associations between methylation of CpG sites within 
ESR1, OBFC2A and SLC39A4 and expression of the corresponding 
genes in the colorectal mucosa from healthy human volunteers            
* denotes statistically significant associations; n=27  
 
Gene CpG methylation Gene expression p value 
ESR1-amp1 S1 ESR1 0.149 
 S2 ESR1 0.141 
 S3 ESR1 0.172 
 S4 ESR1 0.173 
 mean ESR1 0.155 
ESR1-amp2 S1 ESR1 0.157 
 S2 ESR1 0.162 
 S3 ESR1 0.195 
 S4 ESR1  0.039* 
 mean ESR1 0.139 
OBFC2A S1 OBFC2A 0.306 
 S2 OBFC2A 0.411 
 S3 OBFC2A 0.994 
 S4 OBFC2A 0.110 
 S5 OBFC2A 0.246 
 mean OBFC2A 0.271 
SLC39A4 S1 SLC39A4 0.218 
 S2 SLC39A4 0.465 
 S3 SLC39A4 0.214 
 mean SLC39A4 0.435 
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Figure 6.11  Associations between methylation of: A) CpG site 4 at 
ESR1-amp2, B) overall mean of all five CpGs at OBFC2A and C) overall 
mean of all three CpGs at SLC39A4 and expression of ESR1, OBFC2A 
and SLC39A4 (at the mRNA level respectively) in the human colorectal 
mucosa x-axis represents % DNA methylation, y-axis represents 
corresponding gene expression; n=27 
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6.7 Discussion 
6.7.1   Sample selection and baseline characteristics of BORICC 
Study volunteers  
For this study, human colon biopsies were selected from volunteers aged 26-
78 years who participated in the BORICC study. Use of samples from 
participants with this wide age range allowed stratification into two age groups: 
younger (26-48 years, n=18) and older (50-78 years, n=16). In addition, 
participants were selected according to folate status (assessed as red cell 
folate concentration) with the aim of having matched groups of those with lower 
and higher folate status within each age group.  
C 
215 
 
 Adults from the older age group were on average shorter in height and lower 
in weight than those in the younger age group. This difference is consistent 
with other data on differences in height between younger and older adults.  For 
example, in individuals ranged between 30 to 70 years age, Sorkin et al (1999) 
reported cumulative height loss of around 3 and 5 cm for men and women 
respectively. Also, the older subjects had a smaller mean waist but higher 
mean hip circumference, which lead to a lower mean waist/hip ratio for the 
older compared with younger participant groups.   
Folate inadequacy is common worldwide and e.g. around 40% of 15-18 year 
olds in the UK have borderline folate status (serum folate concentrations 
between 5–7 nmol/L, Clark et al, 2003) and individuals over 65 years of age 
are particularly at risk of folate deficiency (Duthie, 2009). For the thirty-four 
subjects selected here, folate concentration in red blood cells was similar 
across both age groups while mean serum folate concentration was slightly 
higher in the older individuals. Values of >0.477 and >2.146 (log10 mcg/l) 
indicate adequate serum and red cell folate levels respectively (Clark et al, 
2003). All subjects in both the older and younger age groups studied here 
achieved these levels, so that, based on these criteria, they had adequate 
recent and long-term folate intake. Importantly, there was no difference in red 
cell folate concentration between the younger and older groups of participants 
so that there was no confounding of age and folate status in this study. 
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6.7.2  Relationships between age, red cell folate concentration 
and DNA methylation and gene expression 
There is a wealth of data showing multiple changes in epigenetic phenomena, 
including DNA methylation in cancers such as CRC (Lao & Grady, 2011). 
However, much less is known about DNA methylation changes in the 
apparently normal colorectal mucosa which precede the development of 
neoplastic lesions despite the evidence that such epigenetic changes may 
drive the development of the disease (Jones & Baylin, 2002). There is a need 
to investigate the methylome in pre-neoplastic tissues from healthy subjects to 
determine how the DNA methylation profile differs between individuals of 
different ages and who have been exposed to different environmental factors 
(Langevin et al, 2011). DNA methylation and gene expression patterns t differ 
with age and may exacerbate the risk of age-related disease (van Otterdijk et 
al, 2013). Genome wide scanning of >27,000 CpG sites in human brain regions 
including frontal cortex, temporal cortex, pons and cerebellum  observed a 
highly significant positive correlation between DNA methylation and age in the 
human brain (Hernandez et al, 2011). In contrast, genome wide investigation 
of CpG sites in DNA from CD4+ T cells in blood covering promoters, exonic, 
intronic and intergenic regions revealed that a 103 year old centenarian had 
more hypo-methylated CpGs compared to cord blood from a newborn (Heyn 
et al, 2012). In the present study, ESR1 methylation increased with age. This 
is in agreement with observation by Kaz et al (2014) and Worthley et al (2010) 
that ESR1 promoter methylation is positively correlated with age in normal 
human colon. Age-dependent changes in methylation of APC, AXIN2, DKK1, 
HPP1, N33, p16, SFRP1, SFRP2 and SFRP4 genes but not ESR1 in the 
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macroscopically-normal colorectal mucosa was reported by Belshaw et al, 
(2008). The non-significant effect of age on methylation of OBFC2A and 
SLC39A4 could be because the mean age difference between the younger 
and older age groups here were just over 30 years compared with the 103 and 
101 years investigated in Heyn et al (2012) and Hernandez et al (2011) 
respectively. Furthermore, tissue specificity and variability between individuals 
can also contribute to the non-significant age effects found for both OBFC2A 
and SLC39A4 methylation. 
Aberrant ESR1 methylation was reported in human colon epithelial cells 
exposed to supra-physiological folate concentrations in-vitro (Charles et al, 
2012). Here higher DNA methylation was observed in the high folate group at 
all CpGs measured in ESR1 in human colon although these differences were 
not statistically significant. The non-significant association between ESR1 CpG 
methylation and expression implies there might be other epigenetic 
mechanism such as histone modifications or micro-RNA expression that could 
contribute to the regulation of expression of this gene in the human colorectal 
mucosa.   
 
6.7.3   Differences in DNA methylation and gene expression 
between male and female participants in the BORICC Study 
Differences between the sexes in DNA methylation of Slc39a4 and Esr1 in 
mouse fetal gut, adult mouse colon and proximal small intestine was observed 
in work presented earlier in this thesis (Chapters 4 and 5). Here, I have 
observed differences between the two sexes in methylation at several CpGs 
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within these same two genes in DNA from the human colorectal mucosa. 
Methylation of SLC39A4 DNA was higher in the gut of females compared with 
males in the human colorectal mucosa and also in all three mouse gut tissues 
reported in Chapters 4 and 5. This finding indicates that mouse could be a 
good model to study Slc39a4 methylation. On the other hand, the higher ESR1 
DNA methylation in human colon in females was in contrast to the higher Esr1 
DNA methylation observed in males in mouse gut tissues. For this reason, 
careful consideration needs to be taken into account when translating the data 
from mouse to human. However, the expression of neither gene differed 
between the sexes. Apart from published data from our research group on the 
fetal mouse gut (McKay et al, 2011b), I have found no other reports of 
differences between males and females with respect to DNA methylation at 
Slc39a4 in either adult mouse or human. The findings here add to the current 
very limited information on how gene-specific DNA methylation differs between 
the sexes. 
In young obese Korean women, expression of Slc39a4 (as well as of other zinc 
transporters) has been inversely associated with higher BMI and body fat (Noh 
et al, 2014). No correlation was found between SLC39A4 expression and BMI 
in females only, and all samples from both sexes investigated here. However 
the current study may lack power to detect such a relationship because of the 
small number of samples measured (n=11 & 27 for females and all samples 
respectively). 
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6.8 Chapter summary 
In summary, compared with the younger participants, there was higher ESR1 
DNA methylation at all 8 CpGs measured in human colorectal mucosal DNA 
from the older participants. This finding is in agreement with published data 
showing that ESR1 methylation increases with age in a number of tissues. 
There were no detectable differences in DNA methylation at any of the loci 
investigated between participants with low and high folate status. However, it 
should be noted that all participants had folate status (assayed as red cell 
folate concentration) within the normal range. Differences between the sexes 
in ESR1 and SLC39A4 DNA methylation were also observed at some CpG 
sites. Overall, differences in DNA methylation were not associated with 
changes in the expression of the corresponding gene but the methylation 
differences observed between groups were small. As expected, the inter-
individual variability in DNA methylation in the human colorectal mucosa for 
each of the three genes investigated here was greater than that in the mouse 
gut. This variability could contributed to the non-significant difference in ESR1 
methylation between those with higher and lower folate status despite the 
higher ESR1 methylation observed at all eight CpG sites in the high folate 
group. 
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CHAPTER 7 
 
General Conclusions 
 
7.1  Main findings 
The main aim of this project was to test the hypotheses that i) maternal folate 
depletion during pregnancy would affect the methylation status of a panel of 
genes in the fetal mouse gut ii) such changes would be sustained into the 
offspring adulthood and iii) early life folate depletion would exacerbate the 
effects of a second nutritional insult (high fat feeding from weaning) on DNA 
methylation patterns in the adult gut. In addition, I aimed to determine whether 
diet-induced effects on DNA methylation were reflected in changes in 
expression of the corresponding genes. Finally, I attempted to translate 
findings from mice to humans by investigating associations between folate 
status and age on methylation of a sub-set of genes in the human colorectal 
mucosa. 
To address these aims, DNA methylation in a panel of 6 genes in 17.5 day gut 
tissue from mouse foetuses whose mothers were exposed to either a folate 
adequate or folate depleted diet for at least 4 weeks before mating and during 
pregnancy was quantified. This showed that two of the genes i.e. Slc39a4-CGI 
and Ppm1k-amp1 were differentially methylated in fetal gut as a result of 
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altered maternal folate supply (Chapter 4). However, analysis of DNA from six 
months old gut tissue (colon and proximal SI) from animals whose mothers 
had been fed the same folate adequate or folate depleted diets throughout 
pregnancy and lactation showed no effect of maternal folate supply on DNA 
methylation in this gene panel in the adult (6 mths old) offspring (Chapter 5). 
When offspring were given sufficient folate after lactation, the differences in 
Slc39a4 and Ppm1k methylation observed in foetuses disappeared in 
adulthood. This result suggests that the effect of low maternal folate supply 
during gestation can be annulled by maintaining adequate folate intake from 
early life throughout adulthood. From the nutritional point of view, this is 
encouraging since it provides proof of principle that positive dietary changes 
in the offspring can reverse the undesirable effects of a nutritional insult during 
pregnancy.      
At weaning, mouse offspring were randomised to either a low or a high fat diet 
and this allowed further investigation of the effects of the double nutritional 
insult (low maternal folate supply combined with high fat diet post weaning) on 
DNA methylation of the same panel of genes in adult life. This investigation 
showed that high fat feeding from weaning altered DNA methylation of 3 genes 
in the colon (Esr1, Slc39a4 and Obfc2a) and 4 genes in the proximal SI 
(Slc39a4, p16, Obfc2a and Ppm1k (Chapter 5). However, there was no 
evidence of any interaction between the two nutritional insults – early life folate 
depletion did not exacerbate the effects of high fat feeding from weaning on 
DNA methylation patterns for this gene panel in the adult gut. Overall, these 
findings suggest that the effects of these two nutritional insults on DNA 
methylation are CpG, locus and tissue specific. Interestingly, although 
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changes in DNA methylation in response to the nutrition interventions were 
relatively small, there were negative correlations between methylation of p16, 
Obfc2a and Ppm1k, and expression of the corresponding genes in prox SI 
from adult offspring (Chapter 5). This provides alternative argument to current 
opinion that statistically significant outcomes with small differences between 
treatment groups are difficult to interpret (Burdge & Lillycrop, 2010). 
The use of both fetal and adult gut tissue in mice allowed comparison of DNA 
methylation profiles from early life to adulthood for the ten loci investigated 
(Chapter 5). DNA Methylation patterns for each of the ten loci examined in this 
project were very similar between the three mouse tissues. However, despite 
the overall conservation of methylation patterns over time and between sites 
in the gut (proximal SI v. colon) there was evidence of plasticity in methylation 
patterns in the mouse gut. In both the foetus and adult, DNA methylation 
responded to nutritional influences (folate supply and dietary fat, respectively). 
In addition, analysis of paired samples of proximal SI and colon from the same 
adult mice showed highly significant between-tissue differences in methylation 
for 9 out of the 10 loci investigated (Chapter 5). The lower Slc39a4 and higher 
Obfc2a methylation observed in mouse colon did correlates to a higher 
(borderline significant) and lower corresponding expression of these two genes 
respectively in colon compared to prox SI regardless of dietary treatment.  
Although not a primary aim of the project, the use of both male and female 
mice allowed the investigation on the effects of sex on DNA methylation 
patterns. This showed differential DNA methylation for Esr1 and Slc39a4 in the 
fetal gut between male and female and this sex-specificity in DNA methylation 
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patterns of both genes was replicated in the adult mouse colon and prox SI. 
This implies the sex-specific DNA methylation pattern established in the 
mouse foetus is sustained into adulthood. 
The effect of folate status (assessed as red blood cell folate concentration) and 
age on DNA methylation and gene expression was investigated in human 
colorectal mucosal biopsies obtained from healthy participants in the BORICC 
study. The higher ESR1 methylation with increasing age reported by others 
(Kaz et al, 2014; Worthley et al, 2010) was confirmed in the BORICC samples 
(Chapter 6). Interestingly, the sex-specific effects on Esr1 and Slc39a4 DNA 
methylation observed in the mouse gut was replicated in the human colorectal 
mucosa. This suggests that, at least for these two genes, the mouse may be 
a useful model for humans for investigation of the effects of sex on DNA 
methylation patterns.  
As expected, inter-individual variation in DNA methylation and in gene 
expression was much smaller in the mouse than in the human. Several factors 
are likely to contribute to this observation including i) the mice were from an 
inbred strain and so would have considerably lower genotypic variation that a 
group of unrelated humans, ii) apart from the specific experimental diets, the 
mice were exposed to very similar (and constant) environmental conditions 
whereas the human volunteers were free-living and exposed to very diverse 
environments and iii) tissue sampling was much easier in the dead mice than 
in the living humans. This greater inter-individual variation could explain why 
fewer significant outcomes were obtained in the study of the human colorectal 
mucosa in Chapter 6. 
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7.2  Strengths and weaknesses 
7.2.1   Experimental design 
Evidence from epidemiological studies suggests that environmental exposures 
during mammalian development contribute to differential epigenetic patterns 
and alter risk of diseases such as metabolic diseases throughout the lifespan 
(reviewed in Seki et al, 2012). This is the DOHaD hypothesis and for the 
investigation of the impact of environmental exposures on the developing 
foetus, animal models can provide valuable and relatively inexpensive 
resources for the elucidation of potential mechanisms involved in modulating 
developmental programming in foetuses (Warner & Ozanne, 2010). The use 
of a mouse model of maternal folate depletion in this study provides an 
opportunity to study the effect of folate availability per se on DNA methylation 
in mouse tissue without potential confounding from other methyl donors such 
as choline, betaine and vitamin B12. This model has been used in our 
laboratory for several years and has been shown to be a reliable means of 
inducing maternal folate depletion whilst ensuring viable pregnancies (McKay 
et al, 2008a). Feeding the dams with the low folate diet for at least 4 weeks 
prior to mating meant that maternal folate status was depleted substantially at 
the point of conception (McKay et al, 2011). This animal model ensured that, 
even for the fetal gut, there was sufficient sample to carry out both methylation 
and expression analysis. In addition, for the adult mouse, it was possible to 
compare effects in matched samples of both the proximal SI and the colon 
which would be much more difficult in humans where access to matched 
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samples of SI and colorectal mucosa would pose much greater logistical and 
ethical challenges.  
Furthermore, the mouse model allowed investigation of the possible effects of 
an additional nutritional insult (high fat feeding from weaning) on DNA 
methylation and gene expression in the gut. In theory, it would be possible to 
investigate such interactions in humans using epidemiological approaches but 
these are likely to be very difficult because: i) the limited availability of relevant 
data on dietary exposures at appropriate times in the life-course, ii) potential 
confounding by other exposures (lifestyle factors), and iii) limited access to 
suitable tissues. Such studies are likely to be restricted to measurements 
made on easily-obtained tissues such as blood or buccal cells. Better 
understanding of the impact of early life nutritional exposures on epigenetic 
control (through altered DNA methylation) of gene expression can provides 
insights into role of nutrition on development and health and, eventually, may 
offer routes to disease prevention (Heijmans et al, 2008). In addition, changes 
in epigenetic marks in response to environmental exposures may be useful in 
early disease detection (Jirtle & Skinner, 2007). 
The human colorectal mucosal samples from the BORICC study used in 
Chapter 6 were a very valuable resource for the study of effects of age and of 
folate status on DNA methylation and gene expression in humans. Importantly, 
all participants in the BORICC Study were recruited using the same 
procedures, against the same inclusion and exclusion criteria and from the 
same out-patients clinic over a relatively short period of time. This minimised 
the likelihood of confounding by unknown, or unmeasured, factors which can 
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affect the utility of samples obtained from conventional clinical-based 
biobanks. Furthermore, the BORICC Study participants were all proven by 
endoscopy to be free of colorectal neoplasia (therefore, designated as healthy 
participants) and all had undergone extensive phenotyping using standard 
procedures by the same research team. Additionally, careful consideration has 
been given when obtaining colorectal mucosal biopsies to avoid potential 
variation between different anatomical locations of colon (Kaz et al, 2014; Mills 
et al, 2001). Such variation was minimised by collecting all mucosal biopsies 
from a site 10 cms from the anal verge. All of these biopsies were suitable for 
DNA methylation analyses, and furthermore, sufficient quality and quantity of 
RNA was obtained from 27 out of 34 colorectal mucosal samples. 
 
7.2.2   Technical Issues 
A strength of this study is the use of pyrosequencing for DNA methylation 
quantification. Combined with bisulphite modification and CpG assay design 
software, pyrosequencing provides robust measurement of CpG site and 
locus-specific methylation (Tost and Gut, 2007) and is considered as the gold 
standard for quantification of CpG methylation. All mouse assays were 
designed and validated to give reliable analysis of methylation at a number of 
CpGs within each gene promoter. However, a limitation of pyrosequencing is 
that each assay can interrogate only a relatively short length of DNA up to 200 
bases but, optimally, 100 – 150 bases (Colyer et al, 2012). Therefore, with a 
single assay, it is often not possible to measure all CpG sites in a given gene 
promoter. This can be addressed by developing multiple assays for the same 
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promoter (Langie et al, 2014), however even with such approaches, total 
coverage of the genomic domain of interest may not be possible. As a 
consequence, the pyrosequencing assays give precise information about DNA 
methylation for the particular CpGs included in the assay but these may not be 
entirely representative of the extent of methylation of the entire promoter for 
each gene. For the commercially sourced pyrosequencing assays for human 
genes, validation curves were generated to ensure that the assays provided 
quantitative measures of DNA methylation as intended. 
The use of real time qPCR technology provides quantitative data on gene 
expression with reference to housekeeping (reference) genes. In this study, I 
checked that expression of my reference genes are not affected by the dietary 
interventions. Furthermore, such analyses require careful attention to sample 
preparation such as amount of RNA template required and handling of RNA 
samples to avoid genomic DNA contamination. In addition, where possible the 
MIQE guidelines for the design of primers and execution of my qPCR 
experiments were followed (Bustin et al, 2009).   
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7.3  Suggestions of future work 
The non-significant relationship observed between red cell folate concentration 
and ESR1, SLC39A4 and OBFC2A methylation and expression of the 
corresponding gene in human colon could due to the fact that all volunteers 
have sufficient long term folate intake. Recruitment of volunteers in future 
study with both adequate and inadequate folate intake would allow for analysis 
of effect in samples with a greater range of folate status. The relatively big 
variation between samples and small sample size in human colon available 
from the BORICC study may also contribute to the lack of effect seen in 
human.  
A remarkable likeness on the DNA methylation patterns between fetal and the 
two adult gut tissues (colon and prox SI) in mouse was observed in the gene 
panel investigated in this project. Furthermore, differential DNA methylation of 
some of the genes investigated here were observed between blood, liver and 
kidney in post-partum dams from the same study. Further study on additional 
mouse tissue in adult offspring could provide extra information on tissue 
specific DNA methylation patterns. Furthermore, maternal folate depletion 
combined with high fat intake after lactation cause DNA damage and affect 
DNA repair capacity in mouse brain from the same study (Langie et al, 2014), 
whether the same effect can be seen in mouse gut remained to be elucidated. 
Given the recent interest in bisulfite sequencing at single base resolution 
(Barua et al, 2014), genome wide scanning of DNA methylation profile of 
tissues from different treatment groups combined with microarray expression 
data can identify additional genes that have differential changes in DNA 
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methylation and corresponding gene expression in response to altered 
nutrition. 
Modifications of epigenetic marks including DNA methylation, post-
translational modifications of histones and micro-RNA has been suggested as 
one of the contributors to metabolic disorders (Seki et al, 2012). It would be 
interesting to examine whether the association between body weight and 
gene-specific methylation observed in prox SI and colon in adult mouse 
offspring would relate to other phenotypic variables such as percentage of 
body fat in mouse from the same study. Studies on other epigenetic 
mechanism, such as microRNAs (one of the non-coding RNA that has been 
shown to be involved in gene regulation) has attracted significant amount of 
interest in the study of environmental exposures on disease susceptibility in 
later life (reviewed in Jung & Suh, 2012; Grillari and Grillari-Voglauer et al, 
2010; Jirtle & Skinner, 2007). Therefore, it could be an appealing candidate to 
investigate the relationship between folate status, age, DNA methylation and 
miRNA expression in the human colon.  
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